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Upon fusion of the viral envelope with the host cell membrane, the capsid of the human 
immunodeficiency virus 1 (HIV-1) is released into the host cell cytoplasm. To productively infect a 
cell, the viral RNA genome needs to be reverse transcribed into viral DNA. This in turn needs to 
become integrated into the host cell genome. Integration can, however, only happen, after the viral 
genome is released from its capsid-container, in a process called uncoating.  
This is a vital process and needs to be regulated and orchestrated in certain ways – which are still 
elusive and controversially discussed. 
Some studies suggest that uncoating takes place soon after -, or concomitant with viral entry. Other 
researchers came to the result that the capsid needs to retain its structure to shield the viral 
components from being sensed by the innate cellular immune system. Both hypotheses, early 
uncoating and prolonged structural retention, are solidly supported by experimental data. Therefore, 
the timing and kinetics of uncoating remain unresolved. Based on previous results from our group, 
we had reason to believe that the capsid might indeed be retained, possibly even within the nucleus. 
A method was developed, that allows the detection of viral DNA. The presence of viral DNA was 
used as a criterion to discriminate between productive and nonproductive subviral particles in 
infected cells. Surprisingly, productive subviral particles displayed an intense, stable signal for 
capsid protein in immunofluorescence experiments, throughout the cytoplasm and even within the 
nuclei of infected cells. A strong signal is can be understood as a high concentration of labeled 
protein, which in turn might indicate the presence of a retained structure. However, intense 
immunofluorescence signals can also mean more efficient binding of antibodies due to structural 
rearrangements (such as uncoating), and a high spatial concentration of proteins cannot be directly 
interpreted as structure retention. 
In this study, we present a unique way to address and solve this important question. We specifically 
focused on the small fraction of productive particles. Light Microscopy allows specific labeling but 
has low resolution. Electron Microscopy yields much higher resolution, but specific 
(immuno)labeling is difficult and often detrimental to ultrastructural retention. We overcame both 
limitations by correlative light – and electron microscopy: Regions of interest were identified by 
specific nuclear subviral particle surrogate markers in light microscopy. On these regions, tilt series 
electron tomography was performed, to visualize the subviral particles’ structure, as well as the 
subcellular environment, around the region of interest. 
Performing high resolution tilt series electron tomography, we could repeatedly and convincingly 
visualize a capsid-reminiscent structure that underlies HIV-1 nuclear preintegration complexes. This 
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apparent structure is very similar in shape, but smaller in size compared to capsids of virus particles 
of mostly identical preparations. 
The discovery of a retained capsid structure in the nucleus of an infected cell will advance on our 
understanding of nuclear entry and provides whole new insights into the overall understanding of 




Während der Fusion zwischen der viralen und zellulären Membran der Wirtszelle wird das Kapsid 
des humanen Immundefizienzvirus 1 (HIV-1) in das Zytoplasma der Wirtszelle entlassen. Um eine 
Zelle produktiv zu infizieren muss das viral RNA Genom in virale DNA revers transkribiert werden. 
Die virale DNA wiederum muss in das zelluläre Wirtsgenom integriert werden. Die Integration 
kann jedoch erst stattfinden, nachdem das virale Genom aus seinem Kapsid-Container entlassen 
wird, in einem Prozess namens Freisetzung. 
 
Dies ist ein unverzichtbarer Prozess und muss auf bestimmte Art und Weise – die noch nicht 
verstanden oder kontrovers diskutiert wird - reguliert und gesteuert werden. 
 
Einige Studien legen nahe, dass das Freisetzen schnell nach -, oder gleichzeitig mit dem viralen 
Eintreten stattfindet. Andere Forscher kamen zu der Schlussfolgerung, dass das Kapsid in seiner 
Struktur erhalten bleiben muss um virale Komponenten vor der Erkennung durch zelluläre 
Immunsensoren zu schützen. Beide Hypothesen, baldiges Freisetzen und längere Erhaltung der 
Kapsid Struktur, werden durch fundierte experimentelle Daten gestützt. Der Zeitpunkt und die 
Kinetik der Freisetzung bleiben daher bisweilen ungeklärt. 
Auf vorangehenden Ergebnissen aus unserer Arbeitsgruppe basierend hatten wir Grund zur 
Annahme, dass das Kapsid tatsächlich in seiner Struktur erhalten bleiben könnte, womöglich selbst 
im Zellkern. 
Eine Methode wurde entwickelt, die es ermöglicht, virale DNA zu detektieren. Das Vorliegen 
viraler DNA wurde als Kriterium herangezogen um in infizierten Zellen zwischen produktiven und 
nichtproduktiven subviralen Partikeln zu unterscheiden. Unerwarteterweise wiesen produktive 
subvirale Partikel in Immunfluoreszenzexperimenten ein stabil intensives Kapsid Protein-Signal 
auf, nicht nur im Zytoplasma, sondern selbst im Zellkern infizierter Zellen. Ein intensives Signal 
kann als eine hohe Konzentration gefärbter Proteine verstanden werden, was wiederum auf das 
Vorliegen einer intakten Struktur verweisen könnte. Jedoch kann ein intensives Signal auch 
aufgrund ausgeprägterer Bindung von Antikörpern verstanden werden, bedingt durch strukturelle 
Umwandlungen (zum Beispiel: Freisetzung). Eine hohe lokale Konzentration von Proteinen kann 
also nicht direkt als der Erhalt einer Struktur interpretiert werden. 
 
In dieser Arbeit präsentieren wir eine einzigartige Methode um diese wichtige Frage zu 
beantworten. Wir haben uns dabei speziell auf den kleinen Anteil produktiver Partikel fokussiert. 
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Lichtmikroskopie ermöglicht spezifische Färbungen, erlaubt jedoch nur eine geringe Auflösung. 
Die Elektronenmikroskopie erreicht eine sehr viel höhere Auflösung, wohingegen spezifische 
(Immun)Färbungen kompliziert sind und oft den Erhalt der Ultrastruktur negativ beeinflussen. Wir 
konnten beide Beschränkungen überwinden durch das Anwenden von korrelativer Licht- und 
Elektronenmikroskopie: Relevante Positionen wurden anhand eines indirekten spezifischen Markers 
mittels Lichtmikroskopie identifiziert. An diesen Positionen wurden Kippserien- 
Elektronentomogramme aufgenommen, um die Struktur des subviralen Partikels, sowie auch die 
subzelluläre Umgebung an dieser Position zu visualisieren. 
 
Mittels hochauflösender Kippserien-Elektronentomographie konnten wir wiederholt und 
überzeugend Kapsid-ähnliche Strukturen visualisieren, die dem nukleären HIV-1 
Präintegrationskomplex inne sind. Diese apparente Struktur hat in Bezug auf ihre Form große 
Ähnlichkeit mit den Kapsiden intakter Viruspartikel, unterscheidet sich jedoch markant in Bezug 
auf die Größe der Strukturen, obgleich die verglichenen Proben beinahe identisch angefertigt 
wurden. 
 
Die Entdeckung einer erhaltenen Kapsidstruktur im Nucleus infizierter Zellen wird unser 
Verständnis für den viralen Eintritt in den Nucleus erweitern und erlaubt neue Einsichten in das 
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1.1 HIV-1 Discovery 
Before the actual virus, its caused disease, the acquired immunodeficiency syndrome (AIDS) was 
described in 1981 (Gottlieb et al., 1981). Immunocompromised patients were found to show 
drastically reduced counts of CD4+ T lymphocytes, being the reason for the suffering of 
opportunistic infections (such as pneumonia and bronchial candidiasis) in AIDS. Moreover, these 
patients were often suffering from Kaposi’s sarcomas. The causative agent, human 
immunodeficiency virus 1, was described only 2 years later, in 1983 (Barre-Sinoussi et al., 1983). 
Considering the at that time available methods and techniques, such a fast isolation and description 
can be considered an immense achievement. Furthermore, the route of transmission, horizontal 
human-to-human during sex, venous application of drugs with contaminated syringes and infected 
blood transfusions, was described. 
HIV-1 is a bona fide example of a human epidemic originating from a zoonotic transmission: HIV-
1, the major virus in the ongoing HIV/AIDS epidemics, is strongly suggested to have been 
introduced into humans by zoonotic transmission of a simian immunodeficiency virus from 
chimpanzees of the subspecies Pan troglodytes troglodytes (SIVcpzPtt) (Gao et al., 1999; Jin et al., 
1994; Keele, 2006; Sharp and Hahn, 2011).  
HIV-1 is subdivided into 4 groups, M (major, responsible for the ongoing epidemics), N (non-M, 
non-O) (Simon et al., 1998), O (Outlier, largely restricted to equatorial western Africa) (De Leys et 
al., 1990; Gürtler et al., 1994; Peeters et al., 1997),summarized in (Gao et al., 1999)) and P 
(putative) (Plantier et al., 2009). Each of these groups is assumed to have originated in independent 
zoonotic transmission events (chimpanzees to humans). Phylogenetic modeling dates the estimated 
introduction for the M group back to the early 20th century, ~1910-1930 (Korber et al., 2000; Lemey 
et al., 2004; Worobey et al., 2008). 
HIV-2 (a related lentivirus) is assumed to have been introduced into humans from sooty mangabeys 
(species Cercocebus atys) (Sharp and Hahn, 2011).  
In general, HIV-2 infected patients have better outcome chances, in comparison to HIV-1 patients, 
due to lower viral loads, accompanied with a reduced risk of virus transmission. Therefore, HIV-2 is 
considered less pathogenic, and so far remains largely restricted to western Africa (Ekouevi et al., 






In 2017, 36.9 million people were estimated to live with an HIV infection. ~940,000 people 
succumbed to the virus (and its accompanied syndrome) while 1.8 million people got newly 
infected. A combination of 3 (or more) antiretroviral drugs (ARV) can efficiently suppress viral 
replication and thereby prevent the AIDS syndrome and considerably lower the risk of virus 
transmission. The combinatorial approach helps to restrict virus evolution to multi drug-resistant 
variants. It is estimated that a total of 70 million people got infected in the HIV/AIDS epidemic, of 
which ~35 million have died due to HIV related sickness (http://www.who.int/gho/hiv/en/). 
The number of global new infections is steadily declining, thanks to efforts in education, 
antiretroviral therapy and research. Yet, the number of people living with an HIV-1 infection is still 
increasing annually. We therefore clearly need to understand the virus’ biology in even more detail. 
Education and antiretroviral therapy can be efficient to reduce human-to-human transmission. But 
without vaccines and cures available, it will hardly be possible to effectively reduce the number of 
patients and eventually eradicate HIV. 
 
1.2 HIV-1 Classification and Morphology 
HIV-1 is the sole member of the Human immunodeficiency virus 1, a lentivirus belonging to the 
Retroviridae. Morphologically, HIV-1 is an enveloped virus particle, measuring ~140 nm in 
diameter (Briggs, 2003). As for all retroviruses, its genome is organized in 4 main coding domains: 
gag-pro-pol (3 coding domains transcribed into 1 mRNA transcript, group-specific antigen, 
protease, polymerase), and env (envelope) (Petropoulos, 1997). Different from simple retroviruses, 
the complex HIV additionally encodes accessory proteins, discussed later. 
Mainly, the Gag polyprotein is expressed from the gag-pro-pol coding domain. Gag-Pro-Pol can 
only be translated upon ribosomal frame shifting. In 5 % of the translations, the ribosome slips into 
the -1 reading frame. This happens at a slippery site in the p6-coding region (3’ end of gag) of the 
gag-pro-pol mRNA. Once shifted into the -1 reading frame, the full Gag-Pro-Pol polyprotein is 
expressed (Hung et al., 1998; Jacks et al., 1988). The polyprotein Gag comprises the structural 
proteins (amino- to carboxyterminus) Matrix (MA), Capsid (CA), Spacer Peptide 1 (SP1), 
Nucleocapsid (NC), Spacer peptide 2 (SP2) and p6. 
The 2 carboxyterminal domains of the Gag-Pro-Pol polyprotein, consist of the protease (PR, 
encoded by pro), the RNA-dependent DNA polymerase also called reverse transcriptase (RT, 
encoded by pol) and the Integrase (IN, encoded by pol). In HIV-1 research, Pro-Pol is mostly 




Gag and Gag-Pro-Pol are translated as polyproteins and are proteolytically cleaved during the 
maturation step. During virus particle assembly at the plasma membrane, MA anchors Gag into the 
inner plasma membrane leaflet via its myristyl anchor (Bryant and Ratner, 1990; Kiernan et al., 
1999; Paillart and Göttlinger, 1999). CA harbors the main Gag-multimerization domain and after 
maturation forms the cone-shaped capsid. Inside the capsid, NC, together with the 2 viral single 
stranded positive-sensed RNA copies, form the ribonucleoprotein particle. PR heterodimerizes, 
cleaves itself proteolytically first, and then the other polyproteins in an orchestrated fashion. 
Thereby, immature virus particles transform into mature, infectious virus particles. RT reverse 
transcribes the viral genomic RNA into viral (ds)DNA. Once completed, the viral DNA can be 
integrated into the host cell genome by IN. 
The third coding domain env comprises the envelope glycoproteins gp120 and gp41. 7-14 Trimers 
of the gp41/gp120 heterodimer are inserted into the plasma membrane-derived envelope (Chertova 
et al., 2002; Zhu et al., 2003), defining the tropism and mediating entry into target cells. 
Furthermore, a set of viral accessory proteins is encoded: viral protein R (Vpr), viral protein U 
(Vpu), regulator of virion (Rev), negative factor (Nef), viral infectivity factor (Vif) and 
transactivator of transcription (Tat) (Coffin et al., 1997). The detailed genomic organization is 
represented in Figure 1 (Campbell and Hope, 2015; Freed, 2015; Sundquist and Kräusslich, 2012). 
Ultrastructurally, HIV-1 particles can be observed in 2 different morphologies: Virus particles are 
released as immature particles from the producing host cell (panels C and E, Figure 1) (Fuller et al., 
1997; Wilk et al., 2001). ~ 2500 Gag and Gag-Pro-Pol polyproteins form an electron dense layer 
attached to the membrane, ~140 nm in diameter (Briggs, 2003; Briggs et al., 2006). After 
maturation and proteolytic cleavage of the polyproteins into single, functional proteins, a major 
rearrangement takes place and the capsid is formed (panel D and F, Figure 1). The capsid consists of 
~200-250 CA hexamers and 12 CA pentamers (Perilla and Schulten, 2017), meaning, only ~50 of 
the total CA make up the capsid. The mature capsid measures 120 nm in length and 60 nm in width, 






Figure 1: Schematic Genome Organization and Structural Organization of HIV-1 
(A) schematically represents the genome organization of HIV-1. The coding regions are flanked by 2 long 
terminal repeats (LTR). Besides the 4 main reading frames, gag-pro-pol (pro-pol is abbreviated as pol) and 
env, a set of accessory proteins is encoded (Vif, Vpr, Vpu, Tat, Rev and Nef). The GagPol polyprotein (B) is 
only expressed upon ribosomal frameshifting during translation, happening in ~ 5% of all translations. (B) 
The single proteins encoded by Gag-Pro-Pol are Matrix (MA), Capsid (CA), Nucleocapsid (NC), Protease 
(PR), Reverse transcriptase (RNA-dependent DNA polymerase, RT) and Integrase (IN). Spacer peptides 1 
and 2 (SP1 and SP2) and p6 are graphically not represented. SP1 resides between CA and NC. Downstream 
of NC, SP2 and p6 are found. 
Gag and Gag-Pro-Pol assemble at the cytoplasmic side of the plasma membrane, forming viral budding 
sites. Eventually, progeny virus particles pinch off the host cell as immature virus particles (C – schematic, E 
– cryo-electron micrograph). During maturation, PR dimerizes and proteolytically cleaves Gag and 
Gag-Pro-Pol into single proteins. This allows major structural rearrangements, most prominently, the 
formation of the cone-shaped capsid, containing the viral ribonucleoprotein particle, IN and RT. The mature 
capsid is a hallmark of mature virus particles (D – schematic representation, F – cryo-electron micrograph). 
The Envelope glycoprotein (Env) resides at the outer surface of the plasma membrane, coordinating target 
cell binding and virus entry (blue trimers with red stems, panels C-D). Images adjusted from (Felli et al., 




1.3 HIV-1 Replication 
Note: The main goal of this study was to structurally identify preintegration – and reverse 
transcription complexes (PIC and RTC). For the structural identification of nuclear PIC, cleavage 
and polyadenylation specificity factor 6 (CPSF6) was used as the main tool. 
For better overview of their respective functions and interactions, CA and CPSF6 are separately 
discussed later in the introduction (Chapters 1.4 & 1.5). 
1.3.1  Entry 
HIV-1 is transmitted by mucosal contact with infected body fluids (during sexual intercourse or 
child birth), by blood transfusion or by reusing infected needles (e.g. in drug abuse) (Barre-Sinoussi 
et al., 1983). The tropism of HIV is defined by Env, which specifically binds the CD4 receptor and 
one of the coreceptors CXCR4 or CCR5 (Berger, 1997). Fusion of the viral and cellular membranes 
follows a defined sequence of events. Env trimers first bind to CD4. This binding leads to 
pronounced rearrangements in the gp120, a prerequisite for Env to further recognize and engage 
with coreceptors (Lu et al., 1997; McNicholl et al., 1997; Swanstrom and Coffin, 2012; Trkola et 
al., 1996). The coreceptor tropism is determined by the Env variable loop 3 (Huang et al., 2005; Liu 
et al., 2008). Upon binding of Env to its coreceptor, gp41 undergoes structural rearrangements: The 
fusion peptide, a functional region of the gp41 extracellular domain, inserts into the host cell 
membrane (Chan et al., 1997; Weissenhorn et al., 1997). A coiled-coil core, consisting of three 
helices from the aminoterminal gp41 heptad repeat, serves as a scaffold for the further binding of 3 
helices from the carboxyterminal heptad repeat. Together, they form the six helix bundle, driving 
approximation between viral and cellular membrane (Caffrey, 2001; Chan et al., 1997; Weissenhorn 
et al., 1997). Putative further insertions into the host cell membrane by gp41 host membrane-
proximal hydrohpobic residues, are suggested to support membrane fusion by increasing membrane 
curvature (Buzon et al., 2010). Structural changes are induced also in CD4 upon binding, bringing 
the viral envelope into closer proximity with the cellular membrane (Liu et al., 2008). Ultimately, 
the lipid bilayers of the cellular and viral membrane have to mix and fuse, requiring high membrane 
curvature, which is reported to strongly depend on the membranes’ lipid compositions (Brügger et 
al., 2006; König et al., 2008). 
Whether membrane fusion occurs at the plasma membrane (Felts et al., 2010) or after virus particle 
internalization/endocytosis (Daecke et al., 2005; Dale et al., 2011) was under debate for a long time. 
One study suggests fusion pore formation at the plasma membrane, while expansion of this fusion 
pore and viral entry eventually takes place in endosomes (Miyauchi et al., 2009). Meanwhile, it is 





Upon fusion with the plasma membrane, the viral capsid needs to bypass a second physical barrier: 
The cortical actin cytoskeleton supports the plasma membrane in shape and is involved in e.g. cell 
motility (Hartwig and Yin, 1988; Salbreux et al., 2012). The HIV capsid can only fully access the 
cytoplasm, once the cortical actin is cleared (Vorster et al., 2011; Yoder et al., 2008). The subviral 
particle can then enter the cytoplasm unhampered and proceed to the next steps of infection to 
eventually integrate its genome into the host cell genome. Uptake in - and fusion from endosomes 
would bypass the cortical actin directly (reviewed in (Blumenthal et al., 2012; Spear et al., 2012; 
Wilen et al., 2012)). 
1.3.2  Reverse Transcription and Transport to the Nucleus 
The capsid is composed of ~1200-1500 capsid molecules (CA) and contains two copies of the 
positive-sense single stranded RNA genome with the attached integrase enzyme (IN), nucleocapsid 
protein (NC), the reserve transcriptase (RT), Vpr and protease (PR) (see Figure 1, (Ganser et al., 
1999; Mattei et al., 2016)).  
Before viral genome integration into the host cell genome, the viral RNA must be reverse 
transcribed into double stranded DNA. This functionality is provided in the RNA-dependent DNA 
polymerase (reverse transcriptase, RT). Reverse transcription takes place in the cytosol, in so-called 
reverse transcription complexes (RTC), mainly consisting of the ribonucleoproteins, IN and RT. CA 
has also been shown to be part of RTC, whether loosely attached, as cone-shaped shell or in another 
shape remains elusive. 
Reverse Transcription follows a sequence of multiple consecutive, unique steps (Hu and Temin, 
1990). In short, the negative strand synthesis is primed by a virion-packaged tRNA, positive strand 
synthesis starts at the nicked template RNA, and 2 DNA strand transfers take place to synthesize a 






Figure 2: Schematic HIV Reverse Transcription 
The viral RNA (black) needs to be reverse transcribed into dsDNA (red & green) for integration. A tRNA 
(blue) binds the primer binding site (pbs, 1), from where DNA synthesis of the minus strand (green) starts 
(2). While replicating, the RNAseH degrades the RNA template’s 5’ LTR (R-U5). After reaching the templates 
5’ end, the minus strand translocates and binds to the template 3’ LTR (3) from where minus strand synthesis 
continues, while the RNAseH activity creates a single strand break (nick) between the polypurine track (ppt) 
and the U3 region (4). Plus strand (red) synthesis starts at the nick and replicates until the pbs (5). A second 
strand transfer takes place (6) and DNA synthesis continues at both strands to complete them. 
 
For DNA synthesis, the host cells dNTP pool is employed. During reverse transcription, the RTC is 
actively transported to the host cell nucleus. Transport along microtubules, employing kinesins 
(towards plus-end) and dyneins (towards minus-end) has been reported. Furthermore, transport 
along actin microfilaments via myosin motors have been suggested (HIV intracellular trafficking is 
reviewed in (Gaudin et al., 2013)). 
The viral DNA, together with cellular and viral proteins (e.g. IN and CA) forms the PIC. When and 
where exactly viral DNA synthesis is completed, so far remains elusive. At one point, the viral DNA 





1.3.3  Nuclear Entry of HIV-1 and Subnuclear Localization 
In contrast to ions and small molecules, the macromolecular PIC requires active transport to enter 
the nucleus (Kabachinski and Schwartz, 2015; Knockenhauer and Schwartz, 2016; Paine et al., 
1975). Numerous viral factors are known to enable nuclear import in nondividing cells: 
The HIV-1 PIC can interact with - and transit through nuclear pores, which is in contrast to other 
retroviruses, such as moloney murine leukemia virus (MoMLV, genus: Gammaretrovirus). MoMLV 
requires breakdown of the nuclear envelope during mitosis for nuclear entry (Emerman et al., 1994; 
Suzuki and Craigie, 2007).  
Replacing the CA-encoding part of gag by the homologous MoMLV CA-encoding gag region was 
found to be sufficient to render the resulting HIV chimera noninfectious in postmitotic cells, and to 
depend on nuclear envelope breakdown. The chimera was apparently not anymore able to have its 
genome transported into the nucleus (Yamashita and Emerman, 2004). 
Besides the nuclear localization signal in CA, further signals promote the import into the nucleus: 
IN e.g. carries a noncanonical nuclear localization signal (NLS) (Bouyac-Bertoia et al., 2001). And 
a special DNA structure (DNA flap) in the polypurine tract (PPT) region of the viral DNA is also 
reported to strongly promote nuclear entry (Arhel et al., 2007; Sirven et al., 2000; Zennou et al., 
2000). 
 
The RTC has been shown to interact with a multitude of nuclear pore proteins (Nup): Nup153 is to 
date identified as the most important interaction partner (Brass et al., 2008). Knockdown of this 
protein results in strongly reduced HIV-1 subviral nuclear import and infectivity (Di Nunzio, 2013; 
Di Nunzio et al., 2012; Woodward et al., 2009). Nup153 resides at the nucleoplasmic side of the 
nuclear pore complex, where its FG-repeats interact with the incoming HIV-1 subviral particle via 
CA (Matreyek et al., 2013). 
Knockdown of Nup358 (also called RanBP2) has also been shown to strongly impair nuclear entry 
of HIV-1 PIC (Zhang et al., 2010). Nup358, in contrast to Nup153, is located at the cytoplasmic 
side of the NPC and believed to be involved in PIC docking to the NPC (Di Nunzio et al., 2012). 
Furthermore, Nup98 and Nup214 are suspected to also affect nuclear entry (König et al., 2008). 
CPSF6 and TNPO3 as host dependency factors will be discussed separately (chapter 1.5). 
In addition to host dependency factors, there are also numerous host restriction factors. Those are 
often interacting with CA, where numerous resistance mutations can repeatedly be identified in. 
Some of the known cellular restriction factors are Cyclophillin A, MX2, SUN1 and SUN2 




These factors are described to reduce infectivity, while the exact mechanism of restriction remains 
largely elusive. PICs are considered to be displaced from preferred integration sites or to be 
hampered entering the nucleus. This clearly points out that we need to understand nuclear entry in 
more detail. 
 
1.3.4  HIV-1 Integration 
A hallmark of retroviruses is the integration of the viral genome into the host cell genome, where it 
resides either as latent provirus (forming an inactive, dormant reservoir that can be activated years 
later) - or as actively transcribing provirus. The central functionality of integration lies within IN. 
Still in the cytoplasm, IN dimers bind to each of the viral DNA long terminal repeats (LTR, 
(Krishnan et al., 2010)), forming the intasome (vDNA with IN tetramer). Of both viral DNA blunt 
ends at the LTRs, 2 nucleotides are removed from the 3’ end (Hare et al., 2010; Maertens et al., 
2010). The PIC (containing the intasome) is then transported into the nucleus, as described above. 
LEDGF and CPSF6 are currently understood to be the host factors with the most pronounced 
influence on integration site targeting. The current opinion is a 2-step mechanism: CPSF6 is 
supposed to first bind CA directly and to target the PIC to sites of high transcriptional activity 
(Sowd et al., 2016). In the second step, LEDGF, also interacting with CA, further directs the PIC 
towards gene bodies (Debyser et al., 2015; Singh et al., 2015). It has in fact been described 
repeatedly that HIV-1 does not integrate randomly into the host cell genome, but strongly prefers 
gene-rich regions.  
Disruption of CPSF6 and LEDGF is reported to affect the integration site targeting (Lusic and 
Siliciano, 2017). 
At the LTR, IN increases the electron-density of the 3’ hydroxyl group oxygens at the shortened 3’ 
ends and thereby renders them strongly nucleophilic. Those nucleophiles attack the host cell DNA 
and produce 1 nick each, usually in distance of 5 nucleotides. The viral DNA 3’ end is ligated to the 
5’ phosphate of the host cell DNA (Vink et al., 1990). The 5’ ends of the viral DNA first remain 
unligated and are sensed as single strand breaks by the host cell. In a process called “gap-repair”, 
also the 5’ ends of the viral DNA are connected to the host cell DNA. Thereby, the viral DNA is 
eventually fully integrated into the host cell genome, flanked by the duplicated pentanucleotide host 





1.3.5  Viral Gene Expression, Particle Budding, Release and Maturation 
This study aims to identify infectious RTC and PIC capsid structures. Progeny virus particle 
production, starting from viral gene expression, is not involved in the analyzed processes and are 
therefore described more concisely. 
Gag and Gag-Pro-Pol polyproteins are translated and localize to the host cell plasma membrane, 
where they insert into the membrane via the myristoyl group attached to MA. Protein-protein 
interactions, mainly within Gag domains, mediate the formation of spherical particles. Env as a 
glycoprotein requires glycosylation and is therefore translated at rough endoplasmic reticulum 
(rER). During transport to the plasma membrane, Env trimers are cleaved into the gp41 and gp120 
subunits. MA interactions with Env mediate the recruitment of Env trimers to the viral budding site. 
2 copies of the genomic viral RNA are packaged into the nascent virus particle via interaction with 
the RNA packaging sequence. Furthermore, accessory proteins and the lysine-tRNA (necessary for 
reverse transcription priming) are packaged into the virus particle by different means. Gag and Gag-
Pro-Pol multimerization is sufficient for particle formation, yet, the final scission from the plasma 
membrane is mediated by the host cell endosomal sorting complex required for transport (ESCRT) 
machinery. Members of the ESCRT complex are recruited by the Gag-carboxyterminal p6 peptide. 
After ESCRT mediated scission from the membrane, the virus particle is released in its immature 
form (see Figure 1, panels C and E). 
In a process called maturation, the viral protease heterodimerizes and proteolytically cleaves the 
Gag and Gag-Pro-Pol polyproteins step wise into the single proteins (reviewed in (Freed, 2015)) as 
described in Chapter 1.2. Ultrastructurally, the final structural rearrangement can be best observed 
via electron microscopy (see Figure 1, panels D and F), but also superresolution microscopy allows 
to observe virus maturation (Hanne et al., 2016a). Virus assembly, budding and Maturation are 
reviewed in (Sundquist and Kräusslich, 2012). 
 
1.4 HIV-1 CA 
CA has been shown to interact with a multitude of cellular factors, being involved in steps during 
cytoplasmic trafficking, but also in nuclear steps of the viral replication cycle (see upper chapters 
1.3.2, 1.3.3 & 1.3.4, reviewed in (Fassati, 2012)). To affect various steps in the viral life cycle, CA 
first of all needs to be present. However, detection of CA (e.g. by immunofluorescence) does not 
allow to draw conclusions about a potentially associated capsid structure. There might be a structure 
retained. Likewise, CA could rearrange into another structure, or could colocalize at RTC and PIC 




therefore the main goal of this study to identify, whether productive RTC and PIC correlate with an 
apparent (capsid-derived) structure or not. In the following chapter, we want to illuminate why this 
question is debated highly controversial and of huge importance to answer.  
 
An average virus particle contains roughly 2500 CA molecules. ~ 50% assembles into the capsid, 
the other half remains without apparent structure (Ganser et al., 1999; Mattei et al., 2016). The 
distinct structure of the HIV-1 capsid consists of ~ 250 CA hexamers and 12 so-called pentameric 
defects. The latter can be considered the corners of the structure, while hexamer arrays organize into 
honeycomb-like planar structures (see Figure 3). The unique capsid structure is achiever by 
interspersing 5 pentamers (or pentameric defects) into the narrow end and 7 pentamers into the wide 
end. This particular arrangement called fullerene architecture, due to its high similarity to elemental 




Figure 3: Fullerene HIV-1 Capsid Model 
This model displays the fullerene-like arrangement of CA hexamers into the unique cone-shaped capsid. 
Pentameric defects, or CA pentamers, are shown as filled gray patches. 5 pentamers are located in the 
narrow end (better recognizable in the bottom view, left), 7 pentamers are located in the wide end of the 
structure. The majority of the capsid structure is made up of ~ 250 CA hexamers. Figure adjusted from 





The capsid contains the viral RNA genome, IN, Vpr and NC (Bukrinsky et al., 1993; Miller et al., 
1997). During entry, the capsid is released into the cytoplasm and at one point must undergo a 
process called “uncoating”. This process is necessary to release the viral DNA and IN from the 
capsid-enclosure, allowing them to access the host DNA for integration. Timing and kinetics of this 
process are still elusive.  
The dimensions of an average capsid structure are 120 nm in length and 60 nm in width. The 
nuclear pore complex, however, has a central pore opening of merely ~ 40 nm nm (Bui et al., 2013). 
This means that the HIV-1 capsid is simply too big to enter the nucleus as such (Matreyek and 
Engelman, 2013; Whittaker, 2003). 
If uncoating takes place before nuclear entry, it happens at some point after fusion, during 
(cytoplasmic) reverse transcription or at the nuclear envelope. 
Biochemical assays were developed to elucidate the uncoating behavior of capsid, called “fate of 
capsid” assays. Permissive cells were infected and lysed after different time points. CA was then 
immunoprecipitated. In ultracentrifugation, particulate CA (arranged in capsids) would sediment 
much faster than soluble CA (Yang et al., 2014). In the afore-mentioned publication the majority of 
CA was found soluble quickly after infection and therefore suggests uncoating taking place soon 
after entry (Karageorgos et al., 1993), reviewed in (Arhel, 2010)). Also, reverse transcription has 
been reported to promote uncoating  (Hulme et al., 2011; McDonald et al., 2002; Rankovic et al., 
2017). The involvement of reverse transcription in uncoating is supported by calculations, saying 
that the viral DNA is too big and inflexible to fit into the capsid shell. This in turn is supported by 
fluorescence microscopy imaging of dual-labeled HIV particles: One fluorophore labels IN and a 
second fluorophore is used as marker for fluid capsid content, mixing with the cytoplasm upon 
(partial) capsid disassembly / uncoating. IN.eGFP positive viral particles where shown to lose the 
fluorescent fluid phase marker early after entry, which was interpreted as uncoating or loss of capsid 
integrity (e.g. (Francis et al., 2016)). Lastly, the HIV-1 capsid requires an optimal stability for 
infection: Both, hyper- and hypostabilization by introducing CA mutations, reduce the infectivity 
(Forshey et al., 2002). So far, it was only possible to visualize intracellular capsids upon 
introduction of hyperstabilizing CA mutations (Jun et al., 2011). If the capsid was retained in shape 
for prolonged periods of time, it should have been possible to also visualize metastable wildtype 
capsids. 
Uncoating taking place in the cytoplasm poses the risk of HIV detection by cellular immune sensors 




Maelfait et al., 2014). In this regard, uncoating happening directly at the nuclear envelope would 
seem the ideal location for uncoating. 
However, recent studies repeatedly detected CA in the nuclei of infected cells, arguing for at least a 
partial amount of CA to stay attached with the subviral particle (Francis et al., 2016; Hulme et al., 
2015; Peng et al., 2014). It is worth mentioning that only a minor fraction of the HIV particles 
productively contribute to infection and progeny virus production (Marozsan et al., 2004; Vogt, 
1997). Yet, this is also controversially discussed (Thomas et al., 2007). This means that bulk assays, 
such as the fate of capsid-assay cannot be extrapolated to the single infectious subviral particle. 
Also, when single particles are analyzed, it is necessary to regard the ones, which contribute to 
infection. These prerequisites are given in a study from our lab: the CA fluorescence intensities of 
viral particles was highly comparable to viral DNA-positive nuclear PIC, arguing for high CA 
amounts retained throughout the cytoplasmic stages and nuclear entry. As mentioned before, merely 
detecting CA cannot be extrapolated necessarily detecting an associated capsid structure, yet, it 
poses the possibility. 
 
1.5  Cleavage and Polyadenylation Specificity Factor 6 - CPSF6 
CPSF6 was first thought to be a cellular restriction factor for HIV-1: The expression of a truncated 
murine CPSF6, mCPSF6-358, has been shown to reduce viral infectivity (Lee et al., 2010). 
Truncated versions of CPSF6 can interact with CA but lack their serine-arginine-rich domain (SR-
domain). This domain is necessary for CPSF6 to interact with the importin ß-like karyopherin 
TNPO3. TNPO3 is reported to mediate the nuclear import of SR proteins, such as the full-length 
CPSF6 (Brass et al., 2008; De Iaco et al., 2013; Gallay et al., 1997; Valle-Casuso et al., 2012). 
Truncated versions of CPSF6 (murine mCPSF6-358 or human hCPSF-375, (Hori et al., 2013; Lee 
et al., 2010)) are therefore not located to the nucleus, but primarily to the cytoplasm. The same 
holds true for full-length CPSF6 when its nuclear import-mediator TNPO3 is knocked out. Under 
native conditions, when CPSF6 is mainly located to the nucleus, it has been found to have key 
functions as a host dependency factor for HIV-1. CPSF6 has been shown to increase HIV-1 
infectivity by supporting nuclear import of viral DNA (reviewed in (Lusic and Siliciano, 2017)). 
Interestingly, it was found that CPSF6 shares its CA-interaction site with Nup153 (CA K70 and 
S102, as has been shown before ((Price et al., 2014), see Figure 4). This means that premature 
interaction of CPSF6 and CA in the cytoplasm, due to altered subcellular CPSF6 localization, 




calorimetry experiments with Nup1531407-1423 and CPSF6313-327 showed only marginal differences 
between Nup153 and CPSF6 binding affinities to CA hexamers (Price et al., 2014). 
 
Figure 4: Binding Sites of CPSF6 and Nup153 at Hexameric CA 
This figure illustrates the interaction of CPSF6313-327 (yellow, A and C) and Nup1531407-1423 (pink, B and D) 
with hexameric CA. Panels A and B show in gray the molecular surface of hexameric CA. The interaction 
footprint is shown in red (A) and yellow (B). Panel C and D show CPSF6313-327 (C) and Nup1531407-1423 (D) 
peptides bound to hexameric CA, one monomer shown in gray, and a second one shown in cyan. CA key 
residues are highlighted in panels A and B, CPSF6 and Nup153 residues in panels C and D. Figure adjusted 






Experimental data from our lab led to a working model hypothesis: After the incoming subviral 
particle engages with Nup358 at the cytoplasmic site of the NPC, it starts to translocate into the 
nucleus. Nup153, closer to the nucleoplasmic side, interacts with CA and thereby might promote its 
import. Within the nucleus, the CA-Nup153 interaction is competed off by CPSF6. Thereby, the 
Nup153 is free again to interact with other CA molecules, located closer to the cytoplasm. The 
cycle of CA interacting first with Nup153, then with CPSF6, might lead to a pulling force, into the 
nucleoplasm (manuscript in preparation, David Bejarano, Dr. Ke Peng).  
 
Most importantly for this study, a published microscopy study from our lab (Peng et al., 2014), 
clearly showed a strong colocalization of nuclear PIC with CPSF6 cluster fluorescence signals.  
Here, we employed CPSF6 as a surrogate marker to identify nuclear PIC, by expressing it as a 
fluorescence protein fusion (rCPSF6wtAA.mCherry). 
 
1.6 Technical Implementation: Correlative Light and Electron Microscopy 
(CLEM) 
Light Microscopy was already invented in 1676 by Antoni van Leeuwenhoek (Khattab, 1995). He 
was the first person to build a microscope that would allow visualizing bacteria, a breakthrough in 
sciences. Ever since, this method was continuously advanced, in particular by 2 important 
inventions / discoveries: 
Immunohistochemistry 
In 1940, Albert Coons, was the first to develop the immunohistochemistry methodology 
(immunofluorescence labeling) (Coons et al., 1941). The possibility to specifically label antigens of 
interest and define localization and colocalization with other proteins and factors is invaluable. The 
restriction of this technique being limited to still images of fixed cells was then overcome by the 
second huge improvement: 
 
Isolation and Implementation of Fluorescence Proteins 
In 77 A.D. already, Pliny the Elder (Gaius Plinius Secundus) observed marine glowing animals. 
Two of his observations were the purple jellyfish (Pelagia noctiluca) and an edible clam, making 
his mouth glow (Phalos dactylus) (Pieribone and Gruber, 2005). Almost 2 millennia later, the Green 
Fluorescent Protein (GFP) was isolated from Aequora victoria jellyfish (Shimomura et al., 1962). 
Another 30 years later, the GFP coding sequence was solved (Prasher et al., 1992), and 2 more 




(Osamu Shimomura, Martin Chalfie and Roger Tsien were awarded with the Nobel Prize in 
Chemistry for the discovery and development of GFP in 2008). Henceforth, it was possible to 
follow fluorescent fusion proteins over time in living organisms. Further fluorescence proteins were 
identified and developed, today offering a huge variety of more - or less stable, faster - and slower 
maturing and more – or less bleaching-resistant proteins (Day and Davidson, 2009; Miyawaki, 
2011). Besides fluorescence protein fusions, a variety of other labeling methods has been developed 
and implemented for molecular research, e.g. also allowing to label lipids (e.g. TF-Chol, reviewed 
in (Klymchenko and Kreder, 2014), labeling techniques reviewed in (Hanne et al., 2016b; Sakin et 
al., 2016)). However, light microscopy also has its limitations: Ernst Abbe defined the resolution 
limit of lense-based systems with respect to the light’s wavelength, suggesting the highest possible 
resolution to roughly equal half of the wavelength (Abbe, 1873). In other words, when working 
with visible light, the maximum resolution amounts to ~200-300 nm. Our structure of interest, the 
HIV capsid, measures merely 120 by 60 nm. Even though superresolution microscopy techniques, 
such as PALM/STORM and STED (Sahl et al., 2017; Sydor et al., 2015; Vicidomini et al., 2018) 
allow higher-resolution imaging, it would not be sufficient to undoubtedly answer the question 
about the putative shape underlying productive HIV-1 RTC and PIC. Additionally, fluorescent 
labeling allows to specifically label and image distinct structures / proteins, whereas the cellular 
environment remains mostly unknown, appearing simply dark (unlabeled). 
Electron microscopy on the other hand allows to image at much higher resolution and without 
specific labeling. Therefore, it would not only allow to image putative RTC and PIC structures of, 
but also to visualize the complexes’ subcellular environment. 
The first electron microscope (the “Übermikroskop”) was developed by Ernst Ruska and Max Knoll 
in March 1931 (Knoll and Ruska, 1932). Since an electron’s wavelength is much shorter than a 
photon’s, the achievable resolution is much higher (Abbe, 1873) in comparison to light microscopy 
(Ernst Ruska, Gerd Binning and Heinrich Rohrer were awarded with the Nobel Prize for Physics in 
1986). In 1939, tobacco mosaic virus particles were imaged, the very first time, the elusive term 
“virus [particle]” could be linked to a visual representation (Kruger et al., 2000). Like in light 
microscopy, fascinating developments have been achieved, allowing researchers today to solve 
structures at few Å resolution (e.g. (Schur et al., 2016)). 
 
In contrast to light microscopy, electron microscopy cannot be applied on living specimen. Specific 
labeling (using e.g. colloidal gold-coupled antibodies) can generally be performed. However, 
retaining the accessibility and antigenicity of antigens for detection by immunolabeling usually 




Both, light - and electron microscopy, offer powerful advantages but also have strong drawbacks. 
Correlative Light and Electron Microscopy (CLEM) combines the advantages of both techniques: 
Light microscopy allows to specifically label and image the event or structure of interest (in this 
study: RTC and PIC), while electron microscopy at the very same position yields high resolution 
images of the region of interest (ROI), including the surrounding environment. Fulfilling the 
requirements of both imaging methods, can be highly demanding, technically. However, the gained 
information is extremely valuable. The method and protocol of choice depend on a multitude of 
factors (e.g. nature of samples (cell layers or full organisms), expected size of observed structures, 
possibilities of fluorescent labeling, required correlation precision, etc), therefore, it is not 
surprising that the variety of applied protocols is overwhelming (e.g. On-section CLEM: (Kukulski 
et al., 2011), Live-cell imaging CLEM (Jun et al., 2011; Rijnsoever et al., 2008), reviewed in (de 
Boer et al., 2015; Bykov et al., 2016; Koistinen et al., 2016)). Identifying and adjusting a fitting 
method can be laborious, but, once it works, can yield unforeseen results - as presented in this 
study. 
 
1.7  Aim and Relevance of This Study 
The structure underlying the HIV-1 RTC and PIC is of immense interest. Whether fast uncoating 
occurs, or whether the HIV-1 capsid is retained in its shape for a prolonged time, is important to 
answer in order to provide more detailed insights into the HIV-1 biology, and maybe even to lay the 
foundation for rationally designed inhibitors: Is a capsid structure retained in RTC and PIC? If yes, 
is the retention of that structure important? Can the capsid be targeted for destabilization and can 
that way infection be reduced? Or, in the case of fast uncoating, should we aim stabilizing the 
structure to prevent infection? 
 
Since these questions could not be answered to date, the final goal of this study was to shed light 
(and electrons) onto the presence or absence of a capsid structure in RTC and PIC.  
Here, we present how we assessed the possibility to specifically identify cytoplasmic RTC and 
nuclear PIC complexes. While the technical problems did not allow to gain structural information 
on RTC, we developed and applied a protocol for high precision on-section correlation of light - and 
electron micrographs which allowed us to visualize the structure of the elusive HIV-1 nuclear PIC. 
We were able to repeatedly image nuclear PIC structures. These structures visually appear 
reminiscent of viral capsids. While fitting in shape, we observed considerable differences between 




1.8 Term Definitions 
Scientific exchange can only be effective when terms and definitions are clarified and used 
correctly. Minor differences in the interpretation of key terms can lead to misunderstandings and 
complicate scientific progress. To best convey the content of this, it is therefore my ambition to 
clearly state study-relevant definitions and to apply nomenclature correctly. 
1.8.1  Virus, Virus Particle, Virion and Subviral Particle 
The term virus has two distinct meanings, the italic written virus species (i.e. Human 
immunodeficiency virus 1) and the actual virus name (i.e. human immunodeficiency virus 1). 
Virus in the sense of a species definition is nothing tangible, but a human understandable definition, 
allowing to assign an observed entity to phylogenetic classes (Human immunodeficiency virus 1 
belongs to the genus Lentivirus). The actual human immunodeficiency virus 1 (abbreviated as HIV-
1) is the sole member of the species Human immunodeficiency virus 1 (species names are not 
abbreviated). Such as humans being members of the species Homo sapiens sapiens. 
The actual organism is referred to as virus particle. Virus particles can be isolated, injected and 
subjected to e.g. electron microscopy. A virus particle is the ultrastructural or functional 
representation of a virus. (Kuhn and Jahrling, 2010) It has been further suggested to name the 
productively infectious subpopulation of virus particles “virions”, which has so far not been 
officially implemented (Kuhn et al., 2013). 
“Subviral particle” is defined as an incomplete virus particle. An enveloped virus particle that has 
fused with the plasma membrane at that moment separates into the fused membrane and the virus 
particle content, e.g. the core. The core, lacking its envelope to ultrastructurally represent the full 
virus particle, therefore represents a subviral particle. 
1.8.2  Capsid Protein, Capsid and Core 
Retrovirologists agreed on a definite nomenclature for retroviruses, coding domains and encoded 
(poly)proteins (Petropoulos, 1997). The relevant nomenclature is summarized here: 
While “The capsid” defines the conically shaped, roughly 120 x 60 nm big structure observed in 
virus particles, “capsid” (without article) is defined as the capsid protein, also written as CA. 
Therefore, CA monomers make up the Capsid. “The core” is used interchangeably with “the 
capsid”. “Factor X interacts with CA” has therefore a very different meaning from “Factor X 
interacts with (the) capsid”. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and Consumables 
 
Chemical / Consumable   Supplier                                                                                                 
0.45 µm sterile filter (Cat# KH55.1)  Carl Roth, Karlsruhe, Germany 
6x agarose gel loading dye   New England Biolabs, Ipswitch, MA, USA 
Acetone, dry (Cat# 481007.1611)  AppliChem, Darmstadt, Germany 
Acrylamide 4K, 29:1 solution  AppliChem, Darmstadt, Germany 
Agarose     Carl Roth, Karslruhe, Germany  
Albumin Fraction V    Sigma-Aldrich, Steinheim, Germany 
Ampicillin     Carl Roth, Karlsruhe, Germany 
APS      Carl Roth, Karlsruhe, Germany 
Bromophenolblue    Chroma, Fürstenfeldbruck, Germany 
BSA Fraction V (Cat# A2153)  Sigma-Aldrich, Steinheim, Germany 
CaCl2      Merck (Sigma-Aldrich), Darmstadt, Germany 
Cell Culture Material 
o 8 chamber microscopy slide  Nunc, Rochester, NY, USA 
o 6 well plate (Cell Star, Cat# 657160) Greiner bio-one, Frickenhausen, Germany 
o 10 cm dish (Cell Star, Cat# 664160) Greiner bio-one, Frickenhausen, Germany 
o 15 cm dish (Cell Star, Cat# 639 160) Greiner bio-one, Frickenhausen, Germany 
o T25 (Cell Star, Cat# 690160)  Greiner bio-one, Frickenhausen, Germany 
o T75 (Cell Star, Cat# 658170)  Greiner bio-one, Frickenhausen, Germany 
o T175 (Cell Star, Cat# 660160)  Greiner bio-one, Frickenhausen, Germany 
o Cell Scraper S    Techno Plastic Products, Trasadingen, Switzerland 
Chloroform     VWR, Fontenay-Sous-Bois, France 
Click-It EdU Detection Kit   Molecular Probes, Life Technologies, Eugene, OR, 
      USA 
DMSO     Merck, Darmstadt, Germany 
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Chemical / Consumable   Supplier                                                                              continued            
Dulbecco’s Modified Eagle’s Medium, Gibco/Invitrogen, Karlsruhe, Germany  
 high glucose (4.5 g/l) 
EDTA (Cat# 324503)    Merck, Darmstadt, Germany 
EGTA (Cat# 324626)    Merck, Darmstadt, Germany 
EndoFree Plasmid Maxi Kit   Qiagen, Hilden, Germany 
Epon-812     Electron Microscopy Sciences, Hatfield, PA, USA 
Ethanol     Merck (Sigma-Aldrich), Darmstadt, Germany 
Fetal calf serum    Biochrom, Berlin, Germany   
Filter Paper     VWR, Leuven, Belgium 
Finder Grids     PLANO, Wetzlar, Germany 
Fish skin gelatin (Cat# G7765)  Sigma-Aldrich, Steinheim, Germany 
Gel Red Nucleic Acid Gel Stain  Biotium, Fremont, CA, USA 
Gelatin     AppliChem GmbH, Darmstadt, Germany 
GeneRuler 1kb Plus ladder   Fermentas, Thermo Scientific, Schwerte, Germany 
Glass slides for Pioloform   Diagonal, Münster, Germany 
Glass Vials (Cat# B793)   Agar Scientific, Essex, England 
Glutaraldehyde, 25% solution  Electron Microscopy Sciences, Hatfield, PA, USA 
Glycerol     AppliChem GmbH, Darmstadt, Germany 
Glycine     Fisher Scientific, Loughborough, UK 
HEPES (cell culture grade)   Carl Roth, Karlsruhe, Germany 
Hexadecene (Cat# 8.22064.0500)  Merck, Darmstadt, Germany  
Hoechst 33258    Sigma-Aldrich, Steinheim, Germany 
Isopropanol     Sigma-Aldrich, Steinheim, Germany 
Kanamycin     Carl Roth, Karlsruhe, Germany 
LB Medium Powder    Carl Roth, Karlsruhe, Germany 
Lead Nitrate (Cat# 1.07397.1000)  Merck, Darmstadt, Germany 
LiCor blocking buffer   Licor Biosciences, Lincoln, USA 
Lintfree tissues (Cat# 75512)   Kimberly-Clark, Reigate, UK 
Lowicryl HM20    Polysciences, Warrington, PA, USA 
LR Gold (Cat# 17412)   Polysciences, Warrington, PA, USA 
Methanol     AppliChem, Darmstadt, Germany 
Methylcellulose (Cat# M-6385)  Sigma-Aldrich, Steinheim, Germany 
Methylene Blue (Cat# A514.1)  Carl Roth, Karlsruhe, Germany  
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Chemical / Consumable   Supplier                                                                              continued            
NH4      Carl Roth, Karlsruhe, Germany 
Nucleospin Gel and PCR Cleanup Kit Macherey Nagel, Düren, Germany 
Osmium tetroxide, 4%   Science Services, Munich, Germany 
Paraformaldehyde, 16% solution  Electron Microscopy Sciences, Hatfield, PA, USA 
Penicillin / Streptomycin    Invitrogen, Karlsruhe, Germany 
Pioloform F     PLANO, Wetzlar, Germany  
PIPES (Cat# 9156.3)    Carl Roth, Karlsruhe, Germany  
Protein A-coupled colloidal gold  CMC, Utrecht, Netherlands  
Protein marker (PageRuler Prestained) Thermo Scientific, Schwerte, Germany  
PVDF membrane (Immobilon-P)  Millipore, Billerica, MA, USA 
Razor Blades (Cat# T 5016)   PLANO, Wetzlar, Germany 
Restriction Enzymes    New England Biolabs, Ipswitch, MA, USA 
RPMI-1640     Invitrogen, Karlsruhe, Germany 
Sapphire Discs 50µm (Cat# 405)  Engineering Office Wohlwend, Sennwald, Switzerland 
SDS      AppliChem, Darmstadt, Germany 
Sodium Cacodylate    Serva Electrophoresis, Heidelberg, Germany 
Sodium Citrate    Honeywell Riedel-de Haën, Seelze, Germany 
Sodium Hydroxide Pellets   Merck (Sigma-Aldrich), Darmstadt, Germany 
ß-mercaptoethanol    Sigma-Aldrich, Steinheim, Germany 
Sucrose     AppliChem, Darmstadt, Germany 
TAMRA (Cat# BCFA-008)   baseclick, Neuried, Germany 
TEMED     Biomol, Hamburg, Germany 
Tetrakis(acetonitrile)copper(I)   Sigma-Aldrich, Steinheim, Germany 
Tetrafluoroborate 
TetraSpeck Fiducials (100 nm)  Sigma-Aldrich, Steinheim, Germany 
Tris      Carl Roth, Karlsruhe, Germany 
Triton X-100     Merck, Darmstadt, Germany 
Trypsin     Biochrom, Berlin, Germany   
Tween 20     Carl Roth, Karlsruhe, Germany   
Uranyl Acetate (Cat# 22400)   Electron Microscopy Services, Hatfield, PA, USA 
Western Blot blocking buffer concentrate Li-Cor, Lincoln, NE, USA 
   
MATERIALS AND METHODS 
Page 22 
 
2.1.2 Devices and Instruments 
Device / Instrument    Supplier                                                                                                 
AFS2      Leica Mikrosysteme, Vienna, Austria 
o Binocular S6E    Leica Mikrosysteme, Vienna, Austria  
o Robot EM FSP    Leica Mikrosysteme, Vienna, Austria 
o 16707153 Filling Needles   Leica Mikrosysteme, Vienna, Austria 
o 16707154 Reagent Bath   Leica Mikrosysteme, Vienna, Austria 
o 16707157 Flowthrough Ring  Leica Mikrosysteme, Vienna, Austria 
o 16707158 Reagent Container  Leica Mikrosysteme, Vienna, Austria 
o Syringe, 10 mL Luer Lock  Braun Melsungen, Melsungen, Germany 
Bacteria Incubator (IN75)   Memmert, Schwabach, Germany 
Bacteria Shaker Multitron Pro  Infors, Bottmingen, Switzerland 
Carbon Coater EMACE600   Leica Mikrosysteme, Vienna, Austria 
o Carbon Thread BP2308   Baltic Präparation, Niesgrau, Germany 
Cell Culture Centrifuge (MegaFuge 40R) Heraeus, Hanau, Germany 
CLEM sandwich holder (Cat# A7816) Invitrogen, Karlsruhe, Germany 
o 25 mm round glass (Cat# G31-0171) VWR, Fontenay-Sous-Bois, France 
Cover glasses 12 mm    Menzel Gläser, Thermo Scientific, Schwerte, Germany 
DNA Electrophoresis Mini Sub Cell GT Biorad (Hercules), CA, USA 
Electrophoresis Power Supply - EPS 601 Amersham Pharmacia Biotech, Little Chalfont, UK 
Tecnai F20 TEM    FEI, Eindhoven, The Netherlands 
o 4k Eagle CCD camera (In-column)  FEI, Eindhoven, The Netherlands 
o DT Holder (Model 2040)   Fischione, Export, PA, USA 
Grid Box (Cat# G276N)   PLANO, Wetzlar, Germany 
Heat Plate OTS 40.253   Medite Medizintechnik, Burgdorf, Germany 
High Pressure Freezer HPM010  Abra Fluid, Widnau, Switzerland 
o 0.1/0.2 mm planchettes (Cat# 241)  Engineering Office Wohlwend, Sennwald, Switzerland 
o 0.0/0.3 mm planchettes (Cat# 242)  Engineering Office Wohlwend, Sennwald, Switzerland 
Infrared Scanner (Odyssey)   Li-Cor, Lincoln, NE, USA  
Laboratory centrifuge  Avanti J-26 XP Beckman Coulter, Krefeld, Germany 
Leica TCS SP2 Laser Confocal   Leica Microsystems, Wetzlar, Germany 
Scanning Microscope 
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Device / Instrument    Supplier                                                                              continued            
Microwave (R-28SWT)   Sharp, Köln, Germany 
Nanophotometer NP80 Touch  Implen, Munich, Germany 
Neubauer Counting Chamber  Marienfeld, Lauda-Königshofen, Germany 
Oven (Vacutherm)    Heraeus, Hanau, Germany 
PCR cycler (Flex Cycler²)   Analytik Jena, Jena, Germany  
Perfect Loop     Diatome, Bienne, Switzerland 
pH-Meter (FiveEasy)    Mettler-Toledo, Columbus, OH, USA 
Precision scale (Cat# EW220-3NM)  Kern, Balingen, Germany 
Resin capsules    PLANO, Marburg, Germany 
Rocker (for WB, Duomax 1030)  Heidolph Instruments, Schwabach, Germany 
Rotation wheel mixer (Cat# SB1)  Stuart Scientific, Essex, United Kingdom 
Scale (Cat# 650-2NM)   Kern, Balingen, Germany 
SDS-PAGE System    Biometra, Göttingen, Germany 
Spinning disc microscope   PerkinElmer, Rodgau, Germany 
Sterile working bench    The Baker Company, Sanford, ME, USA 
 Sterile Guard III Advance  
Tabletop centrifuge 5417C   Eppendorf, Hamburg, Germany 
Tabletop Ultracentrifuge TL-100  Beckman Coulter, Krefeld, Germany 
TEM EM10     Zeiss, Oberkochen, Germany 
Ultracentrifuge L8-M    Beckman Coulter, Krefeld, Germany 
o Ultracentrifugation tubes (Cat# 7052) Seton, Petaluma, CA, USA 
Ultramicrotome EM UC6   Leica Mikrosysteme, Vienna, Austria 
o Cryo-Chamber FC6   Leica Mikrosysteme, Vienna, Austria 
o Cryo-Micromanipulators   Leica Mikrosysteme, Vienna, Austria 
o Cryo-Aluminum pins (Cat# 16701950) Leica Mikrosysteme, Vienna, Austria  
o Ultramicrotome cryo-immuno knife Diatome, Bienne, Switzerland 
o Ultramicrotome ultra 35° knife  Diatome, Bienne, Switzerland 
Vortexer Vortex Genie 2   Scientific Industries, Bohemia, NY, USA 
Water bath Julabo UC   Julabo, Seelbach, Germany  
WB semidry blotter (Transblot SD)  Biorad (Hercules), CA, USA 
Wide field microscope Observer.Z1  Zeiss MikroImaging, Göttingen, Germany 
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2.1.3 Media and Buffers 
Buffer / Medium   Contents                                                                                                                                    
2x HBS    280 mM NaCl 
     50 mM HEPES 
     1.5 mM Na2PO4 
     in H2O, pH 7.10 
4x PHEM    20 mM HEPES 
     140 mM PIPES 
     40mM EGTA 
     8mM MgCl2 
     in H2O, pH 6.9 
6x WB sample buffer   10% sucrose 
     0.1% Bromphenol blue 
     5 mM EDTA (pH 8.0)  
     200 mM Tris-HCl (pH 8.8) 
     3.5% SDS 
     0.35% ß-mercaptoethanol 
CaCl2     250 mM CaCl2  
     in H2O 
Caco buffer    50 mM sodium cacodylate  
     in H20, pH 7.2 
Chelated-copper click mix  0.1 M HEPES pH 7.4 (KOH) 
     20 µM azide dye 
     2 mM Tetrakis(acetonitrile)copper(I) tetrafluoroborate 
DMEMcomplete    10% FCS 
     100 units/mL penicillin 
     100 µg/mL streptomycin 
     in DMEM 
Freeze Substitution Medium  94.6% dry Acetone 
     3.0% H2O 
     0.1% UA 
     2.3% MeOH 
IF blocking buffer   2% BSA  
     in PBS 
LB Medium    1% tryptone 
     0.5% yeast extract 
     171 mM NaCl 
     in H2O 
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Buffer / Medium   Contents                                                                                 continued                                                   
LB agar    13% agarose  
     in LB medium 
Methylcellulose    2% methylcellulose 
     in H20 
PBS     140 mM NaCl,  
     2.7 mM KCl 
     8mM Na2HPO4  
     1.8 mM KH2PO4 
     in H2O, pH 7.4 
PBST     0.1% Tween 20 
     In PBS 
PHF     10% FCS 
     20 mM HEPES  
     in PBS 
RPMIcomplete    10% FCS 
     100 units/mL penicillin 
     100 µg/mL streptomycin 
     In RPMI-1640 
SDS running buffer   25 mM Tris-HCl 
     200 mM glycine 
     1% SDS 
Sort10     1 µg/mL puromycin 
     in DMEMcomplete 
Sort50     50% DMEM 
     50% FCS 
     100 units/mL penicillin 
     100 µg/mL streptomycin 
     1 µg/mL puromycin 
Tokuyasu blocking buffer   50 mM glycine 
     0.8 % BSA 
     0.1% fish skin gelatin     
     in 1x PBS 
WB blocking buffer   30% Western Blot blocking buffer concentrate 
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Buffer / Medium   Contents                                                                                 continued                                                   
WB blotting buffer   48 mM Tris-HCl 
     39 mM glycine 
     20% MeOH 
     1.3 mM SDS 
     In H2O 
2.1.4 Primers 
 
Name  Direction Sequence (5’→ 3’)               
delFLAG  fwd  GGGTTTGCCGCCAGAAC 
   rev  TTGCGCCGGATCCTTACTCGAGTCCACTCCCACCACGATG 
mChIns  fwd  GGGAGTGGACTCGAGGTGAGCAAGGGCGAGGAG 
   rev  TTGCGCCGGATCCTTACTTGTACAGCTCGTCCATGC 
SNAPIns  fwd  GGGAGTGGACTCGAGGACAAAGACTGCGAAATGAAGCG 
  rev  TTGCGCCGGATCCTAAGCCCAGCCCAGGC 
eGFPIns fwd  GGGAGTGGACTCGAGGTGAGCAAGGGCGAGGAG 
  rev  TTGCGCCGGATCCTTACTTGTACAGCTCGTCCATGC 
AgeIrCPSF6 fwd  TAAGTGCAGTAGTCGCCG 
mChNheI rev  ATTGCTAGCCTTTACTTGTACAGCTCGTCCATG 
 
2.1.5 Plasmids 
Plasmid Name and Reference   Description             
pLENTICRISPR-rCPSF6wtAA.FLAG  Expression vector for rCPSF6wtAA.FLAG  
o Designed by David Bejarano & Dr. Ke Peng 
o Synthesized by Eurofins Genomic 
pLENTICRISPR-rCPSF6wtAA.mCh   Expression vector for rCPSF6wtAA.mCh and 
o This thesis     shRNACPSF6 
pNL4-3      Proviral full-length infectious HIV-1 Group M 
o (Adachi et al., 1986)    molecular clone for virus particle production. 
vpr.IN.eGFP      Expression vector for vpr.IN.eGFP fusion 
o (Albanese et al., 2008)    protein for fluorescent virus particle labeling 
o Anna Cereseto (CIBIO, Mattareo, Italy) 
pMD2.G      Vesicular stomatitis indiana virus G protein  
o Didier Trono, EPFL, Lausanne, Switzerland  (VSV-G) expression vector for pseudotyping 
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Plasmid Name and Reference   Description    continued       
pCHIV      pcDNA3.1-based noninfectious molecular  
o (Lampe et al., 2007)    HIV-1 clone. Depleted of LTR and parts of nef. 
pcHIV-mCh      pCHIV-based. mCh gene fused to gag  
o (Eckhardt, 2010)     at MA carboxyterminus 
pcHIV-SNAP      pCHIV-based. SNAP gene fused to gag 
o (Eckhardt et al., 2011)    at MA carboxyterminus 
pQE31-rsEGFP2     Vector for rsEGFP2 expression 
o Addgene #102879 
o (Grotjohann et al., 2012) 
psPAX2      Packaging vector for lentiviral particle 
o Addgene #12260     production 
o Didier Trono, EPFL, Lausanne, Switzerland  
AAV helper       Based on pVAE2AE4-5, AAP depleted. 
o (Grosse et al., 2017; Matsushita et al., 1998) For AAV particle production 
AAV6 Capsid      Expression vector for AAV6 capsid protein 
o (Grosse et al., 2017)    For AAV particle production 
AAVDJP2 Capsid     Expression vector for AAVDJP2 capsid protein. 
o (Grimm et al., 2008)     For AAV particle production 
 
2.1.6 Mammalian Cells 
Cell Line   Origin                 
HEK 293T   (Sena-Esteves et al., 1999)  
HeLa TZM-bl   (Wei et al., 2002) 
U874/4  Modified from ATCC HTB-14, received from Caroline Goujon 
(King’s College, London, United Kingdom) 
MT-4    (Harada et al., 1985)  
Monocyte-derived  Extracted and differentiated from healthy blood donors’ buffy coats  









Target Protein   Species  Dilution Supplier           
CPSF6    rabbit   1:500  Sigma (Cat# HPA039973) 
CA1    rabbit   1:1,000 inhouse 
Cytochrome C  mouse   1:500  BD Pharmingen (Cat# 556432) 
TOM20   rabbit   1:500  Santa Cruz (Cat# SC-11415) 
α-tubulin    mouse   1:1,000 Sigma (Cat# T5168-2ML) 
IRDyeTM anti-mouse 700 donkey  1:10,000 Rockland 
IRDyeTM anti-rabbit 800 donkey  1:10,000 Rockland 
Alexa Fluor anti-mouse IgG goat   1:1,000 Invitrogen 
Alexa Fluor anti-rabbit IgG goat   1:1,000 Invitrogen 
 
2.1.8 Programs, Plugins and Services 
2.1.8.1 Image Analysis 
Program    Application               
FIJI / ImageJ    Image Analysis and Quantification 
Icy     Image Analysis and Quantification 
- ec-CLEM plugin   LM-EM Correlation 
2.1.8.2 Electron Tomography and Modeling 
Program    Application               
IMOD package 
- eTomo    Tilt Series Reconstruction 
- 3DMOD    Structure 3D Modeling 
- SerialEM    Electron micrograph acquisition and microscope control 
TIA     image acquisition F20 electron microscope 
MatLab (with Dr. Martin Schorb) 
- correlation scripts   EM-EM Correlation   
- custom scripts    3D model evaluation and measurement 
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2.1.8.3 Others  
Program    Application               
Ugene     DNA vector program 
GIMP     Figure assembly 
Microsoft Office   Document writing, presentations 
LibreOffice    Document writing, presentations 
Zotero     Reference manager 
2.1.8.4 Services 
Company    Service               
GATC     Sequencing 
Eurofins Genomics   Primers and DNA synthesis 
2.2 Molecular Biology Techniques 
2.2.1 Construct Cloning 
2.2.1.1 rCPSF6wtAA.GOI Constructs 
PCRs were performed with the following reagents: 
Amount Reagent    
100 ng  template DNA 
1 µL   25 µM dNTPs 
2.5 µL  10 µM forward primer 
2.5 µL  10 µM reverse primer 
10 µL   5x Phusion GC buffer (NEB) 
0.5 µL  Phusion DNA Polymerase (NEB) 
to 50µL  ddH2O 
 
To replace the FLAG-Tag by an XhoI site for insertion of different genes of interest (GOI), a PCR 
was performed with pLENTICRISPR-rCPSF6wtAA.FL.FLAG, using the XhoIns primers. Annealing 
temperature was 58°C, elongation time 2 min. The PCR product was purified with the PCR Cleanup 
& Gel Extraction Kit. 
The purified PCR product and the parental plasmid were digested with BamHI and AgeI in 
CutSmart buffer according to the manufacturer’s instructions. AgeI was heat-inactivated at 65°C for 
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5 minutes. The digestion reactions were then mixed with 6x agarose gel loading dye and separated 
on a 0.8% agarose gel at 85V for 50 minutes. The bands for the processed PCR product (~1.8 kb, 
insert) and the longer parental plasmid restriction product (~10 kb, backbone) were cut out of the 
gel and the DNA was purified using the PCR Cleanup & Gel Extraction Kit. 20 ng backbone DNA 
were mixed with the ~3-fold molar excess of insert DNA (10 ng) with 1 µL T4 DNA Ligase buffer, 
1 µL T4 DNA Ligase, and H2O to 10 µL. This ligation reaction was incubated for 1 hour at RT and 
transformed into competent DH5alpha bacteria as described below. The transformed bacteria were 
plated on ampicillin selective plates. In the produced plasmid, the FLAG-tag was hereby replaced 
by a unique XhoI restriction site and the plasmid then called pLENTICRISPR-rCPSF6wtAA.XhoI. 
This plasmid was then used to insert GOIs, i.e.: mCherry, SNAP, eGFP and rsEGFP2. mChIns 
primers were used with pCHIV-mCh, SNAPIns primers with pCHIV-SNAP plasmid, eGFPIns 
primers with vpr.IN.eGFP plasmid and also with the pQE31-rsEGFP2 plasmid, as eGFP and 
rsEGFP are mostly homologous. Those PCRs were performed as described above, annealing 
temperature set to 56°C, elongation time set to 2 minutes. As described for the deletion of the 
FLAG-tag above, purified PCR products and pLENTICRISPR-rCPSF6wtAA.FL.XhoI were digested 










Figure 5: Schematic of Cloning pLENTICRISPR-rCPSF6wtAA.GOI Constructs 
Using the synthesized plasmid 1 (pLENTICRISPR-rCPSF6wtAA.FLAG) as a template, a PCR was performed 
to add an XhoI site downstream of the flexible linker (FL, 1). The PCR fragment was digested (2) and 
inserted into the backbone of the AgeI/BamHI (scissors) digested plasmid 1 (3), yielding the 
pLENTICRISPR-rCPSF6wtAA.FL.XhoI plasmid (4). 
XhoI and BamHI sites were added to GOIs by PCR using mutagenic primers (5) and inserted into 
pLENTICRISPR-rCPSF6wtAA.XhoI-shRNA
-, yielding pLENTICRISPR-rCPSF6wtAA.FL.GOIshRNA
- (6). In a 
last step (not shown), an shRNA was inserted to be expressed under U6 promoter control. 
 
2.2.1.2 shRNA insertion 
The pLENTICRISPR-rCPSF6wtAA.FL.GOI plasmids were restriction digested using KpnI and 
EcoRI, using CutSmart buffer according to the manufacturer’s instructions, subjected to gel 
electrophoresis at 85V for 50 min and purified. An already digested DNA fragment encoding 
shRNA (provided by David Bejarano) was ligated into the excised and purified backbone DNA as 
described above and transformed into E. coli stable II bacteria. Plasmids were prepared and tested 
by restriction digest for the presence of the GOI and the shRNA. Once confirmed, the plasmids 
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In this study, we limited our work to the pLENTICRISPR-rCPSF6wtAA.mCh, while cloning the 
other constructs for potential later uses in live cell- or superresolution microscopy. 
 
2.2.2 AAV Construct Cloning 
For the transduction of primary human macrophages, we transferred the rCPSF6wtAA.mCh 
expression cassette from the pLENTICRISPR-rCPSF6wtAA.mCh vector to a single-stranded AAV 
vector construct. The rCPSF6wtAA.mCh cassette was amplified by PCR, using the primers 
AgeIrCPSF6 and mChNheI to add an AgeI site upstream of the 5’ end of the rCPSF6 and to add a 
stop codon and an NheI site to the 3’ end of mCh. The PCR product was digested with AgeI and 
NheI in Cutsmart buffer (according to the manufacturer’s instrictions), separated via agarose gel 
electrophoresis, the band cut out of the gel and purified (=insert). The AAV transduction vector was 
also AgeI and NheI digested and separated on an agarose gel. The backbone band was cut out of the 
gel an purified (=backbone). Backbone and insert were ligated using T4 DNA ligase and 
transformed into chemically competent bacteria. Single colonies were grown in 5 ml selective LB 
medium, plasmids purified and subjected to restriction digest to validate correct insertion of the 
rCPSF6wtAA.mCh cassette. 
 
2.3 Cellular Biology Techniques 
2.3.1 Heat Shock Transformation 
Chemically competent E. coli bacterial cells (Inoue et al., 1990), stored at -80°C, were thawed on 
ice. Once thawed, 1 ng (for retransformation of a plasmid preparation) or up to 100 ng (for 
transformation of ligations) were added to the cells and mixed. After 10 minutes incubation on ice, 
the cells were heat-shocked at 42°C in a water bath for 45 seconds, then returned to ice and mixed 
with 100 µL cool LB medium w/o antibiotics. After 2 minutes incubation on ice, the bacteria were 
shaken at 37°C for 1 hour to recover. For transformation of plasmids with ampicillin resistance, the 
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recovery step was skipped since ampicillin is not cytotoxic. Afterwards, the cells were plated onto 
selective LB-Agarose plates and incubated at 37°C o/n. Colonies were visible after 12 hours 
incubation.  
 
2.3.2 Plasmid Preparations 
To produce plasmid stocks, the desired plasmids were transformed into bacteria via heat shock 
transformation (see chapter 2.3.1). E. coli strain stable II cells were used for plasmids with 
repetitive elements prone to recombination (proretroviral - and AAV vector plasmids). E. coli strain 
DH5α cells were used for all other transformations.  
A single cell clone colony was picked from the plate with a sterile plastic pipette tip, inoculated into 
selective LB medium and incubated for 2-16 hours in an incubator (37°C, shaking with 150 rpm). 
The medium was transferred into 2 mL reaction tubes (“MiniPrep”) or 50 mL conical tubes 
(“MidiPrep”). The cells were pelleted at 1400 rpm in a table top centrifuge (MiniPrep) or at 8000 
rpm in a laboratory centrifuge (MidiPrep). Supernatant was discarded. 
The bacteria pellets were further processed according to the manufacturer’s instructions. 
 
For optimum yield, DNA was eluted in 2 steps, for each using 50% of the suggested H2O volume. 
The plasmid preparations were vortexed prior to DNA concentration measurement using a 
Nanophotometer. 
 
2.3.3 Mammalian Cell Culture 
U874/4, 293T and Hela TZM-bl cells were maintained in DMEMcomplete medium at standard 
conditions, i.e. 37°C, 90% relative humidity and 5% CO2 in incubators. 
For cell splitting or seeding, the cell supernatant was removed, and cells once washed in PBS. 
Trypsin was added, spread over the complete surface and removed. Depending on the cell line, cells 
were then incubated 1-10 minutes in an incubator. Fresh DMEMcomplete medium was added to 
inactivate residual trypsin and to resuspend the loosened cells. Whenever necessary, cells were 
counted using a Neubauer Counting Chamber, diluted and seeded accordingly. 
MT-4 cells were maintained in RPMI-1640complete.  
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2.3.4 Virus Particle Production 
Virus particles were mostly produced by transfecting proviral plasmids into producer cells (293T). 
HIV-1 virus particles were concentrated by ultracentrifugation through a 20% sucrose cushion and 
resuspended in PHF (PBS with 20 mM HEPES and 10% FCS). HEPES is used as a pH buffer, FCS 
prevents clustering of particles when thawed. Labeled aliquots were frozen at -80°C. 
2.3.4.1 HIV-1 NL4-3 Preparation 
At day 1, ~90% confluent 293T cells were split 1:6 (area wise) and seeded into 15 cm cell culture 
dishes. At day 2, 30 µg of pNL4-3 proviral plasmid DNA was diluted into 1 mL 2.5 M CaCl2 
solution in a 15 mL conical reaction tube. While vortexing, 1 mL HBS 2x was drop-wise added to 
the solution. This mixture was incubated for 30 minutes at RT to allow crystal formation. 
Afterwards, this transfection mixture was added to the 293T cells. After 8 hours incubation time, the 
cell supernatant was removed and replaced by fresh complete DMEM. Virus particles were 
harvested 48 hours and 72 hours after transfection: Cell supernatant was collected and centrifuged 
at 1500 rpm for 5 minutes (cell culture centrifuge) to pellet cell debris. The supernatant was 0.45 
µm sterile filtered and in 40 mL ultracentrifuge tubes, 32 mL filtrate were layered over 6 mL 20% 
sucrose in PBS solution. Ultracentrifugation was performed at 28.000 rpm for 100 minutes. The 
supernatant was decanted, and residual supernatant wiped with tissue paper. 100µL PHF was added 
and incubated for 5 minutes. The virus particle pellet was resuspended, aliquoted and stored at -
80°C. 
 
2.3.4.2 MT-4 Coculture Virus Preparation for Virus Particle Pellet Tokuyasu 
Preparation 
MT-4 cells were initially infected with NL4-3 virus preparation, produced by transfection of 
proviral pNL4-3 into 293T cells. Twice per week, when infected MT-4 cells showed signs of 
cytopathic effects, a 10-fold excess of uninfected MT-4 cells was added and mixed. Virus particles 
were harvested 1.5 days after addition of uninfected cells to the coculture. 
Virus particles were harvested 30 hours after addition of uninfected cells to the coculture. Cell 
supernatant was collected and centrifuged at 1500 rpm for 5 minutes (cell culture centrifuge) to 
pellet cell debris. The supernatant was 0.45 µm sterile filtered and in 40 mL ultracentrifuge tubes, 
32 mL filtrate were layered over 6 mL 20% sucrose in PBS solution. Ultracentrifugation was 
performed at 28.000 rpm for 100 minutes. The supernatant was decanted, and residual supernatant 
wiped with tissue paper. The virus particle pellet was incubated with 100 µL PHF per tube for 5 
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minutes at RT. Resuspension from the ultracentrifugation tubes was pooled and again layered over 
200 µL 20% sucrose in PBS in a tabletop ultracentrifuge. Ultracentrifugation was performed 45 
minutes at 44,000 rpm. The supernatant was carefully removed, and the virus particle pellet was 
fixed for 90 minutes at RT with 4% PFA and 0.2% GA in PBS. The fixed virus particle pellet was 
then processed according to the Tokuyasu technique (see Chapter 2.5.2). 
2.3.4.3 Lentiviral Transduction Vector Preparation 
At day 1, ~90% confluent 293T cells were split 1:6 (area-wise) and seeded into 6 well plate-wells in 
2 mL DMEMcomplete. At day 2, for each well 1.3 µg pLENTICRISPR, 0.24 µg psPAX2 and 0.6 µg 
VSV-G plasmids were mixed in 250 µL CaCl2 added. 250 µL HBS 2x were added drop-wise while 
vortexing. The solution was incubated for 30 minutes at RT allowing crystals to form, and then 
drop-wise added to the cells. 8 hours after transfection, the cell supernatant was replaced by fresh 
DMEMcomplete. Lentivirus particle-containing supernatant was harvested 48 and 72 hours after 
transfection and sterile filtered through a 0.45 µm filter. 
2.3.4.4 AAV Transduction Vector Preparation 
At day 1, ~90% confluent 293T cells were split 1:6 (area wise) and seeded into 6 well plate-wells in 
4 mL DMEMcomplete. At day 2, the cells were transfected with the following plasmids, 1.3 µg each 
(per 1 well): AdenoHelper, AAV Capsid (AAV6 or DJP2) and AAV-rCPSF6wtAA.mCh plasmid. The 
plasmids were mixed in 400 µL DMEM complete. 8 µL Turbofect transfection reagent were added 
and the solution vortexed for 15 seconds. After 15 minutes incubation, the transfection mixture was 
added to the cells. 
3 days after transfection, the cells’ supernatant was removed, and cells were washed once with PBS. 
1 mL PBS was added, and the cells were loosened by scraping. The cell suspension was collected in 
a 1.5 mL reaction tube and centrifuged for 10 minutes at 800 g. The supernatant was removed, and 
the pellet resuspended in 200 µL PBS. 5 freeze-thaw cycles were performed: First, flash freezing 
the reaction tubes in LN2, then thawing them in a 37°C water bath followed by vortexing. 
Afterwards, the cell debris was pelleted at 8000 g for 10 minutes, the supernatant removed, 
aliquoted and frozen at -20°C until further use. 
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2.4 Virological Methods and Cell Line Characterization 
Note: Many samples were initially treated similar, but later handled differently for different 
methods, e.g. for light – or electron microscopy, or for different EM techniques. To not be too 
repetitive, we describe e.g. fixation methods only once and refer to the according chapter.  
2.4.1 Generation of the rCPSF6wtAA.mCh U874/4 Stable Cell Line 
150,000 U874/4 cells were seeded per well in a 6 well plate. While seeding, 2 mL lentivirus particle- 
containing supernatant (packaged pLENTICRISPR-rCPSF6.mCh) were added per well. 24 hours 
after incubation, the cell supernatant was removed and replaced with new lentivirus particle-
containing supernatant (lentivirus particle production was synchronized). After another 24 hours of 
incubation, the supernatant was removed and replaced by fresh DMEM complete medium. 
The cells were incubated for ~5 further days until a nuclear mCherry signal became visible. At that 
point, the cells were split 1:2 and seeded in a 6 well plate well in 2 mL Sort50 Medium (50% FCS, 
50% DMEM, Pen/Strep, 1 µg/ml Puromycin). The next day, the medium was replaced by fresh 
Sort50 Medium to wash off dead cells. Once grown confluent again, the cells were split into a T25 
bottle in Sort50 Medium. Once the cells were confluent, medium was changed to Sort10 medium 
(DMEMcomplete w/ 1 µg/ml Puromycin). Without selection pressure, the fluorescence was lost within 









Figure 6: Schematic of the Generation of The U874/4 rCPSF6wtAA.mCh 
A lentiviral construct was packaged and used for transduction of U87 parental cells, encoding a short 
hairpin RNA targeting CPSF6 (shRNACPSF6) under U6 promoter control and a cassette under EF1 promoter 
control: Coding for a CPSF6, carrying silent mutations to confer resistance to shRNA driven degradation 
(rCPSF6wtAA), fused to mCherry (mCh), followed by a 2A Peptide bridge linked to a Puromycin resistance 
gene. After successful lentiviral transduction, the encoded shRNA can degrade the endogenous nuclear 
CPSF6, while rCPSF6wtAA.mCh is expressed and not degraded. Those cells’ nuclei autofluoresce in red, due 
to mCherry. 
 
2.4.2 Western Blot for CPSF6 Detection 
For Western Blotting, proteins of sample lysates are separated according to their apparent molecular 
weight via SDS polyacrylamide gel electrophoresis (SDS-PAGE). SDS binds unspecifically to 
proteins and thereby provides them a negative charge relative to their number of amino acids. In gel 
electrophoresis, all proteins experience an electric force, relative to the bound SDS. Smaller 
proteins experience less resistance in the polymer gel and can therefore travel faster towards the 
anode. Larger proteins are more retained and therefore travel slower. This leads to a separation of 
proteins according to their molecular mass. Proteins are then transferred from the gel to a membrane 
(blotting) and immunolabeled with antibodies against proteins of interest. The amounf of protein 
that is initially loaded onto the gel can be normalized by so called house keeper proteins, such as 
GAPDH or (α-)tubulin. Such proteins are thought to be of constant concentration. 
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2.4.2.1 Cell Lysis 
U874/4 rCPSF6wtAA.mCh or wt cells were growing confluent in 6 well plates at 5 days after 
transduction (see Chapter 2.4.1). When these cells were split (see Chapter 2.3.3), 50% were further 
passaged and 50% were transferred into 2 mL reaction tubes and pelleted by centrifugation at 800 g 
for 10 minutes. The supernatant was mixed with 6x WB sample buffer and vigorously mixed using 
a vortexer. This cell lysate was incubated for 10 minutes at RT. Incubating the samples at 95°C for 
10 minutes disrupts intra- and intermolecular bonds, like hydrogen bonds and salt bridges. 
Furthermore, disulfide bonds are reduced by the ß-mercaptoethanol in the 6x WB sample buffer. 
 
2.4.2.2 Polyacrylamide Gel Preparation and Electrophoresis 
Homemade SDS gels were prepared in 2 steps: A total of 10 mL solution was prepared for the 
separation gel: 12.5% acrylamide, 375 mM Tris-HCl (pH 8.8), 0.1% SDS, 0.1% APS, 0.0015% 
TEMED. This solution was filled in between glass slides to ¾ and overlayered with isopropanol to 
prevent surface drying. 4 mL of stacking gel solution was mixed: 4.5% acrylamide, 125 mM Tris-
HCl (pH 6.0), 0.1% SDS, 0.06% APS and 0.3% TEMED. Isopropanol was removed from the 
polymerized separation gel and briefly blotted. The volume between the glass slides was filled with 
stacking gel solution and a comb was added to create sample pockets.  
After polymerization, the glass slides were installed into the SDS-PAGE system, filled with SDS-
PAGE running buffer and loaded with 20 µL cell lysate per lane and one pocket lane was filled with 
10 µL protein size marker. Gel electrophoresis was performed at 160 V for 50 minutes. At this 
rather high voltage, the obtained bands did not show the typical smiley effect but remained well 
horizontally aligned (Most likely due to even heating, caused by the high voltage).  
 
2.4.2.3 Membrane Blotting and Immunolabeling 
The gel was removed from the system and the glass slides, briefly washed in blotting buffer and 
stacked for blotting as follows: 3 layers of blotting paper, 1 methanol-activated PVDF membrane, 
polyacrylamide gel, 3 layers of blotting paper (all layers soaked in blotting buffer). A semi-dry blot 
was performed, applying 25 V at a current of 3 mAmp/cm² for 50 min. The membrane was removed 
and incubated in WB blocking buffer, for 30 minutes rocking at RT (to sequester unoccupied 
protein binding sites and prevent antibodies from unspecific binding). Anti-CPSF6 (rabbit) and anti-
α-tubulin (mouse) antibodies were mixed in 10 mL WB blocking buffer and incubated for 1 hour at 
RT. The membrane was washed 3 times 5 minutes in PBST (0.1% Tween in PBS) and incubated 
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with 10 mL WB blocking buffer with 1:10,000 IRDyeTM anti-rabbit 800 and IRDyeTM anti-mouse 
700 secondary antibodies, each. Secondary antibodies were incubated for 1 hour at RT, rocking and 
washed 4 times in PBST for 5 minutes, and in PBS for 3 minutes. 
The Western Blot membrane was imaged with an infrared scanner. 
2.4.3 U874/4 Cell Infection for Cell Line Characterization and PIC Correlation 
20,000 U874/4 rCPSF6wtAA.mCh cells per chamber were seeded onto prepared sapphire discs 
(chapter 2.5.1.1) in 8 chamber microscopy slides, and transferred into the BSL3 laboratory. U874/4 
cells were infected in a total volume of 100 µL, reduced to a minimum for maximal efficient 
infection. 5 µL virus particle preparation was added per well. We have identified 4 hours infection 
to be a good time point for the analysis of nuclear PIC (Peng et al., 2014). 
Therefore, cells were further incubated for 4 hours at standard conditions before chemical fixation 
(described in chapter 2.4.5.3), then continued in chapter 2.5.4). 
 
2.4.4 Virus Particle Arrest at the Cellular Plasma Membrane 
To analyze core structures from surface-bound virus particles as a reference, it was necessary to 
prepare samples under identical conditions. Therefore, 20,000 HeLa TZM-bl cells per well were 
seeded onto prepared sapphire discs (chapter 2.5.1.1) in 8 chamber microscopy slides. HeLa TZM-
bl cells were used preferentially due to better binding of virus particles to the plasma membrane 
(see Figure 35). 10 µL virus preparation in a total of 100 µL inoculum was added per chamber. To 
prevent entry and endocytosis of viral particles, the cells were incubated o/n at 16°C. To prevent 
cytotoxic pH changes, 20 mM HEPES was added to the cell culture medium. Virus inactivation was 
done as described above (chapter 2.4.5.3). Fixed samples were then processed as samples for PIC 
correlation (chapter 2.5.4) 
 
2.4.5 Cell Fixation and Virus Inactivation 
Samples were fixed according to the specific needs and downstream processing. When a specific 
kind of fixation was performed, it is either mentioned in the downstream chapter, or described 
separately. 
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2.4.5.1 Fixation for CA immunofluorescence labeling 
Fixing for 90 minutes with aldehydes strongly reduces the signal obtained from CA 
immunofluorescence staining. Therefore, an alternative protocol was used for reliable inactivation 
of BSL3 HIV-1. 
Infected cells’ supernatant was removed, and cells were washed with warm PBS, before adding 4% 
PFA in PBS for 20 minutes at RT. The fixative was removed, and cells washed once in PBS. For 
permeabilization and full virus inactivation 0.5% Triton X-100 in PBS was added and incubated for 
20 minutes at RT. The cells were then removed from BSL3. For samples that were directly 
immunofluorescence labeled, see Chapter 2.4.5.2. For samples, where EdU click labeling was 
performed in between, see Chapter 2.4.6.1. 
 
2.4.5.2 Immunofluorescence Labeling (General) 
In general, BSL3 samples for immunofluorescence labeling were fixed for 90 minutes at RT in 4% 
PFA in 1x PBS buffer, and removed from the BSL3 laboratory.  
In contrast, when incubating cells on sapphire discs for high pressure freezing, these were typically 
fixed for 90 minutes in 4% PFA, 0.2% GA in PHEM buffer. After sapphire discs have been removed 
from the chambers, the residual cells were used as a phenotype control.  
For samples, where CA was immunolabeled, cells were fixed as described in chapter 2.4.5.1. 
The fixative was removed, cells washed once in PBS and permeabilized in 0.2% Triton in PBS for 
20 minutes. After 2 times 3 minutes washing with PBS, residual aldehyde groups were inactivated 
in IF blocking buffer for 20 minutes. Primary antibodies were diluted accordingly into IF blocking 
buffer and incubated for 1 hour at RT. Samples were washed 5 times 3 minutes with PBS, before 
incubating secondary antibodies with Hoechst33258 (whenever enough channels were available), 
diluted in IF blocking buffer for 1 hour at RT. Samples were washed again 5 times 3 minutes and 
left in PBS for imaging and storage at 4°C. 
2.4.5.3 Virus Inactivation for High Pressure Freezing by Chemical Fixation 
For best possible retention of ultrastructure and fluorescence, we made use of published protocols 
and adjusted them to meet the needs of our cells and conditions (Kukulski et al., 2011). Throughout 
this protocol we used the less extracting PHEM buffer instead of PBS. Additionally, PHEM is 
devoid of phosphate ions, which precipitate easily with uranyl ions and thereby form electron-
dense, insoluble crystals. 
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Before further processing, it was necessary to fully inactivate infectivity of cells and virus particles. 
Therefore, cell supernatant was removed, cells were once washed with 1x PHEM buffer and then 
fixed in 4% PFA and 0.2% GA in 1x PHEM buffer for 90 minutes at RT. The samples were then 
removed from the BSL3 laboratory. The Fixative was removed, and the cells washed and stored in 
PHEM buffer until further processing. Further preparation for EM was typically continued within 
30 minutes (see Chapter 2.5.4.1) Samples for light microscopy were stored up to 1 day at 4°C 
before further processing. 
After removing and processing the sapphire discs, some cells were remaining in the used well. 
Those that were growing directly on the well’s plastic surface, in the space between sapphire discs. 
These cells were used as light microscopy samples to either directly confirm the presence of 
rCPSF6wtAA.mCh clusters or for additional immunofluorescence stainings (see chapter 2.4.5.2). 
2.4.6 EdU Click Labeling 
The thymidine-analog EdU is readily taken up by living cells and incorporated into nascent DNA: 
In nuclei during S-Phase, in mitochondrial DNA (mtDNA) during replication and in viral DNA 
during reverse transcription (Salic and Mitchison, 2008). Click labeling is employed to label viral 
DNA, which is considered a sign for productive infection, or to label mtDNA, which was used as a 
model for viral DNA throughout protocol establishment. This application has been proven to 
faithfully identify viral DNA in subviral complexes (Peng et al., 2014). 
2.4.6.1 EdU Click Labeling in Fixed Cells 
For EdU click labeling, cells were incubated with 10 µM EdU during infection (i.e. for 4 hours). 
Cells were fixed as described above (see chapter 2.4.4) and permeabilized for 20 minutes with 0.2% 
Triton in PBS. Residual aldehydes were blocked with IF blocking buffer for 20 minutes at RT. The 
standard EdU click labeling mixture (clickIT kit) or the chelated-copper click mixture was 
incubated for 20 minutes at RT. Cells were washed with IF blocking buffer twice and IF blocking 
buffer was again incubated for 20 minutes. Afterwards, cells were stained by immunofluorescence 
as described below. The click reaction mixture was prepared and applied according to the 
manufacturer’s instructions. 
 
2.4.6.2 Live Cell Click labeling 
Cells were grown on cover glasses, removed from their well and once washed with PBS. The cells 
were then incubated in 100 µL EdU click labeling mixture for indicated durations at RT. 
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Afterwards, they were washed with PBS 3 times for 2 minutes and then placed back into wells with 
fresh DMEMcomplete for recovery, or directly further prepared for epon flat embedding (see chapter 
2.5.3) or cryo-CLEM approaches (see chapter 2.5.3). For live cell click labeling, we used the cell 
permeable TAMRA azide-dye. 
2.4.7  HIV-1 Infectivity Titration by Wide Field Microscopy 
20,000 U874/4 wt or rCPSF6wtAA.mCh cells per chamber were seeded in 8-chamber slides. 1 day 
after seeding, cells were infected in 150 µL DMEM complete with 2, 0.5, or 0.125 µL NL4-3 virus 
particle preparation or left uninfected as controls. 4 hours after infection, the inoculum was removed 
and replaced with 200 µL fresh DMEM medium with 50 µM T20 entry inhibitor (Ding et al., 2017) 
to prevent second round infections. After 2 days, cells were washed in PBS, fixed with 4% PFA in 
PBS for 20 minutes at RT, and permeabilized with 0.5% Triton X-100 in PBS for 20 minutes at RT. 
The samples were then removed from BSL3. The permeabilizing solution was removed, cells were 
washed with PBS once and incubated with IF blocking buffer. After 20 minutes incubation at RT, 
the IF blocking buffer was removed and Rb anti-CA1 antibody (diluted 1:1000 in IF blocking 
buffer) was added to the cells. After one hour incubation, the antibody was removed and cells 
washed 4 times for 5 minutes with PBS. Alexa-488 goat anti rabbit IgG (diluted 1:1000 in IF 
blocking buffer with Hoechst 33258) was added and incubated for 1 hour at RT. Secondary 
antibody solution was removed, and cells washed again 4 times for 5 minutes with PBS at RT. 
9 separate images were acquired using the cell culture wide field microscope. Images were analyzed 
using FIJI and infectivity was determined by automatically counting all (Hoechst) and only infected 
(CA-positive) cells. 
2.5 EM Material and Sample Preparations 
2.5.1 Material Preparation – Sapphire Discs and EM Grids 
2.5.1.1 Sapphire Discs 
50 µm sapphire discs were cleaned in 80% Ethanol and dried on filter paper. Once dry, the discs 
were placed into holders for carbon coating. A 15 nm carbon layer was coated onto the sapphire 
discs first. The discs were then removed from the coating chamber and an “F” was scratched into 
the carbon layer, using dentist tools. The discs were replaced into the holder and another carbon 
layer of 8 nm was coated on top of the first one. We found the second layer to improve the overall 
stability of the carbon coat, most likely by providing one continuous, closed surface. The carbon 
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coat allows easier separation of the sapphire disc from the embedding resin after polymerization, at 
the end of EM sample preparation. The scratched in “F” serves as a mark to discriminate the disc’s 
up – and down sides. Cells were grown on the carbon layer. To ensure seeding the cells on the right 
side of the sapphire disc, the F had to be readable as such, observed from above, and must not be 
inverted, meaning the carbon layer would be facing up. 
To fix and stabilize the carbon layer, and for sterilization, the coated sapphire discs were incubated 
at 140°C for at least 3 hours in a closed glass Petri dish. 
Sapphire discs were allowed to cool down to RT for at least one hour prior cell seeding.  
They were then immersed in DMEMcomplete medium and transferred into 8 chamber microscopy 
slides’ wells prefilled with 200 µL DMEMcomplete medium, the carbon layer facing up. First 
immersing the disc in medium prevents floating of the discs and allows to place the sapphire discs 
in distinct positions within the well. Up to 6 sapphire discs were placed into one well. Into these 
prepared wells, 20,000 cells were seeded and allowed to attach and grow for one day before 
infection / treatment (see chapters 2.4.3 & 2.4.4). 
 
2.5.1.2 EM Grids 
A pioloform layer on the EM grid produces a closed surface. Pioloform itself is almost electron-
transparent. When taking up sample sections on pioloform-coated grids, they are flatter and don’t 
hang into the mesh between grid bars. Adding a carbon layer increases the overall stability of the 
surface, and acts as a conductive layer, allowing local electric charges (due to the electron beam-
exposure) to quickly discharge over the EM sample holder. Local charges can otherwise introduce 
artifacts by electrostatic interactions with the electron beam. 
EM grids were briefly vortexed in acetone for cleaning, removed and allowed to air dry on filter 
paper. Glass slides were cleaned with lintfree tissues, before immersing the glass surface to 2/3 in 
1% pioloform in chloroform solution.  
The solution was steadily released through a nozzle, yielding a uniformly thin pioloform layer on 
the glass. The pioloform layer was allowed to dry for ~2 minutes. The layer’s sides were cut with a 
sharp razor blade close to the rim on all 4 sides. By gently immersing the coated cover glass in a 
~45° angle into a water bath, the pioloform coat was loosened from the glass and floating on the 
water surface. Cleaned, dry EM grids were placed with the shiny side up, the dull side facing the 
floating pioloform film. Areas with impurities (like dust particles) were spared. Once completed, 
clean parafilm was placed on top of the grids, sandwiching them between the parafilm and the 
pioloform film. This sandwich was placed with the pioloform side facing upwards and allowed to 
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dry for 1 day at RT. The pioloform coated EM grids were then covered with a ~2.3 nm layer of 
carbon, using the carbon coater according to the manufacturer’s instructions. Those grids were 
stored for up to 6 months in plastic containers to prevent the pioloform from becoming brittle. 
 
2.5.2 Tokuyasu Sample Preparation 
In the Tokuyasu sample preparation, cells are chemically fixed with aldehydes, pelleted, embedded 
in gelatin and infiltrated with sucrose o/n. The latter protects from ice crystal formation during the 
subsequent flash freezing in LN2. Frozen pieces of cell pellets are cryo-thin sectioned and freed 
from gelatin. Since these samples are fully hydrated and only chemically fixed, not solid resin-
embedded, immunofluorescence labeling usually works well because antigens are well retained and 
highly accessible (Slot and Geuze, 2007). 
1.2x106 U874/4 or HeLa TZM-bl cells were seeded per 6 well plate-well. One day later, the cells 
were incubated with 10 µM EdU for 5 hours (see Chapter 2.4.6). Virus particle pellets (chapter 
2.3.4.2) and cells were processed as follows: 
The samples were washed in PBS and chemically fixed in 4% PFA and indicated concentrations of 
GA in PBS for 90 minutes, to mimic BSL3 requirements. The fixative was removed, the cells once 
washed in PBS and incubated for 20 minutes in 50 mM glycine and 1% gelatin in 1x PHEM at RT 
to sequester residual free aldehyde groups. The cells were scraped off in this buffer, transferred into 
a 2 ml reaction tube and centrifuged at 14000 rpm for 2 minutes at RT in a table top centrifuge. 
Supernatant was removed, and cells resuspended in 37°C warm 10% gelatin in PBS. After 
centrifugation at 14000 rpm for 30 seconds, most of the supernatant was removed. The gelatin 
holding the cell pellet was allowed to solidify on ice for 10 minutes. Using a tooth pick, the gelatin 
block was removed from the reaction tube and immersed in 2.3 M sucrose in PBS for further 
handling to prevent drying. Excess gelatin was removed, and the cell pellet cut into 6 pieces, which 
were transferred into 2 ml reaction tubes filled with 2.3 M sucrose for o/n sucrose infiltration at 4°C 
on a rotation wheel mixer. The next day, the surface of aluminum pins was roughened using 
sandpaper, to increase the surface are. Aluminum pins are used to mount the samples for cryo-
sectioning. The pins were washed in 70% EtOH in H2O and dried. One piece of a cell pellet was 
mounted onto one pin, excess sucrose solution removed, the pin flash frozen and stored in LN2. 
The samples were cryo-sectioned using the ultramicrotome with the ultramicrotome cryo-chamber 
and a cryo-knife at -140°C. While milling a flat block surface, single sections were taken up using 
the perfect loop and checked for presence of cellular material using methylene blue. Therefore, the 
section was placed on a microscopy glass slide and dried at 90°C. One drop of methylene blue 
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solution was added and incubated at 90°C until the rim was starting to dry out. Excess solution was 
washed off, and the thawed cryo-thin section was visually analyzed for the presence of cell material 
using a standard wide field microscope. 
The sides were trimmed (45° trim angle) to yield a block face rectangle of 150 µm x 100 µm, and 
serial section ribbons were produced using micromanipulators. The ribbon of serial sections was 
taken up in a drop of 2.3 M sucrose w/ or w/o methylcellulose using the perfect loop. This drop 
holding the section band was then transferred to a pioloform - and carbon coated EM grid on 
parafilm (see chapter 2.5.1.2). Grids with sections were incubated twice for 15 minutes at 37°C, 
first in 2% gelatin in PBS, then in 50 mM glycine in PBS to gently, step-wise remove the 
embedding gelatin from the sample. Before labeling, potential nonspecific protein binding sites 
were blocked using Tokuyasu blocking buffer for 10 minutes, followed by 2 washing steps in PBS 
for 2 minutes each. 
For EdU click labeling, the sections were equilibrated in click reaction buffer without azide-coupled 
dye twice for 30 seconds, and then incubated for 30 minutes at RT in click reaction buffer with 2 
µM azide-coupled dye, protected from light. The section was washed twice in PBS afterwards for 2 
minutes each. 
 
In order to stain and wash the sections they were placed on top of drops out of different solutions 
placed on hydrophobic parafilm. For antibody labeling, primary antibodies were diluted 1:200 in 
Tokuyasu blocking buffer. The sections were incubated at RT protected from light for 45 minutes 
and washed 4 times with PBS for 3 minutes each. The same was repeated for the secondary 
antibody. After washing the sections with PBS, they were washed with water at least 5 times for 2 
minutes. The last 3 washing steps were performed on ice to precool the sample for the next step. 
3 drops of 1.7% methylcellulose and 0.45% UA were prepared on ice, the sections briefly incubated 
on the first 2 drops, and then incubated for 7 minutes on the last drop. The EM grid was picked up 
with a perfect loop. Excess material was removed using filter paper, and the grid allowed to dry at 
RT. UA binds to phosphate groups of e.g. lipids, proteins and the chromatin backbone, providing 
contrast for electron microscopy. The methylcellulose acts as a kind of resin, replacing the water 
while keeping structures in shape. The grids were then ready for electron microscopy. 
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2.5.3 Epon Flat Embedding 
Epon flat embedding is a fast technique, where sample cells are grown on cover glasses, harsh 
chemically fixed with aldehydes, UA and OsO4, dehydrated and finally embedded in Epon resin. 
Epon polymerizes within several hours, so samples can be thin sectioned and imaged the next day 
already. With UA and OsO4, a high contrast is usually yielded. Fluorescence on the other hand 
cannot be preserved, due to thermal requirements for polymerization of the resin (60°C) and OsO4, 
reacting with C-C double bonds. Pi-electron systems, the basis of fluorescence, are thereby 
destroyed. Samples embedded this way typically retain HIV-1 capsid structures well (Bartonova et 
al., 2008). 
 
50,000 U874/4 or HeLa TZM-bl cells were seeded onto round cover glasses in 24 well plate-wells, in 
500 µL DMEMcomplete. 1 day after seeding, the cells were incubated with 10 µM EdU for 5 hours. 
Different fixatives and diluents were tested and compared in this study (see Results Figure 21). To 
mimic BSL3 requirements, cells were fixed for 90 minutes at RT and washed in PBS buffer. After 
removing the samples from BSL3, they were incubated with 2% OsO4 in Caco buffer for 40 
minutes on ice, washed 4 times 3 minutes at RT in Caco buffer and incubated with 0.5% UA in H2O 
for 30 minutes at RT. The samples were washed 3 times 2 minutes in H2O and dehydrated for 5 
minutes each in increasing concentrations of EtOH in H2O, starting from 30% followed by 40%, 
50%, 60%, 70%, 80%, 90%, then 95%, followed by 2 times 10 minutes incubation in 100% EtOH. 
The cover glasses were then removed from the wells and mounted onto resin capsules prefilled 
(slightly overfilled) with Epon, cells facing the resin. Infiltration was done for 15 minutes at RT. 
The samples were then flipped upside down and placed onto the cover glass for solidification in an 
oven o/n at 60°C. 
To remove the cover glasses, solid sample blocks were freed from the resin capsule using razor 
blades. The blocks were flash frozen in LN2 and, once cold, transferred into hot water. Sudden 
temperature shifts lead to loosening of the cover glass from the resin surface. Once all the glass was 
removed, the big sample blocks were sawed into 2 halves. One half was stored for potential later 
use, the second half was mounted into a UC6 sample holder. The surface was trimmed in 45° angles 
to a trapezoid of roughly 0.8 x 0.5 mm. After aligning the trapezoid block face to the diamond knife, 
(ultra) thin sections were prepared and taken up onto prepared EM sample grids.  
 
2.5.3.1 Addition of Colloidal Gold Fiducials to Sections 
All following staining and washing steps were performed in 20 µL drops on clean parafilm at RT. 
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For later tilt series reconstruction, 15 nm PAG fiducials were added to the section surfaces. 
Therefore, grids were incubated first with the side not containing the sample section on 1:50 PAG in 
H2O dilution for 10 minutes, 3 times washed for 10 seconds in H20 and then blotted on filter paper. 
This was repeated for the sample section containing side without blotting at the end. 
To increase contrast, sections were postcontrasted using established protocols for PbCi and UAc 
(Hall, 1995; Reynolds, 1963).  
 
2.5.3.2 Postcontrasting of EM Thin Sections 
Grids were calibrated twice for 5 seconds on 70% MeOH in H2O, transferred onto 3% UAc in 70% 
MeOH solution and incubated another 5 minutes. The grids were washed twice for 5 seconds in 
70% MeOH in H2O and twice for 2 minutes in H2O. Washing in MeOH is necessary to wash off 
excess UA but needs to be kept short to not wash out the contrast again. Drops of PbCi were 
surrounded by 5-10 KOH pellets to prevent CO2 from reacting with the solution and forming 
insoluble PbCO3 precipitates. Grids were equilibrated for 10 seconds on a fist drop and then 
incubated for 3 minutes on a second drop. 2 brief washing steps were performed within the CO2 
depleted area, then another 4 washes in H2O were performed. Finally, the grid was blotted and 
stored in the grid box. 
 
2.5.4 Sample Preparation for On-Section Correlative Light – and Electron 
Microscopy 
2.5.4.1 High Pressure Freezing (HPF) 
HPF is one way of cryo-immobilizing samples. A critical point is met at 2000 bars pressure and -
200°C, where samples of up to 200 µm thickness can be frozen in a minimal time frame, preventing 
formation of crystalline ice (McDonald, 2009). This process is also called vitrification. Cell culture 
medium contains sugars and proteins (FCS), which also serve as cryo-protectants, counteracting 
crystal ice formation in samples that don’t require prefixation. Here, we have to chemically fix our 
sample cells before HPF using aldehydes in buffers (upstream sample preparation: Chapters 2.4.3, 
2.4.4 and 2.4.5.3). Instead of vitrifying cells in plain PHEM, we add 100 mM sucrose to foster 
vitrification. 
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For HPF, planchettes are used to generate a volume over sample sapphire discs, in which the 
samples can be vitrified. 0.0/0.3 mm - and 0.1/0.2 planchettes were sorted and placed on filter paper 
soaked in hexadecene, which helps to exclude air from sample preparation. Air has a high thermal 
insulation capacity, and therefore would slow down the freezing process, thereby strongly 
promoting ice crystal formation. The first planchette was placed with the 0.0 mm (flat) side up into 
the sample holder. One sample sapphire disc was washed and immersed in PHEM with 100 mM 
sucrose and placed on top of the planchette. Using binoculars allows ensuring that the cells are 
facing up by reading the “F” in the carbon layer. A second planchette was placed on top of the 
sapphire disc as a lid, the 0.1 mm side facing the cells, thereby creating a chamber around the cells 
of 100 µm thickness (see Figure 7). Excess liquid was removed by plotting with filter paper and the 
sample holder closed. In an HPM010, the sample was high pressure frozen and quickly transferred 
into a reservoir of liquid nitrogen (LN2), where the sample was stored, sandwiched between the 
planchettes until further processing. Keeping the planchettes sandwich as such, while storing the 





Figure 7: Schematic of a Cross Section Through an HPF Sample Sandwich 
A carbon coated sapphire disc holding sample cells is placed on a 0.3/0.0 mm planchette as a carrier. A 
0.1/0.2 mm planchette is placed on top of the sapphire disc, creating a 100 µm high sample chamber around 
the sample cells in cryo-protectant medium, e.g. 100 mM sucrose in 1x PHEM buffer. This sandwich is 
mounted into the HPF sample holder and vitrified. 
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2.5.4.2 Freeze Substitution (FS) 
During FS, a sample’s vitrified water is first replaced by a polar organic solvent (here acetone) at 
temperatures as low as -90°C, while mildly chemically fixing the sample using UA. The 
temperature can then be raised without crystal ice formation, and the acetone in turn is replaced by 
Lowicryl HM20 resin. The latter will infiltrate the sample, polymerize under UV light and allow 
sectioning of the sample at RT. 
 
2.5.4.2.1 Freeze Substitution–Medium Preparation 
To start the substitution run in an automated freeze substitution system (AFS), the AFS was filled to 
75% with LN2 and set to -90°C. Once this temperature was reached, the FS medium was prepared. 
In the freeze substitution medium, the sample’s H2O is replaced by acetone.  
A minimal percentage of water in the acetone is important: First, H2O needs to be substituted as 
good as possible to prevent ice crystal formation, when rising the temperature. Second, the 
Lowicryl HM20 can only tolerate up to 4% H2O (according to manufacturer’s instructions) for 
infiltration and embedding. 3% UA stocks are prepared by dissolving UA powder in 70% methanol, 
30% H2O solution. 
For one AFS run, 4 mL of dry acetone were pipetted into a 10 mL glass vial and cooled to -90°C in 
the AFS. Once this temperature has been reached, 134 µL 3% UA solution were added. Once 
mixed, 80 µL H2O were added, immediately freezing in the solution. The glass container was 
removed from the AFS and warmed while shaking, until the water dissolved into the solution. The 
now ready FS medium was immediately placed back into the AFS and cooled down to -90°C. 
If solutions are not cooled while mixing them, UA spontaneously precipitates. It remains insoluble, 
and the FS medium in that case is of no use. 
The final concentrations of the FS medium are: 
 
Acetone  94.6 %  
H2O  3.0 % 
UAc  0.1 % 
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2.5.4.2.2 Sample Loading Into the Automated Freeze Substitution System 
The AFS2 incubation chamber was cooled down to -90°C with a metal holder for 2 sample 
processing holders. One sample wheel (holding up to 10 sapphire discs) was placed into the metal 
holder and a metal dish in the middle well was added for easy sapphire disc manipulation. 0.5 mL 
FS medium was filled into the metal dish, to directly immerse sapphire discs in FS medium upon 
transfer from LN2. 
After HPF, the sapphire discs were removed from the planchettes in LN2. The sapphire discs were 
then transferred with a small LN2 container to the AFS. Transfer of the discs from the LN2 to the FS 
medium was performed within the AFS2 incubation chamber, usually in less than one second to 
ensure no sample thawing in between. The precooled tweezers serve as a cryogen during transfer. 
The discs were placed directly into the metal dish prepared with FS medium. Tweezers were used to 
prevent sample sapphire discs from floating on the FS medium. Ideally, the sapphire discs are 
instantly immersed in FS medium. The temperature in the sample chamber is only -90°C, where ice 
crystals could already grow. The discs were rotated and/or flipped, until the “F” in the carbon layer 
was readable. The sapphire discs were then transferred into the sample processing holder using 
tweezers, without further flipping. It was placed down on a rim in the bottom end of the sample 
processing holder. Correct horizontal positioning at the lower rim of the sample in the processing 
holder was ensured using manipulation tools. At the end of embedding, tilted sapphire discs 
eventually result in block faces not orthogonal to the resin block. Such samples cannot be sectioned 
due to their tilt angle. 
When all samples were loaded, the AFS2 Robot was installed with a fresh filling needle. The 
settings of the AFS program are displayed in Figure 8 & Figure 9 for HM20. Modifications for 
embedding in LR Gold are described in chapter 2.5.4.2.4. 
  
Once the program was finished, the sample processing holder with the embedded and polymerized 
samples was removed and wrapped in aluminum foil and stored in the dark, allowing residual 
polymerization and preventing bleaching of the retained fluorescence by surrounding light. 
 
 




Figure 8: AFSII Sample Chamber and Reagent Loading 
Panel A shows the sample chamber of an AFSII and tools, used for sample loading and freeze substitution: 
1) Steel container with aluminum inset for quick and easy transfer of vitrified samples in LN2 from the high 
pressure freezer to the AFSII. 2) Sample processing container: The inner part (left) can hold up to 10 
sapphire discs. It has openings at the bottom of each compartment, allowing chemicals exchange. It is placed 
into the outer part (right) and then into the AFS sample chamber at the position indicated in panel B. 3) 
Tweezers and manipulation tool for disassembling the sample sandwich, and rotation and flipping of 
sapphire discs. 4) Aluminum inset: During sample loading, sapphire discs are first transferred here for 
immersion in FS medium and aligning, before transfer into the sample processing wheel. 
Panel B shows the instructions for loading the reagents needed for freeze substitution. A and B correspond to 
sample processing containers (A is prefilled with FS medium, B unused). Numbers 1-8 correspond to reagent 
containers, filled or left empty accordingly. 
 
2.5.4.2.3 Lowicryl HM20 Embedding 
Lowicryl HM20 allows to retain ultrastructure as well as fluorescence in a sample (Kukulski et al., 
2011). It was always freshly prepared, yielding the best embedding and polymerization results. To 
do so, 4.47 g Crosslinker D were first mixed with 25.53 g Monomer E. 150 mg Initiatior C was 
added and the solution mixed on a rotation wheel mixer for 5 minutes in the dark at 4°C, the wheel 
set very flat to introduce as little air as possible into the resin. 
 
Once all solutions were prepared, they were placed into the AFS2 incubation chamber according to 
the scheme using AFS2 reagent containers.  
 




Figure 9: Freeze Substitution and Embedding Scheme for HM20 Embedding in an AFS2 
This scheme represents duration (x axis, not drawn to scale), temperature (Y axis) and chemicals used for 
freeze substitution, and infiltration and embedding of samples in Lowicryl HM20. Chemical handling was 
performed by the AFS2 Robot. During the first step (9 hours in total), the vitrified water is replaced by 
acetone. In the next step, acetone in turn is replaced by HM20, the infiltrating and embedding resin (total of 
22.5 hours). Once the infiltration is complete, the resin is polymerized by UV light. The sample chamber is 
still being cooled in the beginning, since polymerization creates a lot of heat that needs to be dissipated in 
order to not heat up and thereby deplete residual fluorsescence. After 82 hours, the samples are almost 
polymerized, after another 2-3 days storage in the dark, polymerization is considered complete. 
 
 
2.5.4.2.4 LR Gold Embedding 
Embedding samples in LR Gold is mostly homologous with HM20 embedding (chapter 2.5.4.2.3). 
LR Gold requires higher temperature for embedding, therefore the temperature is raised at the same 
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speed for 9 hours 20 minutes (instead of 6 hours), reaching -20°C. Otherwise, samples were also 
washed with dry acetone, embedded in increasing concentrations of LR Gold in acetone-dilutions 
and UV-polymerized. 
 
2.5.5 Embedded Sample Processing and Sectioning 
The outer plastic layer was removed from the sample processing holder. Razor blades were used to 
cut open the single wells. Sample blocks were only removed for direct processing. Keeping samples 
in the sample processing holder and therefore excluding air as much as possible helps retaining the 
fluorescence, as some fluorophores are susceptible to oxidation. 
The removed block was installed in an ultramicrotome UC6 sample holder. With a razorblade, the 
excess resin, covering the bottom side of the sapphire disc, was removed. The block was removed 
from the holder and held into LN2 atmosphere, to cool down the surface holding the sapphire disc. 
Once cold, the temperature was quickly raised by breathing onto the cold surface. This was repeated 
until the sapphire disc was easily removed from the resin block. 
The block was installed into the ultramicrotome again. Using razor blades, cleaned in 80% Ethanol 
in water, a trapezoid of roughly 0.5 mm x 0.8 mm was introduced, by removing the residual surface 
resin. The sample was then aligned to the diamond knife according to the provider’s instructions. 
 
To ensure the presence of cellular material in 250 nm thin sections, 1-2 sections were taken up using 
the perfect loop and placed on a glass slide. By incubating the section(s) on a 90°C heat block, the 
sections were dried. One drop of methylene blue solution on the section was incubated at 90°C until 
the drop’s rim was turning dry. Then, the methylene blue was washed off using distilled water, and 
dried again on the 90°C heat block. Once dry, the section was examined in a standard wide field 
microscope for the presence of cell sections, stained in blue. 
When cells were present, further 250 nm sections were prepared. Sections were often compressed 
during sectioning, and therefore stretched with chloroform before taking them up onto prepared EM 
grids (see chapter 2.5.1.2). 
The loaded grids were briefly dried (less than five minutes to prevent oxidation) on filter paper in a 
dark box to prevent bleaching. Leaving grids dry for longer time drastically reduces fluorescence. 
Those grids were then incubated on a 1:50 dilution of TetraSpeck Fiducials in 1x PHEM with 
Hoechst33258 for 10 minutes in the dark at RT, the thin section facing the dilution. Excess fiducials 
were washed off by briefly washing the grids twice on water, without any plotting of excess liquids. 
Grids were fully immersed in water and placed into a drop of water (~30 µL) on a 25 mm glass 
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cover slip. Immersing the grid in water completely before placing it, makes it easier to place the 
grid, thin section facing the glass, into, not onto, the drop of water. Placing it within the H2O 
reduces the emergence of air bubbles between the cover slip and the section dramatically, which 
otherwise hampers LM acquisition. 
Another 25 mm cover slip is placed onto the grid, and the now assembled sandwich placed into a 
CLEM sandwich holder. 
This holder was then taken to a Leica SP8 for light microscopy. 
 
2.6 Correlative Light – and Electron Microscopy 
High precision on-section correlation is a lengthy method. For a better overview, we first show a 
schematic of the single steps. 
 
 
Figure 10: Correlative Light - and Electron Microscopy Workflow 
Sample cells are seeded onto carbon coated sapphire discs (chapter 2.5.1.1) in 8 wells. 4 hours after 
infection (chapter 2.4.3), the samples are chemically fixed in aldehydes (chapter 2.4.5.3). The samples are 
high pressure frozen (HPF, chapter 2.5.4.1), freeze substituted and embedded in Lowicryl HM20 resin 
(chapter 2.5.4.2). 250 nm thin sections are prepared and incubated with TetraSpeck Fiducials. Light 
microscopy is performed in at least 2 channels to visualize rCPSF6wtAA.mCh and TetraSpeck Fiducials in the 
red channel and TetraSpecks only in e.g. the green channel. Therefore, rCPSF6wtAA.mCh are red only, while 
TetraSpeck Fiducials appear yellow (red and green, see chapter 2.6.1). The sections are then postcontrasted 
(not shown, chapter 2.6.2) and imaged in EM, where the TetraSpeck Fiducials can be appreciated by high 
electron-densities (chapter 2.6.3). Using the TetraSpeck Fiducials for light – and transmission electron 
micrograph correlation via Icy ec-CLEM (chapter 2.6.4), Regions of interest (boxed) can be identified in the 
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correlated overlay image. High magnification tilt series are acquired to image regions of interest and 
cytoplasmic regions to ensure the quality of ultrastructure preservation (chapter 2.6.5). 
 
2.6.1 Light Microscopy of Thin Sections 
For light microscopy, it was crucial to use a highly magnifying objective (63x) and sensitive 
detectors (HyD detectors). The rCPSF6wtAA.mCh fluorescence in whole fixed cells was usually 
strong and required ~2% laser power for proper imaging. After embedding, thin sections required a 
laser power of ~25% in combination with 2-6 fold frame accumulation for mCh visualization. 
The grid was oriented in the sandwich holder and eventually in the microscope in a way to visualize 
the coordinates readable. Acquiring light – and electron micrographs in a roughly oriented way will 
make the correlation step much easier. 
 
The sandwich holder was placed into the SP8 microscope. Following the Hoechst stain allows to 
find nuclei in sections easily and to approximately set the focal plane (a slight focal offset can be 
observed between channels). The nuclei were imaged in at least two channels: 568 to image 
mCherry and TetraSpeck Fiducials and 647 to image the latter only. By overlaying those two 
channels, TetraSpecks are identified by fluorescing in both channels, whereas rCPSF6wtAA.mCh 
signals will appear in the 568 channel only (compare Figure 29 & Figure 30).  
Areas with a position of interest – an rCPSF6wtAA.mCh cluster signal -  were acquired at ~ 4 fold 
zoom, using 10% laser power in the 647 channel with a single scan and 20% laser power for the 568 
laser, accumulating 2-6 scans to reliably visualize the signal of interest. ROIs too close to grid bars 
(<4 µM distance from rCPSF6wtAA.mCh clusters) have not been recorded, as electron tomography 
would have been hampered by the proximal grid bars during tilt series acquisition. 
 
Once the grid has been scanned, the sample sandwich was removed from the microscope and 
opened with a razor blade. The grid was loosened from the cover slip glass by adding another drop 
of water, on which the grid floats. The grid was then plotted and stored in a grid box until further 
processing, when not further processed directly. 
 
2.6.2 Thin Section Postcontrasting for Electron Microscopy 
All following staining and washing steps were performed in 20 µL drops on clean parafilm at RT. 
For most possible accurate correlation, 15 nm PAG fiducials were added to the section surfaces. 
Therefore, grids were incubated first with the side not containing the sample section on 1:50 PAG in 
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H2O dilution for 10 minutes, then washed 3 times for 10 seconds in H20 and then blotted on filter 
paper. This was then repeated for the sample section containing side without blotting in the end. 
To restore and increase contrast washed out during fiducial incubation, sections were postcontrasted 
using established protocols for PbCi and UAc (Hall, 1995; Reynolds, 1963).  
Grids were calibrated twice for 10 seconds on 70% MeOH in H2O, transferred onto 3% UAc in 
70% MeOH solution and incubated for 5 minutes. The grids were washed twice for 5 seconds in 
70% MeOH in H2O and twice for 2 minutes in H2O. Drops of PbCi were surrounded by 5-10 KOH 
pellets to prevent CO2 from reacting with the solution and forming hardly soluble PbCO3 
precipitates. Grids were equilibrated for 10 seconds and then incubated for 3 minutes. 2 brief 
washing steps were performed in the CO2 depleted area, then another 4 washes in H2O were 
performed. Finally, the grid was blotted and stored in the grid box. 
 
2.6.3 Low Magnification EM for Correlation 
To correlate light- and electron micrographs, low magnification (4000x) electron micrographs are 
needed. At this magnification, we could generally image enough TetraSpeck Fiducials in one field 
of view (~20) to faithfully correlate LM and EM micrographs. Secondly, PAG fiducials are also 
well visible and can later be useful for pinpointing the position of ROIs, when higher magnification 
tilt series are acquired. 
The sample grids were analyzed in an EM10 due to excellent contrast in acquired micrographs. 
Following the EM finder grid’s coordinates, cell sections were found back in the electron 
microscope. Micrographs were acquired at positions, where rCPSF6wtAA.mCh clusters have been 
have been identified in LM (ROI). 
 
2.6.4 Correlation of Light - and Electron Micrographs 
To overlay the light micrographs containing ROIs and electron micrographs containing 
ultrastructural data, the ec-CLEM plugin (Paul-Gilloteaux et al., 2017) for the image analysis 
software Icy (Chaumont et al., 2012) was used.  
Tetraspeck Fiducials have two important properties: 1) Due to their multispectral fluorescence, 
Tetraspecks can be visualized in all fluorescence channels, and therefore can be discriminated from 
specific signals, such as DAPI (only blue channel) or rCPSF6.mCh (only red channel). 2) 
Tetraspeck Fiducials are very electron-dense and can therefore be well identified in electron 
micrographs.  
MATERIALS AND METHODS 
Page 57 
 
Corresponding LM and EM files were loaded into the program and the data type changed to 
unsigned 8bit files. Once all fiducial signals (10-25) were assinged in LM and EM, the light 
micrograph was rotated and scaled to fit the electron micrograph, resulting in an overlay image, 
combining ultrastructural and fluorescence data. The single channels were extracted from Icy and 
overlayed in FIJI (see e.g. Figure 29). 
 
2.6.5 High Magnification Electron Tomography and Reconstruction 
In tilt series electron tomography, the 3D shape of imaged structures is reconstructed by 
computational backprojection of images acquired at different tilt angles. 
The EM sample grid was placed and secured into a dual tilt (DT) tomography holder and inserted 
into the F20 electron microscope. The DT holder allows rotating the sample around the z axis, 
thereby (i) orienting the sample according to the low magnification correlation images, making it 
much easier to reliably identify the ROI and (ii) positioning the grid bars to allow maximum range 
tilt series acquisition. During acquisition, grid bars can be tilted into the imaged region and thereby 
end the acquisition at lower tilt angles. 
SerialEM (Mastronarde, 2005) was used to control the microscope, TIA to control the in column-
camera. ROIs were found back using the coordinates of the EM finder grid (rough) and the LM and 
EM correlated micrographs (fine). 
The ROI was centered, the microscope stag’s eucentricity adjusted to the ROI, focused and tilt 
series acquired at 19,000 fold magnification. Whenever possible, 121 consecutive tilt images, from 
-60° to +60° in 1° increment steps, were acquired. Exposure time and electron beam aperture were 
adjusted to collect ~6000 counts per one image. 
To maximally omit the introduction of bias during hands-on reconstruction, the acquired tilt series 
(*.st files) were automatically reconstructed using batch tomogram reconstruction in eTomo 
(Kremer et al., 1996).  
Patch tracking was used for all tomograms, with a patch size of 300x300 pixels. After 
reconstruction, the volume was automatically trimmed and rotated around the x axis. 
The reconstructed tilt series (*.rec files) was loaded into 3DMOD (Kremer et al., 1996). Each 
apparent structure was modeled as a scatter-model in a single object (point cloud). Object points 
were set at positions with high electron-density within the surface of apparent structures (see 
Results Figure 31 & Figure 36). Models were saved as *.mod files. 
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2.6.6 Model Data Analysis in MatLab 
The model points’ coordinates were extracted out of the *.mod file and imported into MatLab. The 
apparent PIC structure appeared very similar in shape when compared to the cores observed in 
surface-bound virus particles. The cone-shape can mathematically be approximated by an ellipsoid. 
We therefore fit an ellipsoid function into the models and could thereby define the longest axis (= 
major axis) and the 2 minor axes, orthogonal to the major axis. For the envelope of the surface-
bound virus particles, we approximated a ball function, instead. At this point, we corrected for the 
observed compression along the z axis as described below. 
The model points were plotted along the major axis in a rotational projection: The distance of a 
given model point was measured and plotted against the closest position at the major axis. A trend 
function was calculated along the projected model points by applying a sliding average. The global 
maximum in this trend function was defined as the radius of the structure’s widest point (half the 
width). The structures’ length equals the length of the major axis’ eigenvector.  
 
2.6.7 Correction for z Compression / xy Stretching 
In reconstructed tomograms, it was obvious that apparent PIC structures as well as surface-bound 
virus particles appeared compressed in z (or stretched in xy). During model evaluation, we 
implemented corrections to account for this. Since we do directly compare nuclear PIC structures to 
cell surface-bound virus particles’ cores, it is irrelevant, whether the correction is applied by 
stretching the z axis or by compressing in xy. This was done in collaboration with Dr. Martin Schorb 
(EMCF at EMBL Heidelberg), who wrote the scripts and applied them to the model data. 
2.6.7.1 Correction for Surface-Bound Virus Particles 
Full virus particles at the cell surface not only harbor the capsid structure for reference, but are also 
enveloped, since they did not undergo fusion with plasma membranes. Membranes can be assumed 
to ideally be ball-shaped. Additionally, to the capsids, we therefore also modeled the membrane 
envelopes and analyzed their geometry. By comparing the diameters measured in x, y, and z, it was 
possible to directly measure the difference in length and correct for compression in z. 
Example: The envelope measured 90.2 nm, 93 nm and 82 nm in x, y and z, respectively. Ideally, x 
and y would be equal, therefore we calculated the average: (90.2 + 93) nm / 2 = 91.6 nm. The ratio 
of the xy-average and the z-measurement is: 82 / 91.6 = 0.895. Meaning, the volume was 
compressed to 89.5% of its ideal size in z. The correction factor was calculated as the reciprocal of 
this value: 1 / 0.895 = 1.117. The volume was therefore stretched by the correction factor 1.117 in z. 
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After applying this, redone measurements are 90.2 nm, 93 nm and 91.6 nm in x, y and z, 
respectively. The compressed envelope was corrected to best match a perfect sphere. No correction 
was performed in other axes, as the variations were minor and more likely due to sample 
preparation. 
2.6.7.2 Correction in Apparent PIC Structures 
This correction was more difficult to implement, due to the lack of a direct reference (such as the 
envelope for surface-bound virus particles). Like the envelope is assumed to be a perfect sphere, we 
assumed the apparent PIC structure to be rotationally symmetrical along the major (longest) axis. 
The minor axes (orthogonal to the major axis) should in that case be of identical length. By 
comparing the minor axes’ lengths and their orientation in respect to z in the volume, we can 
calculate the factor, by which the z axis was compressed and apply corrections accordingly. 
 
Example (compare Figure 11): An apparent structure is initially analyzed (left structure, oriented in 
x). The major axis (blue) is parallel to x and measures 110 nm. The minor axes, being orthogonal to 
the major axis, are parallel to y (minorY, red, measuring 60 nm) and parallel to z (minorZ, green, 
measuring 52 nm). Assuming a perfect rotational symmetry in the observed structure means that the 
2 minor axes minorY and minorZ would be of equal length. The structure appears compressed in z 
since minorZ is shorter than minorX. Their ratio is: 52 nm/ 60 nm = 0.867, meaning that the volume 
of the image is compressed to 86.7% of its original size. The correction factor is calculated as the 
reciprocal: 1 / 0.867 = 1.154. The volume is stretched in z by the correction factor. Measuring the 
axes again yields 110 nm for the major axis, and 60 nm each for minorY and minorZ (yielding the 
“actual structure” with red and green minor axes of equal length).  
This example is easily calculated. When the major axis is parallel to z, the 2 minor axes will not be 
affected by the compression and would therefore not allow to correct. Therefore, the angle between 
the major axis and the z axis is important to calculate the correct correction factor. 




Figure 11: Schematic Representation of z-Compression 
The top left panel shows 2 idealistic structures in one tomogram, the major axis oriented in z or x. The top 
right panel shows the extrapolated models and their fit axes (blue: major axes, green and red: minor axes). 
The compression in this scheme amounts to 80%. When these structures are extracted and aligned along 
their major axes, the structure oriented in x (lower left panel) appears compressed along the green minor 
axis, while the structure oriented in z (lower middle panel) appears compressed along the blue major axis. 
90° rotations around the green minor axis are displayed beyond the extracted structures. The structure 
oriented in x can be used to calculate the compression factor by comparison of the minor axes’ eigenvectors’ 
lengths. Applying the calculated correction factor 1.25 yields a corrected tomogram, where the 2 structures 







3.1 Ultrastructure Visualization of Productive Reverse Transcription 
Complexes (RTC) 
A hallmark for productive subviral particles (RTC and PIC) is the presence of viral DNA. As earlier 
published by our lab (Peng et al., 2014), it is possible to detect nascent DNA by metabolic 
incorporation of a thymidine-analogue, called EdU, during DNA synthesis. EdU can be labeled by 
Cu-catalyzed click reaction, covalently binding a fluorophore to it. 
Throughout establishment and testing of new and adjusted protocols, we were employing 
mitochondrial DNA (mtDNA) as a model for viral DNA (vDNA). They are similar in genome size 
(16.6 kb mtDNA, 9.7 kb vDNA, (Coffin et al., 1986; Taanman, 1999; Vogt, 1997)) and physical size 
(both ~100 nm in x, y, and z (Briggs, 2003; Brown et al., 2011)). Using mtDNA as a model also 
allows to work under BSL1 conditions, while experiments with infectious HIV-1 particles were 
performed in BSL3. Hence, we mimicked BSL3 conditions by applying BSL3 fixation protocols, 
which would later allow direct transfer of working protocols to infection experiments. 
 
3.1.1 EdU Click Label Retention in HM20-Embedded Samples 
Performing CLEM with high precision correlation can be achieved by retaining the fluorescence of 
the (surrogate) marker on EM sample thin sections (e.g. (Kukulski et al., 2011, 2012)). 
The fluorescence can be retained, when samples are embedded using high pressure freezing and 
HM20 embedding. Importantly, such prepared samples are ultrastructurally very well retained. 
We therefore tried, if we could retain EdU signals throughout EM sample preparation. U874/4 cells 
on sapphire discs were treated with EdU for 4 hours. Samples were fixed for 90 minutes in PFA, 
and EdU click labeled. The labeled samples were high pressure frozen, freeze substituted and 
embedded in HM20. 250 nm thin sections were prepared and imaged in light – and electron 
microscopy, homologous to the samples for nPIC correlation. 
When we imaged those samples, we were able to visualize EdU signals of clearly nuclear shape and 
size (see Figure 12, panel A). However, extranuclear mtDNA was not visible. EM sample 
preparation for HM20 embedding is known to reduce the fluorescence intensity drastically. We 
assume that we therefore can only observe the intense nuclear DNA, but not mitochondrial DNA. 
Additionally, the ultrastructure was not satisfying (see Figure 12, panel B). Generally, not many 




structures, whereas inner mitochondrial membranes (christae) were not recognizable. Although the 
overall ultrastructure was suboptimal, it also needs to be mentioned that the image shows a single 
TEM image of a 250 nm thin section. Tomographic data would reveal more details but did not seem 
promising at this point. 
 
 
Figure 12: Light - and Electron Micrographs of Preembedding-EdU Labeled U874/4 Cells Thin 
Sections 
U874/4 cells were allowed to incorporate EdU for 4 hours. Cells were chemically fixed and EdU labeled 
before high pressure freezing, freeze substitution and embedding in Lowicryl HM20. 250 nm thin sections 
were imaged in light (left panel, EdU signal) and transmission electron microscopy (right panel, TEM). 
Nuclear EdU signals (red) were visualized. Extranuclear mtDNA EdU signals were not detected. Electron 
micrographs of those sections were ultrastructurally damaged and partially extracted. E.g. mitochondria 
appear as dense, blobby structures, christae are not recognizable. Mt: Mitochondrion, Nu: Nucleus, Cy: 
Cytosol. Imaging performed with Leica SP2 (LM) and Zeiss EM10 (TEM). 
 
3.1.2 EdU Click Labeling on HM20 and LR Gold Thin Sections 
Since we could not retain the EdU fluorescence enough during EM sample preparation for HM20 
embedding, we next tried to embed cells that had incorporated EdU before, to then click label the 
EdU directly on sections. Doing so, the EdU-linked fluorophores will not be bleached during 




HM20 and LR Gold resins have been shown earlier, to allow immunolabeling on thin sections of 
embedded samples (van Lookeren Campagne et al., 1991; McDonald et al., 2012). U874/4 cells were 
incubated with EdU for 4 hours before direct high pressure freezing, freeze substitution and 
embedding in HM20 or LR Gold resin. 250 nm thin sections were taken up on EM finder grids and 
incubated with the EdU click labeling mixture for 30 minutes at RT. After click labeling, the 
sections were also incubated with DAPI for easy identification of nuclear DNA.  
Performing light microscopy, we could only detect EdU signals in LR Gold embedded samples (see 
Figure 13, left panel). Lowicryl HM20-embedded samples, in contrast, did not yield any 
fluorescence (data not shown). 
Yet, like in experiments performed before, we could only visualize nuclear EdU signals. 
Extranuclear mtDNA remained undetected. It is sound to assume that embedding cells in solid 
resins limits the accessibility of EdU dramatically. We can only hypothesize about the polymer 
penetration of the click reaction mixture, but EdU might only be readily click labeled at the 
accessible surface of a section. 
Additionally, the EdU click labeling procedure incurred considerable damage to the ultrastructure, 
as can be seen in electron micrographs of click labeled thin sections (see Figure 13, right panel). LR 
Gold thin sections were so much depleted of contrast, the ultrastructural retention cannot even be 




Figure 13: Light and Electron Micrographs of Embedded EdU-Treated U874/4 Cells Thin 




U874/4 cells were allowed to incorporate EdU for 4 hours before high pressure freezing, freeze substitution 
and embedding in LR Gold. 250 nm thin sections were EdU click labeled and imaged in light (left panel)-  
and transmission electron microscopy (right panel). Nuclear EdU signals (red) were well visualized. 
Extranuclear mtDNA EdU signals were not detectable. Electron micrographs of those sections were strongly 
reduced in contrast.  Nu: Nucleus, Cy: Cytosol. Imaging performed with Leica SP2 (LM) and Zeiss EM10 
(TEM). 
 
3.1.3 Tokuyasu Cryosectioning Allows Efficient Immunolabeling 
In the Tokuyasu technique (Griffiths et al., 2015; Painter et al., 1973; Tokuyasu, 1973) samples are 
fixed with only aldehydes and embedded in gelatin. High concentrations of sucrose prevent crystal 
ice formation during flash freezing in LN2, allowing cryo-thin sectioning. The gelatin is gently 
removed from thin sections, which can then be processed for immunolabeling. The samples stay 
fully hydrated throughout the processing. This in combination with mild aldehyde-fixation 
generally yields good retention and high accessibility of antigen epitopes, well suited for 
immunolabeling. Furthermore, it is a relatively quick method that allows to image samples in LM 
and EM already one day after fixation and therefore allows quick evaluation of an applied protocol. 
We were unable to detect mtDNA in samples that were embedded in solid resins (see Figure 13). 
Different from solid resin embedding techniques, the Tokuyasu sample preparation is considered 
and reported to provide good conditions for efficient immunolabeling. We considered that efficient 
immunolabeling might also increase the chances of labeling EdU, since it might be more accessible 
than in other EM techniques. 
3.1.3.1 HIV-1 Capsid Structures can Generally be Retained in Tokuyasu Preparations 
Before assessing EdU labeling itself, we tested the retainability of the capsid ultrastructure. Samples 
prepared following the Tokuyasu technique, in general, show well contrasted membranes, whereas 
proteinaceous structures are less well visualized. 
We therefore prepared an HIV-1 virus particle pellet. Cell supernatant from MT4 cell cocultures are 
generally very rich in HIV-1 virus particles. We collected coculture supernatants, which was 
concentrated by ultracentrifugation in 2 steps. The yielded virus particle pellet was chemically fixed 
and processed according to the Tokuyasu technique. 120 nm thin sections were prepared and 
imaged in TEM. 
We could visualize enveloped virus particles with well appreciable capsids, as well as structures that 
fit in size and shape to capsids, but lack an envelope (Arrow and asterisks, respectively, Figure 14). 




here underwent ultracentrifugation twice, which is considered harmful to particles. However, it also 
has to be mentioned that there is no selection for particles that appear particularly clear, but an 
overall micrograph of a bulk of particles. 
We conclude that (to a certain extent), the ultrastructure of HIV-1 capsids can be retained in 




Figure 14: Electron Micrograph of a 120 nm Tokuyasu Section of a Virus Particle Pellet 
HIV-1 virus particles from MT4 cocultures were concentrated by ultracentrifugation. The obtained pellet was 
fixed with PFA and GA and prepared following the Tokuyasu technique. 120 nm thin sections were prepared 
and visualized in transmission electron microscopy (Zeiss EM10). Enveloped virus particles can be 
appreciated (arrow), as well as multiple core-reminiscent structures (*).  
 
3.1.3.2 High Precision Correlation of Nuclear DNA is Compatible with Tokuyasu 
Preparations 
Next, we tested the feasibility to correlate light and electron micrographs of samples prepared 




sections is quite different to the solid HM20 resin embedded samples. Hence, we wanted to validate 
that TetraSpeck Fiducials can be recognized and used for high precision correlation. 
250 nm thin sections of HeLa TZM-bl cells were prepared and on-section labeled with DAPI. LM 
(Wide Field Microscope) and EM (Zeiss EM10) micrographs were acquired and correlated. Using 
TetraSpeck Fiducials, we were able to correlate light- and electron micrographs with high precision. 
The TetraSpecks were well visualized in LM (multispectral fluorescence) and EM (high electron-
densities). Using these signals to correlate light – and electron micrographs yielded a satisfying 
colocalization of the DAPI signal and the ultrastructurally identified nuclei (EM) (see Figure 15). 
The TetraSpeck Fiducials appear white here, which is due to particular contrasting and image 
acquisition in slight defocus. We could hereby prove that correlation of DNA signals is well 
possible in combination with the Tokuyasu technique. 
 
 
Figure 15: Correlation of HeLa TZM-bl Tokuyasu Section with DAPI Signal 
HeLa TZM-bl cells were fixed and gelatin embedded, 250 nm thin sectioned and on-section DAPI labeled. A: 
Light microscopy of TetraSpeck Fiducials, imaged in the red channel. B: Light microscopy of DAPI and 
TetraSpeck Fiducial signals in the blue channel. C: Correlated transmission electron micrograph. D) Merge 
of fluorescence signals of (A and B) and the transmission electron micrograph (C). The scale bar in (A) is 
representative for all figure panels. The blue DAPI signal correlates well with nuclear sections (D), while the 
TetraSpeck Fiducials appear round and white with a black rim due to high electron density and imaging in 
slight defocus. 
 
3.1.3.3 mtDNA Visualization in Light Microscopy 
Before assessing the visualization of mitochondrial DNA EdU signals in sections, we wanted to be 





HeLa TZM-bl and U874/4 cells were allowed to incorporate EdU for 4-5 hours before fixation.  
For good fixation and structural preservation, it was suggested (Bleck et al., 2010) to prepare a 2x 
concentrated fixative, i.e. 8% PFA, 0.4% GA in 2x PBS buffer, which is prewarmed to 37oC and 
added directly to culture medium in a 1:1 ratio. Such fixation supposedly avoids shocking cells due 
to sudden changes of buffer or temperature. When cells were fixed this way for 90 minutes and 
processed for immunofluorescence, we observed cytochrome c (CC) and transporter of outer 
mitochondrial membrane 20 (TOM20) to not efficiently colocalize (see Figure 16). This is generally 
interpreted as a sign of cellular stress, which was supposed to be suppressed under these fixation 
conditions. When hypertonic 2x fixative is mixed with cell culture medium, the mixed solution is 
1.5 fold hypertonic, which may account for the observed cell stress. Furthermore, proteins in the 
cell culture supernatant (such as FCS) most likely sequester substantial amounts of aldehydes. The 






Figure 16: Light Micrographs of Hela TZM-bl Cells After 2x Fixative Fixation 
HeLa TZM-bl cells were allowed to incorporate EdU for 5 hrs. Samples were fixed by diluting 2x fixative 
(8% PFA; 0.4% GA in 2x PBS) 1:1 in cell culture supernatant, EdU – and immunofluorescence labeled for 
mitochondrial markers. Within 5 hours, only a subset of HeLa cells undergo nuclear DNA synthesis and 
thereby incorportate EdU. Some cells therefore don’t show nuclear EdU signals. While TOM20 looks as 
expected, CC does not colocalize efficiently with TOM20. This is understood as a sign of cellular stress. 
Single confocal planes, acquired with the SP2 microscope. 
 
Fixation does not appear to happen quickly, but to leave the cells enough time to secrete CC from 
their mitochondria. For a satisfying ultrastructural preservation and for little introduction of 
artifacts, it is indispensable to fix cells quickly and efficiently. Additionally, we observed a strong 




mtDNA signals. GA is known to cause or increase autofluorescence, we therefore also tested 
different concentrations of GA in the next fixation experiments (Figure 17). 
 
Fixing cells in 1x buffered fixative (4% PFA, 0.2% GA in 1x PBS) directly, instead of diluting 2x 
fixative in cell culture supernatant yielded much more satisfying results. The CC signals were not 
spread throughout the cells, but confined to mitochondria, as can be seen by the specific shape (also 
by colocalization with TOM20 (not shown). Nuclear EdU signals are always well visualized, 
independent of the used fixative. mtDNA, on the other hand, can only be faithfully recognized when 
no GA was used during fixation (see Figure 17, right lower panel). This is in line with the 
observation in Figure 18. 
We conclude that GA either hampers EdU click labeling, or increases the background 
autofluorescence enough to exceed the mtDNA signals in intensity. Therefore, it is very likely to 
also negatively influence the detection of viral DNA in RTC. On the other hand, GA is important for 





Figure 17: Visualization of mtDNA by EdU Click Labeling Under Different Fixation Conditions 
HeLa TZM-bl cells were incubated with EdU for 4-5 hours, fixed in 1x PHEM buffer with 4% PFA and 
different concentrations of glutaraldehyde as indicated. While cells fixed with GA show strong 
autofluorescence in the EdU channel, this was not observed for cells fixed with PFA only (w/o GA). Only in 
the sample w/o GA, mtDNA (green EdU signal, extranuclear) was well colocalizing with the mitochondrial 
marker CC (cytochrome C, red immunostain). Confocal images have been acquired with identical laser 
power and acquisition settings using the SP2 confocal microscope. It is apparent that GA also reduces the 








3.1.3.4 EdU Click Labeling Strongly Extracts Tokuyasu Sections 
We showed before that mtDNA can only be well visualized, when no GA is used during fixation. 
Therefore, samples were fist fixed with only PFA, prepared according to the Tokuyasu technique, 
click – and immunofluorescence labeled and then postfixed with 5% GA for ultrastructural 
preservation. In light microscopy, TOM20 was repeatedly visualized, appearing in ring-like 
structures, which fit well with the 1 µm diameter of mitochondria (in cross-sections). However, 
only in one particular experiment, we were able to also visualize mtDNA, recognized as EdU 
signals within TOM20 ring structures (white arrow heads, Figure 18, left panel). Nuclear DNA 
(colocalizing with DAPI), on the other hand, was routinely visualized. After light microscopy, the 
Tokuyasu section was incubated with UA and methylcellulose, and dried. In electron microscopy, 
the section appears strongly extracted (Figure 18, right panel). Cytosolic structures, such as 
mitochondria or endosomes were not at all appreciable, and the usually dense Nucleus (Nu), also 
appears strongly reduced in electron-density. Whether the observed extraction was caused by 
insufficient fixation, when using only PFA as a fixative, or by the Cu-catalyzed click labeling, as 
seen in solid resin on-section labeling attempts (see Figure 13), remains unknown. Most likely, it is 
a combinatorial effect of both. With GA as a fixative and without EdU click labeling, the 







Figure 18: Light- and Electron Micrographs of Tokuyasu Sections from PFA Fixed, EdU Click 
Labeled and GA-Postfixed U874/4 Cells 
U874/4 cells were allowed to incorporate EdU for 4-5 hours before fixation in 4% PFA in 1x PHEM buffer. 
After Tokuyasu preparation, 250 nm thin sections were prepared, EdU click – and immunofluorescence 
labeled and postfixed with GA.  
In this particular case, EdU in Nuclei (see EdU and DAPI colocalization, left panel), as well as extranuclear 
DNA colocalizing with mitochondrial marker TOM20 was visualized (green EdU spots in TOM20 red 
labeled structures, examples: white arrow heads, left panel), the latter therefore most likely representing 
mtDNA. The right panel shows an electron micrograph of the corresponding section. The cytosol and nucleus 
are strongly extracted, therefore no cytosolic structures, such as vesicles or mitochondria are visible or 
recognizable. Ex: Extracellular Space, Cy: Cytosol, Nu: Nucleus. 
 
3.1.4 Preembedding LM Correlation with Epon Flat Embedding 
Epon embedding is a standard EM technique widely used and known to well retain cellular 
ultrastructure as well as the structure of the HIV-1 capsid (Bartonova et al., 2008). Retaining 
fluorescence in epon embedded samples, however, is not possible due to harsh fixation with GA, 
post-fixation and contrasting with OsO4 and high temperature (60°C), required for resin 
polymerization, which results in quenching of fluorescent proteins. As mentioned above, retaining 
HIV-1 capsid structures requires fixation with GA. However, we have shown before that detection 
of mtDNA by EdU labeling is hampered when GA is used as a fixative (see Figure 17). Salic and 
Mitchison (Salic and Mitchison, 2008) suggest the possibility to label EdU in living cells. Although 
copper is toxic to cells (Gaetke et al., 2014), the limited time of exposure to Cu might still be short 




was, to counteract extraction (as observed before, see Figure 18 & Figure 13) due to the harsh 
fixation,  
As mentioned before, fluorescence retention did not seem likely when embedding samples in epon. 
Therefore, we aimed to acquire LM z-stacks of labeled cells before embedding to identify ROIs (i.e. 
extracellular mtDNA for protocol establishment or IN.eGFP colocalizing with EdU signal for RTC 
detection), to find the respective cells back after embedding and to correlate the electron 
micrographs with LM data. The EM thin sections cannot be expected to be parallel to the single z-
slices of the LM z-stack, since thin sectioning is never perfectly parallel to the block surface. 
Therefore, this method would require correlating the electron micrograph to a light microscopy 
(sub)volume of the respective cells. 
 
3.1.4.1 EdU Live Cell Labeling is Possible, but Incurs Cellular Stress and Harms 
Ultrastructure 
In a first experiment, we wanted to assess the compatibility of EdU labeling with living cells. U874/4 
cells were allowed to incorporate EdU for 5 hours. They were treated live with the copper-catalyzed 
click reaction mixture for 30 minutes. For this purpose, we used the cell permeable TAMRA azide-
dye. The cells were washed with PBS and then returned into cell medium for recovery o/n. After 
recovery, the cells were fixed, immunostained for CC and TOM20 and imaged (Figure 19). We 
were able to visualize cells that incorporated EdU and were click labeled the day before. As in 
earlier experiments, nuclear DNA was readily visualized. However, using this protocol, we were 
also able to detect extranuclear mtDNA DNA. Such fluorescence signals were partially found to 
colocalize with TOM20 but not with CC (see Figure 19, arrow heads), again arguing for cellular 
stress. Still, live labeled cells do not (all) die and the EdU signals can be well visualized even one 
day after labeling. The extranuclear mtDNA EdU signal was comparably weak. It must be 
considered that EdU dilutes during further mtDNA replication, and might therefore be not as strong 






Figure 19: Immunofluorescence Micrographs of U874/4 Cells After Over Night Recovery From 
30 Minutes Live Cell Click Labeling 
U874/4 cells on cover glasses cells were incubated for 5 hours with EdU, then click labeled for 30 min and 
placed back into DMEM complete. After o/n recovery, the cells were fixed, and immunofluorescence stained 
for mitochondrial markers TOM20 and Cytochrome C (CC). Although cells were allowed to recover, they 
appear stressed, as there is no strong colocalization between TOM20 and CC observed, CC secretion from 
mitochondria being a hallmark for cellular stress. Nuclear as well as extranuclear EdU signals were 
visualized. Arrow heads point to examples, were extranuclear EdU signal colocalized with TOM20, arguing 
that those EdU signals most likely represent mtDNA. 
 
To asses if live cell EdU labeling can be applied for the purpose of identifying productive RTC/PIC 
complexes in light microscopy and correlate that information with EM sections, we incubated living 
cells with click labeling mixture, subsequently fixed after different time points, and processed 
samples in parallel for either light microscopy (immunolabeling) or electron microscopy (epon flat 




for robust identification of extranuclear DNA to a minimum. We again used mtDNA as a model for 
HIV-1 RTC and PIC. 
Live Cu-catalyzed click labeling of cells did yield EdU staining, the intensity and signal-to-
background ratio depending greatly on the duration of click labeling of the sample (see Figure 20). 
While after 1 minute of click labeling (Figure 20, upper left panel), nuclear EdU signals were 
already apparent, longer incubation times were needed to visualize extranuclear DNA, considered to 
represent mtDNA: After 5 minutes incubation, the signal for extranuclear DNA was still blurry and 
not far over the background intensity (Figure 20, upper right panel), which improved for the 10 and 
20 minutes time points (Figure 20, lower panels). We concluded that 10 minutes EdU click labeling 
sufficient for the detection of extranuclear DNA EdU signal. The ratio of signal-to-background was 
high enough and the reduced incubation time is likely to reduce the imposed cellular stress, 

















Figure 20: Fluorescence Micrographs of Live EdU Labeled U874/4, Fixed Cells 
U874/4 cells were allowed to incorporate EdU for 5 hours. Living cells were EdU click labeled with TAMRA 
for indicated times before fixation and light microscopy imaging. Nuclear EdU signals were already well 
visible after only 1 minute live cell click labeling. After 5 minutes, extranuclear mitochondrial DNA 
(mtDNA), became visible over the background of TAMRA signal. After 10 minutes labeling, the extranuclear 
EdU signals developed a better signal to noise-ratio and after 20 minutes labeling, the assumed mtDNA 
yielded a very bright and easily distinguishable signal. 
 
However, comparing electron micrographs of these samples, makes it obvious that already short 
time of Cu-containing EdU label mix exposure caused considerable damage to the cells’ 
ultrastructure: While untreated samples appeared ultrastructurally well retained in electron 
micrographs (see Figure 21, upper right panel), click mix incubation for 1 minute already led to 
vacuolarization of mitochondrial cristae (see Figure 21, upper right panel). Incubation for 5 or 20 




cytoplasm become apparent (see Figure 21, lower panels). Overall, subcellular structures apparently 
became extracted, e.g. the usually electron-dense nucleus became partially electron-transparent (see 
Figure 21, lower right panel, Nu). 
 
 
Figure 21: 100 nm Thin Sections of Epon Flat Embedded U874/4 Cells After Copper-Catalyzed 
Click Labeling 
U874/4cells were allowed to incorporate EdU for 5 hours. Living cells were EdU click labeled with TAMRA 
for indicated durations before fixation and further processing for epon flat embedding. Untreated cells were 
ultrastructurally well retained and cellular details, such as endoplasmic reticulum were appreciable. After 1 




sections already appeared strongly extracted and holey, which became more pronounced after 20 minutes 
click labeling. Ex: Extracellular Space, Cy: Cytoplasm, Nu: Nucleus, Nc: Nucleolus, ER: Endoplasmic 
reticulum, mt: Mitochondrion. The parallel stripes are artifacts, caused by knife marks. TEM images 
acquired with Zeiss EM10. 
 
3.1.5 Cryo-CLEM 
Sample preparation for this method was similar to the methods described above: U874/4 cells were 
treated for 4-5 hours with EdU before live Cu-catalyzed EdU click labeling with TAMRA azide. 
Instead of chemical fixation, the cells were gently scraped and pelleted, before vitrification in 
metallic gold-coated Cu planchettes during high pressure freezing. 250 nm thin sections were 
prepared under cryo-conditions and taken up onto EM grids. In collaboration with Yura Bykov 
(Ph.D. student, Briggs lab, EMBL Heidelberg), samples were further analyzed by cryo-LM for 
retained fluorescence. These experiments did not yield satisfactory results: No EdU signal could be 
detected on the grids. Additionally, we were not successful in visualizing sample cells by cryo-EM. 
Using an easier EM method, the sample sections on grids were rapidly thawed in PHEM buffer with 
4% PFA and 1% GA, and on-section contrasted with UA and PbCi. Using the EM10, we were able 
to identify cell-reminiscent structures (see Figure 22, lower panel). During cryo-sectioning, the 
block face was trimmed to ~ 150 µm in width and length. In the distance of 150 µm, we could 
observe similar repeating structures, pointing to serial sections of the same cells (see red boxes, 
Figure 21, upper panel). Also with this technique, the ultrastructural preservation was unsatisfactory 
(see lower panel Figure 22): There was no structure that could be reliably identified. In conclusion, 
circumventing dehydration and resin-infiltration by employing cryo-LM and -EM, we were not able 





Figure 22: Electron Micrographs of Rapidly Thawed, Fixed and Contrasted Cryo-Thin Sections 
of Vitrified, Live EdU Click Labeled U874/4 Cells 
Sample cells were incubated with EdU for 4 hours, live EdU click labeled, pelleted and high pressure frozen 
for vitrification. 250 nm thin sections were prepared and after cryo-LM and cryo-EM imaging (not shown, 
not successful), quickly thawed on fixative and contrasted. 
The upper panel shows an overview at low magnification (100x). Repetitive structure patterns of ~ 150 µm 
can be observed (red outlines), fitting well to the cryo-sectioning settings (~150 µm x 150 µm block face). At 
higher magnification (lower panel), is also here becomes obvious that ultrastructural details (membranes, 








In several different attempts, we did not succeed to combine Cu-catalyzed EdU click labeling with 
electron microscopy in a way that would allow us to visualize viral DNA, while at the same time 
retaining a useful ultrastructure in electron microscopy. We dissected the EdU click mixture and 
could clearly identify the CuSO4 as the detrimental agent. Using chelated copper 
(Tetrakis(acetonitrile)copper(I)tetrafluoroborate), is supposed to be milder or less toxic to samples. 
However, we could not observe any obvious improvement, when compared to CuSO4. As long as 
other means of viral DNA labeling are unavailable, this approach to identify productive RTC and 
PIC most likely remains unfruitful. 
We then considered alternative ways of labeling productive subviral structures. 
 
3.2 Experimental System for Detection of HIV-1 nPICs by CLEM 
An earlier study from our lab (Peng et al., 2014) found nuclear HIV-1 preintegration complexes 
(nPICs) to colocalize with accumulations of Cleavage and Polyadenylation Specificity Factor 6 
(CPSF6). The colocalization of nPIC with CPSF6 clusters was observed in U874/4 cells as well as in 
primary human macrophages. We have designed and prepared a DNA construct to express an 
shRNA, targeting the endogenous CPSF6 for knockdown. In parallel, from a second promotor, a 
CPSF6 version is expressed, carrying silent mutations at the shRNA-targeted sequence, rendering 
this CPSF6 gene resistant against knockdown of the encoded shRNA (rCPSF6wtAA). To allow live 
cell imaging, the red fluorescence protein mCherry (mCh) was fused to the carboxyterminus of the 
rCPSF6wtAA coding region via a flexible linker (rCPSF6wtAA.mCh). Downstream of the 
rCPSF6wtAA.mCh, a 2A peptide bridge, an oligopeptide, cleaving itself during translation (Trichas 
et al., 2008), was added, allowing the expression of puromycin N-acetyl-transferase (PAC), an 
enzyme conferring resistance to eukaryotic cells against the otherwise lethal antibiotic puromycin. 
The PAC gene should allow us to select those U874/4 cells, which do express rCPSF6wtAA.mCh. 
Like the endogenous CPSF6, the rCPSF6wtAA.mCh is expected to localize to the nucleoplasm, 
where it should interact with CA and thereby specifically form detectable clusters at nPIC. 
For our studies, HeLa TZM-bl and U874/4 cells were used. As these cell lines are routinely used in 
HIV-1 research, they are well suited for establishing new methods and techniques and to gain 
preliminary data before expanding protocols on more relevant cell types, such as primary human 
macrophages or CD4+ T-cells. Based on our previous research (Peng et al., 2014), U874/4 cells are 




3.2.1 Cell Line Generation and Sorting 
The DNA construct was cloned into the pLENTICRIPSR vector, yielding the pLENTICRISPR-
rCPSF6wtAA.mCh plasmid (see Figure 5). In 293T cells, the pLENTICRISPR-rCPSF6wtAA.mCh 
construct was packaged into the lentiviral transduction vector psPAX2, using VSV-G as an envelope 
glycoprotein for efficient transduction. U874/4 cells were transduced with lentivirus particle-
containing cell supernatant. 4-5 days after transduction, red nuclear signals were detectable in 
transduced cells. This was the starting point for treating the cells with puromycin to select for 
transduced cells, expressing the rCPSF6wtAA.mCh-2APB-PAC cassette.  
Dead cells were washed off and the selection medium replaced daily. During the first selection 
process, the number of viable cells was steadily declining. Also, cells with nuclear mCh expression, 
were dying gradually. We hypothesized this might be an effect of very low cell density. To 
circumvent the death of rCPSF6wtAA.mCh.2APB.PAC-expressing cells, we selected cells in Sort50 
medium (50%FCS, 50% DMEM, Pen/Strep and puromycin). Higher percentages of FCS have been 
observed to increase cell survival and overcome effects caused by low cell density (Thorsten 
Müller, personal communication). Doing so, we were able to obtain sufficient numbers of cells. 
Once cells were grown to confluency, the FCS was reduced to regular 10% again. Puromycin was 
used continuously while passaging the transduced U874/4 rCPSF6wtAA.mCh cells. Even though the 
rCPSF6wtAA.mCh.2APB.PAC cassette should be stably integrated, we observed a loss of nuclear 
red signal within ~3 passages, after puromycin was withdrawn. 
To exclude the possibility of mixing phenotypes of lentiviral transduction and lentiviral HIV-1 
infection, the cells were allowed to grow for 3 weeks before performing further experiments. 
 
3.2.2 Transduced Cells express rCPSF6wtAA.mCh Fusion Protein 
After observing a nuclear signal in the red channel, we started validating the expression and 
functionality of rCPSF6wtAA.mCh by Western Blot and confocal microscopy. U874/4 wt and 
rCPSF6wtAA.mCh cells were analyzed by western blot and confocal microscopy. 
In light microscopy, the nuclei (as identified in the DAPI channel) also displayed a signal in the 
mCh channel, while the U874/4 wt cells did not show mCh fluorescence. The mCh fluorescence in 
U874/4 rCPSF6wtAA.mCh was largely restricted to the nucleus, as it is expected for a CPSF6 fusion 
protein. The mCh fluorescence was variable, which was observed throughout all experiments (see 
Figure 23, panel B). Higher expression levels might be a consequence of multiple lentiviral vector 
integration or might be cell cycle-dependent. Overall, more than 90% of cells kept under constant 




To confirm that the observed mCh fluorescence is no consequence of mere mCh expression, but due 
to the rCPSF6wtAA.mCh fusion protein, we also performed WB. 
The house keeping protein α-tubulin was immunolabeled as a marker for the total amount of 
protein, loaded onto the gel. Using a second antibody against CPSF6, A specific band at ~70kDa in 
wt and rCPSF6wtAA.mCh cells was visible (molecular mass of CPSF6: 68 kDa). A second specific 
band at ~37 kDa can be observed, potentially due to residual GAPDH antibodies in the incubation 
vessels from former experiments. 
2 bands between the 100 and 130 kDa marker bands are visible in U874/4 rCPSF6wtAA.mCh 
samples only. The upper and lower bands might account for rCPSF6wtAA.mCh.2APB.PAC (~130 
kDa) and cleaved rCPSF6wtAA.mCh fusion proteins (~110 kDa, including the flexible linker and 
parts of the 2APB), respectively. While the tubulin band is more intense in U874/4 
rCPSF6wtAA.mCh lysates (indicating more total protein loading), the intensity of the endogenous 
CPSF6 at ~70 kDa is less intense, in comparison to wt cells, clearly speaking for a partial 






Figure 23: Confirmation of rCPSF6wtAA.mCh Expression in Transduced U874/4 Cells by Western 
Blot and Light Microscopy 
A) U874/4 wt and rCPSF6wtAA.mCh cells were lysed in WB sample buffer, 5 days after transduction. Proteins 
were separated by SDS-gel electrophoresis, transferred onto a PVDF membrane, blocked and incubated with 
antibodies against CPSF6 and the house-keeping protein α-tubulin. Marker size is given in kDa. A CPSF6 
band of ~70 kDa is recognizable in both samples, while only the rCPSF6wtAA.mCh cells show additional 
bands at ~130 kDa and ~110 kDa, size-wise fitting to different rCPSF6wtAA.mCh fusion proteins. The 
reduced intensity of the 70kDa band in the U874/4 rCPSF6wtAA.mCh cell sample indicates downregulation of 
endogenous CPSF6 due to the encoded shRNACPSF6. 
B) U874/4 rCPSF6wtAA.mCh cells were, one day after seeding, stained for DAPI and imaged in a confocal 
microscope (single confocal z-slice. Leica SP8). In nuclei (DAPI, represented in blue), red signals, variable 
in their intensities were recorded, most likely derived from rCPSF6wtAA.mCh fusion protein expression. 
 
3.2.3 HIV-1 Infection Causes CPSF6 Clustering in Nuclei of Infected Cells 
After confirming the expression of the rCPSF6wtAA.mCh fusion protein, by light microscopy and 




U874/4 rCPSF6wtAA.mCh cells, as it was reported for wild type CPSF6 (Peng et al., 2014). For this, 
U874/4 rCPSF6.mCh cells were infected with IN.eGFP labeled HIV-1 virus particles for 4 hours 
before fixation and immunolabeling for CPSF6. In infected cells, we were able to observe nuclear 
mCh clusters, exceeding the basal nuclear mCh signal in intensity, which was not observed in 
uninfected control cells. 
To characterize the observed rCPSF6wtAA.mCh clusters, we performed immunofluorescence 
labeling against CPSF6 in infected U874/4 rCPSF6wtAA.mCh cells. We found the mCh signal 
clusters in infected cells’ nuclei to efficiently colocalize with the fluorescence signal for CPSF6. We 




Figure 24: Colocalization of Nuclear rCPSF6wtAA.mCh Clusters with IN.eGFP and CPSF6 
Immunofluorescence Signal 
U874/4 rCPSF6wtAA.mCh cells were infected with IN.eGFP NL4-3 virus particles for 4 hours, fixed and 
immunostained for CPSF6. In the mch channel (mCh AF), a background signal and intense clusters are 
visible, colocalizing well with the CPSF6 immunofluorescence signal (CPSF6 IF), indicating that the 
observed mCh autofluorescence (mCh AF) truly represents rCPSF6wtAA.mCh molecules. The observed 
clusters colocalize with IN.eGFP signals, indicating that the CPSF6 clustering is being caused by viral 
particles. Single confocal z-slice, Leica SP2. 
 
3.2.4 The HIV-1 Surrogate Marker IN.eGFP Colocalizes Efficiently With CPSF6 
Clusters in the Nuclei of Infected Cells, While CA Signal Detection Varies 
To verify that mCh signal clusters are truly caused by and localized to subviral particles, we made 
use of a fluorescence surrogate marker, IN.eGFP. The integrase enzyme is thought to stay attached 
to the viral genome until vDNA integration into the host cell genome (Albanese et al., 2008). It has 




(~50%) colocalize with CA immunofluorescence signals. Here, we aimed to reproduce the 
colocalization of CA in rCPSF6wtAA.mCh clusters. For this, U874/4 wt and rCPSF6wtAA.mCh cells 
were infected with NL4-3 IN.eGPF virus preparation (as shown before in Figure 24) and 
additionally immunostained against CA. 
We found the vast majority (>90%) of nuclear IN.eGFP signals to colocalize with mCh cluster 
signals, letting us deduce that using rCPSF6wtAA.mCh as a surrogate marker does not (strongly) 
bias for a subpopulation of IN.eGFP positive subviral particles, but can be used to identify nuclear 
subviral particles in general. However, positions positive for rCPSF6wtAA.mCh clusters and 
IN.eGFP signals, were not found to colocalize with CA immunofluorescence signals under these 
conditions. As no colocalization was observed for the transduced, as well as for the parental U874/4 
cell line, we assume this not to be an artifact introduced by lentiviral transduction or puromycin 
selection. Not detecting any nuclear CA immunofluorescence signal, but only cytoplasmic ones, is 
in disagreement with U874/4 data obtained earlier in our lab (Peng et al., 2014). 
 
 
Figure 25: IN.eGFP-Positive Subviral Particles Colocalize With CA in the Cytoplasm But not in 
the Nuclei of Infected Cells 
rCPSF6wtAA.mCh (upper panel) and parental wildytpe (lower panel) U87
4/4 cells were infected with IN.eGFP 
labeled NL4-3 virus particles, fixed and immunostained. In both cell lines, it can be observed that 




arrow heads), whereas nuclear IN.eGFP signals are devoid of colocalizing CA staining signals (red arrow 
heads). IN.eGFP signals being nuclear or cytoplasmic was defined by colocalization with DAPI. In U874/4 
rCPSF6wtAA.mCh cells, nuclear IN.eGFP signals colocalize with intense rCPSF6wtAA.mCh cluster signals, 
as observed before (see Figure 24). Single confocal Z slices, Leica SP8. 
 
3.2.5 rCPSF6.mCh Clusters Colocalize With IN.eGFP, CA and EdU Signals 
To assess, whether the observed nuclear subviral particles can be considered productive 
preintegration complexes, we performed EdU click labeling experiments in U874/4 
rCPSF6wtAA.mCh cells to potentially visualize the presence of viral DNA. 1 hour before infection, 
cells were treated w/ or w/o aphidicolin (APC) to block synthesis of cellular nuclear DNA (APC 
does not impair viral and mitochondrial DNA synthesis). The thymidine analogue EdU was present 
throughout infection to become integrated into nascent DNA during reverse transcription. Infected 
cells were fixed and processed for EdU click labeling as described in Materials and Methods. LM 
images were acquired using the Leica SP8 microscope.  
We observed nuclear mCh clusters, colocalizing with IN.eGFP (~ 85%) and EdU click signal (> 
90%).Different from the experiment before (see Figure 25), in these samples, we were able to detect 
CA immunofluorescence signals colocalizing with nuclear rCPSF6wtAA.mCh clusters and IN.eGFP 
signals (colocalization ~ 80%). After click labeling in this experiment, the CA immunostaining 
appeared generally different: In comparison to Figure 25, the background in the click labeled 
samples is much more evenly distributed over the whole cell and does not appear reduced in the 
nucleus. In follow up experiments, we could only detect nuclear CA, when samples were 
extensively click labeled (for 30 minutes or more) or extracted o/n in 70% EtOH (experiments 
performed by Dr. Vojtech Zila).  
Detecting the viral hallmarks IN.eGFP, CA and viral DNA (identified by EdU signal) in 
rCPSF6wtAA.mCh clusters clearly shows that rCPSF6wtAA.mCh can be used as a reliable surrogate 






Figure 26: Confocal Fluorescence Microscopy of EdU-Treated, IN.eGFP-Labeled Virus 
Particles Infected U874/4 Cells Show PIC Colocalization With rCPSF6wtAA.mCh Cluster Signals 
U874/4 rCPSF6wtAA.mCh cells were infected with IN.eGFP labeled NL4-3 virus particles in the presence of 
EdU. Cells were fixed, EdU click labeled and immunostained against CA (CA IF). rCPSF6wtAA.mCh signal 
clusters colocalize with IN.eGFP (not shown), EdU signals and, under these circumstances, also with CA 
immunofluorescence signals. The two zoom-ins show that the CA signal was variable in intensity, but 
specifically colocalizing with the other signals. rCPSF6wtAA.mCh cluster signals therefore serve as a reliable 
surrogate marker for productive PIC. Single confocal z-slice, Leica SP8. 
 
3.2.6 Infectivity of wt and Transduced U874/4 Cells is Comparable 
We have observed before that nuclear mCh cluster signals colocalize with IN.eGFP and EdU, 
representing productive preintegration complexes. Such complexes are thought to lead to 
integration of vDNA into the host cell genome, further leading to expression of viral proteins.  
We did not assess so far, whether expression of the rCPSF6wtAA.mCh fusion protein might affect 
viral gene expression. Nuclear CPSF6 does only affect steps starting from nuclear entry on and 
therefore does not affect entry of viral DNA synthesis. Therefore, observed alterations in viral gene 
expression would hint towards an effect on nuclear entry or provirus integration, where CPSF6 has 
been shown to play major roles. 
To assess viral gene expression of infected cells, wt and rCPSF6wtAA.mCh U874/4 cells were 
infected in parallel with serial dilutions of NL4-3 wt virus preparations. At 4 hours after infection, 
the inoculum was removed and replaced by fresh medium with the entry inhibitor T20 to block 
second-round infections. The samples were fixed 2 days after infection and immunostained for CA. 




observed between wt and transduced U874/4 cells. Inoculating 0.125 µL virus preparation yielded 
7.3% infected cells for wt cells and 3.9% for transduced cells. Inoculating 0.5 µL, lead to ~16.5% 
infection in both cell lines. Inoculating 2 µL of virus particle preparation yielded 38.6% and 31.2% 
infected wt and transduced cells, respectively (images not shown). 
We conclude that neither lentiviral transduction and the associated rCPSF6wtAA.mCh expression, 
nor puromycin selection of transduced cells had major effects on virus infectivity, measured by CA 
expression. 
The same virus particle preparation has been used throughout all experiments. Since we seeded 
20,000 cells in this experiment, the virus particle titer for U874/4 cells can be calculated to ~ 6400 
infectious units per µL. 
 
 
Figure 27: Representative Wide Field Fluorescence Micrographs Used for Infectivity 
Quantification in U874/4 wt and rCPSF6wtAA.mCh Cells 
U874/4 wt (upper panel) and rCPSF6wtAA.mCh (lower panel) cells were infected with serial virus particle 
dilutions in parallel, fixed and immunostained for newly produced CA, which was used as marker of viral 
gene expression. Infectivity was quantified using FIJI’s particle analyzer, counting all cells (DAPI) and 
infected cells (CA). The volume of particle preparation and infectivity quantification are displayed at the 




wt and transduced cells, this was not observed for 0.5 µL virus preparation. Infection with 2 µL virus 
preparation lead to 38.6% (wt) and 31.2% (transduced) cells (not shown). Green: CA IF, blue: DAPI, red: 
rCPSF6wtAA.mCh. 
3.2.7 The Applied CLEM Protocol Yields Good Ultrastructural Preservation 
While developing protocols for fluorescence retention during EM sample preparation, we also 
needed to ensure that the ultrastructure can be preserved well by the used techniques. Therefore, we 
acquired several tomograms of non-ROI regions, where more subcellular ultrastructure would be 
visible, than in the nucleus.  
The reconstructed tilt-series clearly show that the ultrastructure is indeed very well retained (see 
Figure 28). Rough endoplasmic reticulum (rER) can be easily identified by the tubular appearance, 
decorated with electron-dense ribosomes. Distinct cytoskeletal filaments are well recognizable. 
Membranes always serve as a good indicator for successful EM sample preparation. We could see 
that e.g. the nuclear envelope can clearly be appreciated as 4 distinguished membrane leaflets 
(double-membrane with 2 leaflets, each. Figure 28 see NE). NPC were harder to appreciate in single 
computational slices, but recognizable in tomograms (Tomograms are included as supplementary 
data on the attached DVD). This well retained ultrastructure provides the basis for the recognition 





Figure 28: Electron Micrograph Showing Good Ultrastructure Preservation of CLEM Sample 
Sections 
U874/4 rCPSF6wtAA.mCh cells were infected for 4 hours with NL4-3 virus preparation before chemical 
fixation. The sample was high pressure frozen, freeze substituted and embedded in Lowicryl HM20. 250 nm 
thin sections were prepared. 
This micrograph is one extracted computational slice of a reconstructed tilt series tomogram. The tilt series 
was acquired in an area, where ROI have been detected to validate the good ultrastructural preservation. 
Fine ultrastructural details can be appreciated: Free ribosomes (Rib) as well as ribosomes at rough 
endoplasmic reticulum (rER). Lengthy cytoskeletal filaments are visible (Fil) in the cytoplasm (Cy). The 
nuclear envelope (NE) can partially be appreciated as a stack of 4 membrane leaflets (2 leaflets per 
membrane). At some positions, the NE is interrupted by nuclear pore complexes (NPC). An additional 







3.2.8 CLEM of U874/4 rCPSF6wtAA.mCh Cells 
So far, we were able to prove that HIV-1 infection causes rCPSF6wtAA.mCh clustering (see Figure 
25), which represent true rCPSF6wtAA.mCh signals (see Figure 24). The observed clusters 
colocalize with IN.eGFP efficiently and are positive for vDNA and CA under certain circumstances 
(see Figure 26). Therefore, these rCPSF6wtAA.mCh clusters represent productive preintegration 
complexes, leading to viral gene expression. In conclusion, nuclear viral preintegration complexes 
can be faithfully identified by rCPSF6wtAA.mCh cluster signals. 
To examine the ultrastructure of preintegration complexes, we aimed to perform correlative light 
and electron microscopy. The size of viral particles being ~120-140 in size (e.g. (Briggs, 2003)), the 
resolution limit of conventional (~300 nm) and superresolution (~20 nm) fluorescence microscopy 
would not allow to visualize potential subviral structures, but only the identification of regions of 
interest (ROIs), by e.g. nuclear CPSF6wtAA.mCh cluster signals. Visualizing these ROIs in EM 
would yield much higher resolution and information about the underlying putative ultrastructure 
and subcellular environment. 
3.2.8.1 CLEM Sample Preparation 
U874/4 rCPSF6wtAA.mCh cells were seeded on carbon-coated sapphire discs and infected with NL4-
3 virus particles for 4 hours. These BSL-3 samples were fixed for 90 minutes with aldehydes to 
meet the requirements for high pressure freezing, operated under BSL-1 conditions. PHEM buffer 
was used instead of the more commonly used PBS, as the latter is believed to extract more cellular 
content (Dr. Krijnse-Locker, personal communication) and might therefore deplete valuable 
information. Furthermore, PHEM, in contrast to PBS, does not contain phosphates, which form 
insoluble, electron-dense precipitates with uranyl. 
During high pressure freezing, the sample cells are vitrified under high pressure (~2100 bars) in a 
minimal timeframe of ~20 ms. The cooling rate (>15,000 K/s) does not allow crystal ice formation, 
which would otherwise result in cell membrane damage and suboptimal preservation of the cellular 
ultrastructure. In a process called freeze substitution (FS), the sample’s frozen water is first replaced 
by a polar solvent (here: acetone), which is in turn replaced by an electron transparent EM sample 
resin (here: Lowicryl methacrylate type HM20). HM20 will infiltrate the sample, polymerize and 
harden, and eventually allow thin sectioning of sample cells. Similar protocols have been applied 
successfully in the past for CLEM (e.g. (Kukulski et al., 2011)). 
250 nm thin sections were prepared from HM20-embedded samples and taken up on EM finder 
grids. This special kind of grids has alphanumerical coordinates at the grid bars. Imaging the same 




Additionally, we also used TetraSpeck Fiducials, which can be visualized in both, LM and EM. 
Using such fiducials allows to correlate light – and electron micrographs with high precision. The 
rCPSF6wtAA.mCh fluorescence signal can then be used to identify regions of interest (ROI) in the 
subcellular environment. 
We found the number of TetraSpeck Fiducials on a sample to strongly depend on the used diluent: 
When diluted in PHEM buffer instead of water, much more Fiducials were bound to the thin section 
(data not shown). Hoechst or DAPI was added to the fiducial dilution to easily identify nuclei and 
the focal plane during LM.  
It is critical to keep the thin section in water or buffer, as exposure to air reduces the retained 
fluorescence signal dramatically.  
To prevent sample bleaching, HM20 blocks were stored dark, in the sample processing holder, until 
sectioning and imaging. Excess material and sapphire discs were only removed directly before thin 
sectioning and subsequent LM imaging. Once a block has been processed, the fluorescence faded 
within one week. 
3.2.8.2 CLEM Micrograph Acquisition 
The sample grid was imaged in a sample holder, sandwiched between 2 cover glasses, to meet the 
LM objective’s (63x oil immersion) requirements. During fixation and FS processing, the 
fluorescence signal intensity is strongly reduced. Using the Leica SP8 microscope, 
rCPSF6wtAA.mCh in whole cells can well be visualized with ~3 % intense lasers, while thin 
sections require a laser power of 25-30% and 2-6 fold frame accumulation, to properly identify 
rCPSF6wtAA.mCh-positive nuclear clusters. 
After LM, the sample contrast was enhanced for EM, using heavy metals. Regions of interest, as 
identified in LM, were then imaged in an EM10 transmission electron microscope. Light and 
electron micrographs were correlated, allowing the identification of regions of interest within the 













Figure 29: Representative Example of Light – and Electron Micrograph Correlation 
U874/4 rCPSF6wtAA.mCh cells were infected with NL4-3 virus preparation on sapphire discs for 4 hours, 
followed by chemical fixation, vitrification, freeze substitution and embedding in HM20 resin. 250 nm thin 
sections were prepared and incubated with TetraSpeck Fiducials. 
Light micrographs in the mCh channel (upper left) and far-red channel (lower left) are shown in red and 
green respectively. TetraSpeck Fiducials are visible in both images (yellow arrowheads), while mCh nuclear 
background and cluster signals appear in the mCh channel only (red arrowhead). In a TEM image (upper 
right) of the corresponding region, Tetraspeck Fiducials can be identified by high electron-densities (yellow 
arrowheads). Correlating the light- and electron micrographs yield the correlated merge image (lower right), 
where the rCPSF6wtAA.mCh cluster signal can be visualized merged into the subnuclear environment. Scale 
bar is consistent among all images. Cy = Cytosol, Nu= Nucleus. 
 
Tilt series tomograms were then acquired, using a Tecnai F20 microscope, operated at 200 kV, at 
19,000 fold magnification. After 3D tomogram reconstruction, the exact positions of the 
CPSF6wtAA.mCh clusters were determined and the region visually screened for potential structures. 
We could indeed identify structures reminiscent of HIV-1 capsid structures that were modeled by 




We acquired tomograms at a total of 57 regions of interest, i.e. nuclear rCPSF6wtAA.mCh cluster 
signals. Only 3 tomograms did not reveal any apparent structure, another 3 tomograms showed 
aberrant fiducials that were recognized as false-positive signals. In these 3 instances, we found 
perfectly round structure of ~ 100 nm. We hypothesize that the greens fluorophores were not present 
at their surface. These particular fiducials were fluorescent in only the mCh channel and therefore 
mistaken as rCPSF6wtAA.mCh cluster signals. 
In the remaining 51 regions of interest, we could visualize a total of 63 conical structures. In 42 tomograms, 
we could only appreciate a single conical structure, while in 9 tomograms, >1 structures were apparent. It is 
worth mentioning that the number of regions of interest with multiple structures most likely is and 
underestimate, since potential additional structures may be physically cut off during sectioning. The 21 
conical structures that were not analyzed were either only contained partially, of too low contrast and / or 
could not be reliably segmented. We could also image 2 nuclear PIC in very close proximity to NPC, 
potentially still interacting with it (Figure 33). It appears as I those structures were caught just entering the 
nucleus. However, this cannot be judged do to the static nature of these data. 
The complete set of correlated positions is available in Figure 34 & Table 1. Cropped tomograms of all 









Figure 30: Representative Example of a High Magnification Correlation With High Precision   
Samples were processed as described for Figure 29. All images are extracted computational z slices of a 
reconstructed tilt series tomogram. Left panels are merged with the correlating fluorescence signals (red and 
green = yellow: TetraSpeck Fiducials, red only: CPSF6wtAA.mCh). The dashed red line outlines the 
CPSF6.mCh cluster signal for better visualization in the left and right panels. Panels A show the top 
computational section of the sample with the electron-dense TetraSpeck Fiducials. Panels B show the center 
of the sample containing a capsid-reminiscent structure within the CPSF6.mCh cluster signal. Panels C 
show zooms of the boxed regions in panels B. Panels D show 3 different extracted computational slices of the 
tomogram of the correlated nuclear PIC structure. A cone-shaped architecture is clearly recognizable. 
Structure 66 (as in Table 1 & Figure 31, panels C-E & Figure 34). 
Scale bars panels A-C: 200 nm, panel D: 100 nm.  
3.2.9 PIC Model Generation and Structure Evaluation 
The apparent nPIC structures were situated in the very electron-dense nucleus and were therefore 
not easily 3D rendered. In a similar project, according to Dr. Martin Schorb, the best way to 
generate models in 3D structure of such objects was by hand, taking into account the modeler’s 
possible bias. The modeling was done in 3DMOD by manually adding model points to electron-
dense (apparent dark points) positions at the surface of the observed apparent structures (see Figure 






Figure 31: Representative Examples of Modeling Nuclear PIC Structures 
U874/4 rCPSF6wtAA.mCh cells were infected for 4 hours with NL4-3 virus particles. Samples were chemically 
fixed, vitrified, freeze substituted and 250 nm thin sectioned. Nuclear PIC were identified by CPSF6.mCh 




Panels A and B show an example of 2 apparent nPIC structures in direct proximity, contained in a single 
region of interest. The structure numbers are 52 and 53 (see Figure 34 & Table 1). Panel C shows structure 
66 (same as in Figure 30, also see Table 1 & Figure 34). Panels X1 show the structure as observed in 
reconstructed tilt series, panels X2 additionally show the model points that were added by hand. 
All images are extracted computational slices from reconstructed tilt series tomograms. Scale bars: 150 nm 
(AB) & 100 nm (C-E). 
 
 
Figure 32: Exemplary Models with Major and Minor Axes and Exemplary z-Compression 
This image shows 3 different models of different orientations in the tomogram volume. Indicated structures 
according to Figure 34 & Table 1). 
Panel A shows the model (green points) of structure 4, where the major axis was almost parallel to z. During 
z compression, the minor axes (shown in red bars) were not affected. The apparent structure therefore 
appears almost ideally rotational symmetrically, as can be appreciated in the top (xy) view. Panel B shows 




minor axes (yellow vertical bars in xz and xy views) are of different length. This can also be appreciated in 
the top (yz) view, where the yellow ellipse indicates the imperfect rotational symmetry. The ratio of the minor 
axes was ~ 1 : 0.63. 
Panel C shows the model (red points) of structure 12. The major axis (yellow) and one minor axis (blue) 
were modeled by hand) and measured in 3DMOD and therefore are not identical to the measures in Table 1 
& Figure 34, measuring 116 nm in length and 69 nm in width.  




Figure 33: Nuclear PIC Structures in Close Proximity to Nuclear Pore Complexes 
U874/4 rCPSF6wtAA.mCh cells were infected for 4 hours with NL4-3 virus particles. Cells were chemically 
fixed, vitrified, freeze substituted and embedded in HM20 resin. The shown regions have been identified by 
CPSF6.mCh cluster signals in light microscopy and correlated with electron micrographs. 
The upper and lower panels show 1 PIC structure each in different computational planes of a reconstructed 
tomogram. Both are very close to -, or still partially within nuclear pore complexes. At those positions, the 
nuclear double membrane envelope, dividing the cytosol (Cy) from the nucleoplasm (Nu) is interrupted by 
NPC (left of the red marks). Obviously, the methodology does not allow to draw conclusions about the mode 
















Figure 34: Gallery of all Correlated rCPSF6wtAA.mCh Cluster Signals 
U874/4 rCPSF6wtAA.mCh cells were infected for 4 hours with NL4-3 virus particles. Samples were chemically 
fixed, vitrified, freeze substituted and 250 nm thin sectioned. Nuclear PICs were identified by CPSF6.mCh 
signal clusters in LM. 
Each single image shows the structure (if recognizable) of an rCPSF6wtAA.mCh cluster signal. The images 
were prepared with 3DMOD using the Slicer tool and attempted to align in xy. The structures are numbered 
(first number as identifier). Green labeled text indicates that the structure was analyzed and measured and 
includes the measurements in nm. Structures that were hard to recognize, not completely contained in the 
volume, not apparent or identified as aberrant fiducials are labeled in red and have not been analyzed and 
measured. The enumeration is consistent with Table 1. Occasional red and yellow crosses are added by 
3DMOD. Scale bars: 100 nm. 











Table 1: Complete Summary of all Correlated rCPSF6wtAA.mCh Cluster Signals 
This table summarizes relevant information about all correlated rCPSF6wtAA.mCh cluster signals. An overall 
summary can be found at the very end of the table. Column 1 (Correlated Position #) is consistent with the 
enumeration in Figure 34. ST: single tilt tomogram, DT: dual tilt tomogram, Axis A or B: tomogram was 
acquired in 2 tilts, but only the indicated axis (A or B) axis was used for modeling. ROI: regions of interest. 
Green labeled structures have been modeled and analyzed, red indicated correlated positions have not been 
















3.2.10 Intact Viral Particle Cores as Reference Structures, Analysis and 
Comparison of Models 
By visual examination, the apparent nPIC structures are intriguingly reminiscent of the HIV-1 capsid and 
could represent just this: Full HIV-1 capsids or remnants thereof. As a most direct reference structure, we 
next analyzed intact viral particles cores under largely identical conditions. Cells on sapphire discs were 
incubated with NL4-3 virus particles, of the same preparation as used for infection experiments, at 16°C 
overnight. At this temperature, neither virus-cell membrane fusion, nor endocytosis can take place (Doms 
and Moore, 2000; Frey et al., 1995; Weigel and Oka, 1981). Therefore, virus particles were bound to specific 
receptors (CD4) and nonspecific attachment factors at the cell surface (Wilen et al., 2012). HeLa TZM-bl 
cells were used in this experiment, as this cell line binds more virus particles at the cell surface, possibly due 
to higher expression levels of unspecific attachment factors, in comparison to U874/4 cells (see Figure 35). 
These samples were identically processed as the samples for CLEM of nuclear PICs described above, except 
for that no light microscopy was performed here. 
Virus particles at the cell surface were identified based on their unique morphology (compare Figure 1, 
Figure 36 & Figure 37). Tilt series tomograms were acquired and reconstructed, of a total of 22 viral cores 
of cell surface-bound viral particles. Their cores and envelopes were modeled in analogy to the nuclear PIC 
modeling (see Figure 36). A complete gallery (Figure 37) and Table 2 summarize the measurements of the 
cell surface-bound virus particles. The measurements of intact viral particles’ cores and the correlated nPIC 




Figure 35: Hela TZM-bl Cells Bind NL4-3 Virus Particles More Efficiently Than U874/4 Cells 
HeLa TZM-bl and U874/4 wt cells were incubated with NL4-3 virus particle preparation o/n at 16°C, not 




HeLa TZM-bl cells bind virus particles much more efficient than U874/4 cells. Since the cells in this 
experiment merely serve as a virus particle binding platform, we assume the choice of cell line negligible. 
Single confocal z-slice, Leica SP8.  
 
 
Figure 36: Exemplary Modeling of Cell Surface-Bound Virus Particle 
HeLa TZM-bl cells were incubated with virus particle preparations at 16°C before chemical fixation, high 
pressure freezing, freeze substitution and HM20 embedding. 250 nm thin sections were prepared and visually 
analyzed for bona-fide HIV-1 virus particles, which were then imaged by electron tilt series tomography. 
Panels A-C show 3 different extracted computational z slices from a reconstructed tilt series tomogram. The 
conical capsid is clearly recognizable. X2 panels are identical to X1 models, except for the addition of 
modeled points in X2. Those were added manually to the apparent edge of the structure. Scale bars: 100 nm. 









Figure 37: Gallery of all Analyzed Cell Surface-Bound Virus Particles 
Each single image a single cell surface-bound virus particle. The images were prepared with 3DMOD using 
the Slicer tool and attempted to align in xy. The structures are numbered (first number as identifier) and the 
measurements of length and width are indicated in nm. 
The enumeration is consistent with Table 2. Occasional red and yellow crosses are added by 3DMOD. Scale 
bars: 100 nm. 













Table 2: Complete Summary of all Analyzed Cell Surface-Bound Virus Particles 
This table summarizes the relevant information of all analyzed cell surface-bound virus particles. The 
enumeration is consistent with the one in Figure 37. The model dimensions indicate the length and width of a 
given core structure. The measurements are graphically represented in Figure 38. Images and cropped 





The model analysis was purely based on the created models, the actual tomograms were not further 
taken into account. This was done in collaboration with Dr. Martin Schorb (EMCF, EMBL, 
Heidelberg). For all data processing, we developed and applied MatLab scripts. As a conical 
structure was observed for the vast majority of structures (see Figure 34 & Table 2), an ellipsoid 
function was fit to the model as an approximation. The longest model axis was defined as the major 
axis. An ellipsoid function has 2 minor axes, which in the case of a rotational symmetry would be of 
equal length. In the observed models, a compression along the z axis was observed, as structures 
seemed flattened in z (or stretched in xy). A perfect rotational symmetry is never reached in 
biological samples, but, in the sense of lowest energy, fair to assume, and therefore used as an 
approximation. This means, the length of the minor axes, is assumed to be practically equal, not 
appearing so in the tomograms. In the case of the major axis being parallel to z, the minor axes 
would not differ from each other, unless the compression being so strong, an actual minor axis 




z. When the observed structure’s major axis is not parallel to z, comparing the 2 minor axes can be 
used as quantification for the compression and allows calculation of the correction factor. 
The overall compression was calculated and amounts ~89 % on average and in median (meaning 
the apparent, measured z thickness was compressed to 89% of the original thickness). To 
compensate for this, all tomograms and models were computationally stretched in z by a factor of ~ 
1.12 (=100/89). After compression correction, the major axis was plotted as length, and the minor 
axes average was plotted as width of the observed core-like nuclear structures, or viral particles’ 
cores (see Figure 38). Exemplary models and z compression are shown in Figure 32. 
For the reference structures (cores of cell surface-bound virus particles), instead of using minor axes 
to calculate the z compression, we used the viral envelope. Ideally, the envelope would have the 
shape of a perfect sphere, as this is energetically favorable. Therefore, the viral envelope was 
modeled and fit to a perfect sphere function. The tomograms were stretched in z until all 3 axes of 
the approximated ball were mostly equal. The cores were then analyzed as described above, by 
fitting an ellipsoid function and measuring the length and width. See all analyzed viral particles in 
Figure 37 & Table 2. Eventually, the apparent nuclear PIC structures (Table 1 & Figure 34) were 
compared to the reference cell surface-bound virus particle reference structures (Table 2 & Figure 
37) were compared (see Figure 38). 
PIC structures were 119 nm long and 55 nm wide, on average. The reference capsids from cell 
surface-bound virus particles, on the other hand, merely were measured 89 nm long and 40 nm 
wide, which is considerably smaller (see Figure 38). However, the structures appear very similar in 
shape. The ratio of width to length accounts to 0.45 and 0.49 for viral cores and nPIC structures, 
respectively. When compared to previously published cryo-ET data, viral cores have been measured 
119 nm in length and 60 nm in width, accounting to a width to length-ratio of 0.5 (Briggs, 2003; 







Figure 38: PIC Structure and Virus Particle Core Model Measurements 
The models created for nuclear PIC (left) and the virus particle cores as a reference (right) were analyzed 
and measured in length and width using custom MatLab scripts together with Dr. Martin Schorb. Every point 
represents one model, the box plots show the median (solid line) and the inner 2 quartiles (colored box), and 
the biggest and smallest measurements (upper and lower whisker, excluding outliers). Depicted below each 
box is the average measurement and standard deviation. 
 
 
3.3 rCPSF6wtAA.mCh Expression in Primary Human Macrophages 
We have successfully visualized the structure of nuclear preintegration complexes in U874/4 model 
cells. Since they are no natural target cells, they were engineered susceptible to HIV-1 infection by 
transducing CD4 and CXCR4. Also, it is an immortal cell line. Therefore, the observations we made 
can not necessarily be extrapolated to natural primary target cells. 
For this reason, we tried to express the rCPSF6wtAA.mCh cassette also in primary monocyte-
derived macrophages macrophages (MDM), derived from healthy blood donors, isolated and 
differentiated by technical assistant Anke-Mareil Heuser. Lentiviral transduction was to be omitted, 




not be clearly assigned to the infection or transduction. We therefore chose adeno-associated virus 
particles for gene-delivery. These have been shown before to successfully transduce primary human 
macrophages. Especially well performed the capsids AAV6 and AAVDJP2 (Dr. Kathleen Börner). 
We produced AAV particles in 293T cells, packaging the rCPSF6wtAA.mCh cassette and a double 
stranded vector encoding YFP as a positive control. Before harvesting, the cells were visually 
checked for fluorescence protein expression, which was clearly visible 2 days after proviral plasmid 
transfection. Yet, when we transduced primary MDM, we repeatedly could not detect any mCh 
fluorescence (see Figure 39). Neither one of the 2 tested capsids lead to detectable expression of the 
mCh fusion protein. Further experiments for CPSF6.mCh fusion protein expression in primary 
macrophages are being planned. 
 
 




AAV virus particles were produced in 293T cells, using the AAVDJP2 capsid to package the 
rCPSF6wtAA.mCh or YFP expression sequences. MDM were transduced with crude lysates and 1 week after 
transduction subjected to fluorescence microscopy, to check the transduction efficiency. 
Panel A and B show bright field and YFP fluorescence images, respectively. YFP expression can readily 
appreciated in B. Panel C  and D show bright field and mCh fluorescence images, respectively. In contrast to 





CPSF6 colocalizes as intense clusters with infectious nuclear preintegration complexes. We could 
clearly show that the surrogate marker rCPSF6wtAA.mCh, is very well suited to minimal invasively 
label these complexes. We could not detect any particular changes in terms of infectivity or cellular 
phenotype due to the expression of rCPSF6wtAA.mCh and/or the downregulation of the endogenous 
CPSF6.  
In CLEM experiments, we could clearly show that correlating rCPSF6wtAA.mCh clusters yields 
capsid-reminiscent structures. Finding these structures has implications for further HIV-1 research. 
Here, we want to discuss limitations and considerations concerning the employed technique and the 
obtained results. 
4.1 Implications of Using rCPSF6wtAA.mCh as a Surrogate Marker 
1) The rCPSF6wtAA.mCh expression is mediated by lentiviral transduction. Using a lentiviral 
transduction vector might lead to overlapping phenotypes when infecting with HIV-1 (a lentivirus) 
afterwards. In fact, during the first 2 weeks following lentiviral transduction, we could observe mCh 
signal clusters in cells without additional infection. During further passaging, this phenotype 
disappeared. This shows the importance of our colocalization studies, to prove, what the CPSF6 
fusion protein really detects (see chapter 3.2.3). In principle, rCPSF6wtAA.mCh cluster signals can 
be caused also by lentiviral vectors, or remnants thereof. In primary macrophages, CPSF6 cluster 
signals are observed several weeks after infection (David Bejarano, data not shown). 
 
2) CPSF6 is a key factor in integration site targeting (Lusic and Siliciano, 2017; Sowd et al., 2016). 
We could show that the rCPSF6wtAA.mCh fusion protein is functional in binding nuclear CA (see 
Figure 26). Whether the integration site targeting might be altered, due to the mCh fusion or CPSF6 
overexpression was not address. We could prove that the infectivity in U874/4 rCPSF6wtAA.mCh is 
not different from wildtype cells. If proviruses were to integrate differently in transduced cells, e.g. 
into loci with low gene expression, this would likely affect viral gene expression, and thereby the 
infectivity score. Analyzing this in detail would require deep integration site analysis. Since here we 
merely CPSF6 here as a surrogate marker for nPIC detection and did only analyze postentry events 
up to nuclear localization, it did not appear necessary to investigate viral integration sites. 
3) CPSF6 predominantly localizes to the nucleus. Therefore, using CPSF6 as an identifier marker 
also means that experiments were limited to only nuclear subviral structures, nuclear PIC. CPSF6 




358 (Lee et al., 2010), or human hCPSF6-375 (Hori et al., 2013)). Downregulation of the CPSF6 
nuclear import factor TNPO3 is reported to also localize full length endogenous CPSF6 to the 
cytoplasm (De Iaco et al., 2013; Gallay et al., 1997; Logue et al., 2011).  
In both cases, the cytoplasmic CPSF6 is able to interact with theoretically all CA-positive subviral 
particles.  
CPSF6-positive nuclear PIC are considered likely to contribute to infection, since they contain viral 
DNA and already overcame the nuclear envelope barrier by translocating into the nucleus. 
We do not know about the correlation of CPSF6 colocalization and infectivity of subviral particles 
in the cytoplasm, when expressing truncated CPSF6 versions or knocking down TNPO3. CPSF6 
has been shown to bind CA hexamers with high affinity (Price et al., 2014). Therefore, specific 
binding to productively infectious RTC seems unlikely. The expectation is rather that cytoplasmic 
CPSF6 would bind any CA-positive complex. Furthermore, CPSF6 relocation to the cytoplasm 
would be highly artificial. hCPSF6-375 and mCPSF6-358 have been reported to negatively affect 
reverse transcription and to restrict viral infection (Ning et al., 2018). 
 
For these reasons, using CPSF6 as a surrogate marker for cytoplasmic complexes does not appear to 
be an obvious alternative. Visualization of viral DNA, as we have tried in this study, would still be 
the superior method of choice. 
 
4.1.1 rCPSF6wtAA.mCh Colocalizes with Immunofluorescence Staining against 
CPSF6 
The functionality of fusion proteins can be greatly influenced by different factors: Position and size 
of the fusion tag / protein (Hanne et al., 2016b; Sakin et al., 2016) as well as choice of linkers 
between the actual protein and the fluorescence protein (Chen et al., 2013). 
In first experiments, we were able to show that the autofluorescence signal of rCPSF6wtAA.mCh 
colocalizes efficiently with the CPSF6 immunofluorescence signal (see Figure 24). 
Fusion proteins often degrade to some extent in cells. Those degradation products could potentially 
form clusters similar to the expected infection phenotype. However, mCh cluster signals were only 
detected in infected cells, uninfected cells only displayed basic nuclear CPSF6wtAA.mCh signals. 





4.1.2 IN.eGFP-Labeled Subviral Particles Colocalize With rCPSF6wtAA.mCh 
Clusters 
To further prove that the observed rCPSF6wtAA.mCh cluster phenotype is caused by HIV subviral 
particles, we next infected transduced cells with IN.eGFP-containing virus particles. IN.eGFP 
fusion proteins have been demonstrated as efficient virus particle labels (Albanese et al., 2008). The 
IN protein must stay attached to the viral genome until integration and is therefore used as a 
subviral particle marker throughout infection events until integration is completed. The nucleus is 
no perfect sphere but is of unregular shape and contains invaginations. It is therefore not always 
clear whether an IN.eGFP positive structure is really in the nucleus, at the nuclear envelope or close 
but yet cytoplasmic. All IN.eGFP signals we considered truly nuclear were colocalizing with mCh 
cluster signals. On the other hand, we were also able to detect few rCPSF6wtAA.mCh cluster signals 
that did not show any IN.eGFP signal. This can be explained by the labeling efficiency of IN.eGFP. 
The Vpr.IN.eGFP and a proviral plasmid were cotransfected for virus particle production, a 100% 
labeling efficiency is never reached, as there will always be cells transfected with the proviral 
plasmid only. As described before, the observed phenotype was only observed in nuclei of infected - 
but not in uninfected cells. In combination, these results indicate an efficient labeling of subviral 
particles by the rCPSF6wtAA.mCh fusion protein in the nuclei of infected cells. The possibility to 
bias our CLEM experiments to subviral particles colocalizing with mCh cluster signals can be 
mostly ruled out, as we could not observe nuclear IN.eGFP signals without mCh cluster signal 
colocalization. 
 
4.1.3 Ambiguous Results on Nuclear CA Signal Detection 
To show the presence of further viral hallmarks, we performed immunofluorescence staining 
experiments to detect the CA protein and Cu-catalyzed click labeling to detect EdU signals (i.e. 
nascent viral DNA). I was never able to detect a CA signal in the nuclei of infected cells, neither in 
wt nor in transduced cells. Cytoplasmic subviral particles, on the other hand, always yielded easily 
detectable CA immunofluorescence signals. This is dissonant with the experimental outcome of 
David Bejarano and Dr. Ke Peng in our laboratory. Both have been able to detect nuclear CA 
signals in their experiments, also without Cu-catalyzed click labeling (observing pronounced 
variation in CA signal intensity and colocalization efficiency). This is still under investigation. 
Protocols have been compared and reagents shared. So far, the cause for this dissonance could not 
be pinpointed. We are still working on the reproducibility. As we are trying to shed light on the CA 




CA signals efficiently in nuclei of infected cells ((Francis et al., 2016), KewalRamani, personal 
communication). We have assumed that our polyclonal rabbit serum against CA used in our studies 
should be superior in detection, compared to the monoclonal antibodies we ordered. 
In single experiment, however, when EdU click labeling was performed, I was able to detect CA 
signals colocalizing with both, IN.eGFP and rCPSF6wtAA.mCh signal clusters. As shown in the 
experiments aiming to combine EdU click labeling and electron microscopy, the labeled cells 
appeared heavily extracted, which was dependent on the duration of the click reaction mixture 
incubation (see Figure 21). When the click reaction mixture was applied for 60 minutes, nuclear CA 
signals were readily visualized, whereas 20 minutes labeling did not suffice. We hypothesize that 
extraction of nuclear (and cellular) content during the click procedure seems a prerequisite for the 
accessibility of nuclear CA. Potentially, CPSF6 and other nuclear host factors shield the nuclear CA 
from antibody detection. CA detection in the cytoplasm worked efficiently under all tested 
conditions, as assessed by colocalization with IN.eGFP. Experiments in monocyte-derived 
macrophages, performed by Dr. Vojtech Zila in our laboratory, showed that also incubation with 
70% EtOH o/n, which is also known to extract cellular contents, enabled nuclear CA detection. 
 
To show the presence of further viral hallmarks, we performed immunofluorescence staining 
experiments to detect the CA protein and Cu-catalyzed click labeling to detect EdU signals (i.e. 
nascent viral DNA). CA signals could not reliably be detected inside nuclei of infected wt or 
rCPSF6wtAA.mCherry transduced cells. Cytoplasmic subviral particles, on the other hand, showed 
easily detectable CA immunofluorescence signals. While it was thought for many years that capsid 
uncoating happens in the cytoplasm because most labs could not detect any nuclear CA signals 
(which appears to be strongly cell line-dependent), some more recent studies indicate that CA can 
still be detected inside nuclei ((Francis et al., 2016; Peng et al., 2014), David Bejarano, 
unpublished). This apparent contradiction might be explained by the fact that staining and fixation 
conditions, as well as the choice of antibody appear to be a major factor influencing the ability to 
detect nuclear CA. Similar to extraction, allowing nuclear CA detection, different fixatives are also 
thought to affect the accessibility of epitopes. e.g. GA fixation, leading to crosslinking, would be 
expected to stabilize the shielding factors around the CA-positive structure, thereby lowering the 
antibody accessibility and hampering CA detection. 
We do not fully understand the circumstances of the dissonance in nuclear immunofluorescence CA 





4.1.4 rCPSF6wtAA.mCh Overexpression Does not (Greatly) Affect Postentry 
Events 
Overexpression of the rCPSF6wtAA.mCh fusion protein and constant puromycin selection could 
influence postentry events and cause artifacts. To assess this, infectious virus particle preparation 
was titrated on wt and rCPSF6wtAA.mCh U874/4 cells, and the percentage of CA expressing cells 
was scored 48 hours after infection. We did not observe differences in the percentage of CA-
expressing cells, which could not be accounted for by biological variation. It therefore seems to us 
that there was no apparent influence on postentry events by the overexpression of the fusion protein 
(unless positive and negative effects compensate for each other). Whether there are effects on 
downstream processes, such as integration site specificity, virus particle budding, release, etc., we 
did no assess, since the purpose of the fusion protein expression was to label incoming nuclear PIC. 
Overall, we did not observe any negative aspects by transduction or puromycin treatment. Based on 
this basic readout, we assume our surrogate marker system to not cause considerable artifacts in the 
processes we analyze (i.e. postentry events). 
 
4.2 Structure Visualization and Processing 
4.2.1 Modeling 
DNA, lipids and phosphorylated proteins are rich in phosphate groups, which are stained with 
uranyl (acetate) during EM sample preparations. The nuclear chromatin (histones and DNA) 
therefore appear electron dense in electron micrographs. In the already electron dense nuclear 
background, it was not sure, whether it would be possible to detect potential nuclear subviral 
structures. This concern held true: It was very challenging to visually identify these structures in 
electron tomograms, even for experienced EM users. The nuclear electron-dense background 
impeded the recognition and modeling of intranuclear structures. This was additionally complicated 
by considerable variations in contrast, which varied not only between different samples and block, 
but even within the same section. Lastly, the apparent structures were oriented in random angles in 
the section volume, which plays a certain role during tomography acquisition, considering the 
missing wedge, a part of the tilt-series volume, which is comparably low in information 
(Baumeister et al., 1999). 
 Under these circumstances, we could not identify distinct traits or characteristics that would allow 




Martin Schorb (EMCF EMBL Heidelberg), we agreed to model the structures by hand (Figure 31 & 
Figure 36). 
This was unproblematic for obvious apparent structures (see Figure 31), but likewise challenging in 
samples with low contrast, or when the observed structure was close to the top or bottom of the thin 
section and only parts thereof contained. The ends of the structures (top and bottom edges, narrow 
ends) were challenging to model, as there is a very limited amount of protein and therefore also low 
information and contrast. 
To circumvent the introduction of a bias during by-hand modeling, it would be favorable to render 
the apparent structures in 3D computationally. At the moment, Dr. Vibor Laketa (IDIP, CIID 
Heidelberg) is assessing the possibility to 3D render the apparent structures using the ILASTIK 
software (Sommer et al., 2011). The software is based on pattern recognition and requires minimal 
input to define background and structure. First results look promising and will provide additional 
support for the study at hand. Once the automated segmentation works well and a workflow is set 
up to measure the single structures, the measurements can be compared with the models prepared 
by hand, to yield more reliable numbers. Exact measurements will be interesting and helpful for 
comparing PIC structures to the viral particle core reference. Yet, the repeated visualization of the 
apparent structures is a highly interesting result by itself. This will be elaborated on in chapter 4.2.4. 
 
4.2.2 Tetraspeck Fiducials Allow High Precision Correlation 
The only surrogate marker we were using in this study is the signal of the rCPSF6wtAA.mCh fusion 
protein, which is mainly localized to the nucleus. While the cytoplasm provides a number of 
subcellular structures, useful for correlation between lower and higher magnification (such as 
mitochondria or vesicles), the nucleus is, except for nucleoli, rather uniformly electron-dense. 
Nuclei of U874/4 are rather big (~10 µm in diameter), while the area acquired in a tomogram is 
comparably small (~ 4 µm²). In first attempts, we were fitting the nuclear background 
rCPSF6wtAA.mCh fluorescence signal by hand into the ultrastructurally identified nucleus. This was 
already good enough to eventually identify first apparent PIC structures but was not reliable 
enough. Addition of TetraSpeck Fiducials allowed much higher correlation precision, by enabling 
an almost exact overlay of light and electron micrographs. In general, resins tend to shrink when 
exposed to the electron microscope’s electron beam. When imaging close to an end of a section or 
close to a hole (due to incomplete resin infiltration), the EM thin section can shrink to some extent 
unidirectionally. In that case, scaling and rotating the light micrograph does not yield a perfect 




TetraSpeck Fiducials in respect to the shrinking area, also nonlinear transformation reaches its 
limitations.  
Yet, the correlation worked stably well, so that the vast majority of apparent structures was 
identified within a distance of <300 nm from the center of the fluorescence cluster signal (see 
Figure 29).  
In some cases, the mCh cluster signal was correlated to autofluorescent dust particles or aberrant 
fiducials, fluorescing in the mCh channel only. These were considered false-positives and neglected 
for further analysis. As dust particles were readily identified as false negatives, no tomograms were 
acquired at these positions. Aberrant fiducials were only apparent after tilt-series reconstruction and 
are therefore included in the full list of tomograms (Table 1 & Figure 34). 
 
4.2.3 Loss of Fluorescence Intensity During EM Sample Preparation Poses a Risk 
for Introducing Bias 
Unless performing cryo-CLEM, the mCh fluorescence is greatly reduced during sample 
preparation. mCh signal clusters as well as the nuclear mCh background were considerably reduced 
(estimate >90%) in fluorescence intensity. The selection of regions of interest starts with a visual 
examination through the microscope’s oculars. Areas that seemed promising, were then imaged by 
confocal laser scanning. Imaging the complete sample grid would be too time-consuming and 
potentially lead to drying of the thin section. 
This procedure involves the possibility of introducing a bias depending on the fluorescence 
intensity: Structures of low mCh cluster intensities are more likely to be overseen than such of 
strong signal intensities. Automated imaging and ROI identification of the whole sample could rule 
out this potential bias. However, thin sections mostly are not perfectly flat on the sample grid. The 
samples overall fluorescence could be bleached already during automated focal plane identification. 
For this study, we considered this potential bias acceptable, while keeping the implications on the 
apparent structures in mind (discussed below). The acquisition of the Leica SP8 microscope in early 
2016 was a huge advancement. Its HyD detectors are much more sensitive, than the formerly used 
Leica SP2’s PMT. A laser power of ~25% and 2-8 times frame accumulation was still necessary, 





4.2.4 Apparent Structures 
So far, the only truly convincing electron micrographs of intracellular HIV-1 subviral particles was 
presented in (Jun et al., 2011). They made use of the CA E45A mutation, which renders the capsid 
more stable (Forshey et al., 2002). Cone-shaped structures could only be detected for hyperstable 
mutant -, but not for wildtype intracellular subviral particles. The study at hand is the first to report 
a structure associated with wildtype HIV-1 nuclear PIC. 
 
The apparent structures were clearly cone-shaped, reminiscent of the HIV-1 capsid. Whether the 
modeled electron-densities represent a particular CA (i.e. a capsid lattice), cannot be judged due to 
the limited resolution, resulting from extensive sample processing (chemical fixation, vitrification, 
infiltration and embedding). Higher resolution imaging by e.g. cryo- ET and data processing such as 
subtomogram-averaging might in the future resolve this question. The detection of nuclear CA 
signal colocalizing with the surrogate marker rCPSF6wtAA.mCh supports the possibility that the 
apparent structure indeed is particular capsid CA. On the other hand, in earlier experiments, CA 
protein was only detected in ~50% of nPIC in U874/4 cells (David Bejarano, unpublished data). As 
discussed above, nuclear CA immunofluorescence detection is still being investigated. Assumed our 
hypothesis of restricted antigen accessibility held true, the 50% colocalization of CA with nuclear 
PIC might simply be an underestimate. 
Genetically engineered CA, incorporating noncanonical aminoacids by Amber-suppression, which 
can be click labeled with small fluorophores instead of fusion proteins, could offer an alternative for 
CA immunofluorescence detection in infected cells. 
Eventually, it can’t be ruled out that the observed electron-densities represent a coat of host factors, 
such as CPSF6. 
 
To get a better understanding of what these structures represent, we acquired tomograms of intact 
virus particles bound to the cell surface as a reference under almost identical conditions (Figure 37, 
Figure 36 & Table 2). Cores of these cell surface-bound virus particles were modeled analogous to 
the apparent nuclear PIC structures. We observed a considerable difference in size (cell surface-
bound particle cores are ~30% smaller), in comparison to the PIC structures (Figure 38). Their 
shapes, on the other hand, are very similar. For the time being, we can’t provide an experimentally 
based explanation for this observation. However, there are some possible explanations. 
 
1) As mentioned before, embedding resins tend to shrink when exposed to the electron beam. The 




particles. Nuclear PIC are surrounded by high amounts of host factors, histones and dense 
chromatin, while surface-bound particles are mainly surrounded by plain HM20 resin, also meaning 
that the absolute amount of HM20 resin is much higher for extracellular particles. It appears logic 
that more resin can shrink to a higher extent. Furthermore, the chromatin and proteins in the PIC’s 
direct environment might serve as an interlinked scaffold, potentially being much sturdier and less 
likely to shrink. This assumption could be experimentally addressed and validated by vitrifying 
cells with surface-bound viral particles in protein solution, which might then prevent shrinkage of 
the particles. Alternatively, Env- virus particles can be pseudotyped with VSV-G, bound to the cell 
surface and incubated additionally with NH4Cl. Virus particles would then be taken up into 
endosomes, but could not fuse due to the NH4Cl. Trapped in endosomes, the virus particles would 
then be surrounded by scaffolding material, proteins and membranes that might also prevent 
shrinkage. The latter option was tried in one experiment but did not yield enough data for a 
comparison. Searching for – and identifying virus particles in endosomes throughout the cytoplasm 
is much more laborious and less efficient. Also, we were concerned about using NH4Cl, as it alters 
the pH value in endosomes and might thereby also influence the structural appearance, thereby 
potentially being a worse reference than surface-bound virus particles. 
 
2) As described above, the applied method requires extensive processing of samples, and does 
therefore not allow to retain the apparent structure to a degree, where substructures (hexamers, 
pentamers) could be observed, or computationally rendered using subtomogram-averaging. We 
assume the apparent structure to represent capsid, or remnants thereof, due to the similarity in 
shape. The observation of the strong CPSF6 clustering at nuclear PIC could also mean that the 
incoming capsid serves as a scaffold for CPSF6, which multimerizes around it. This would create an 
additional protein layer that would increase the dimensions of the apparent structure. On the other 
hand, the additional CPSF6 layer would then rather be assumed to increase the length and width of 
the apparent structure by a given, consistent layer thickness. As an example: The length of viral 
particles’ cores and nuclear PIC structures in average measures ~89 nm and 117 nm, respectively. If 
an additional CPSF6 (or also other factors) coat would account for the observed difference in size, 
one would assume a coat thickness of 14 nm at the wide and the narrow end, each (89 nm + 2*14 
nm = 119 nm). Assuming the coat thickness would be of consistent thicknes all over the structure, 
one would also add 28 nm to the width of the viral particle cores (40 nm). This would add up to a 





Therefore, if an additional protein coat would account for the difference in size measurements, it 
would have to be considerably thinner (~ 50%) at the sides, in comparison to the ends. The first 
explanation therefore appears more likely. 
 
3) A size distribution is always observed in particle preparations, just like in our model 
measurements (see Figure 38). Theoretically, structures that are bigger to begin with, might recruit 
more host factors, or only those might be big enough for reverse transcription within the capsid 
shelter, while smaller capsid might break due to DNA-synthesis induced increase of pressure frim 
within. As a consequence, bigger structures would be less likely to be sensed and degraded by 
cellular sensors, and more likely to complete reverse transcription and to enter the nucleus. This 
hypothesis would then argue against considerable resin shrinkage, but for a big capsid being a 
quality feature for successful infection. 
 
To prove these speculations right or wrong, higher resolution imaging is crucial. Ideally, chemical 
fixation would be circumvented by using S1 or S2 lentiviruses as models, which should behave 
similarly in early postentry events. Samples would then be directly vitrified and imaged in cryo-
EM. Hexamers and pentamers could potentially be visualized and counted, in nuclear structures as 
well as in surface-bound particles’ cores, and directly compared. These experiments are currently in 
planning. 
 
4.2.5 When do Virus Particles Uncoat? 
The visualization of the apparent structure in the nuclei of infected cells raises the question: When 
do virus particles uncoat, when such a structure is apparent within the nucleus? Recent studies from 
other groups also indicated the presence of (residual) CA in infected cells’ nuclei (Francis et al., 
2016; Mamede and Hope, 2016). However, the authors interpret these observations as gradual 
uncoating in the cytoplasm and at the NPC, which leaves nuclear PIC with only small amounts of 
CA. As discussed above, the CA staining procedure is not trivial and needs close examination. 
Nuclear CA detection strongly suggests that the fate of capsid bulk analysis assay cannot reflect the 
behavior of infectious subviral infectious particles (Yang et al., 2014). The presence of CA can also 
not directly be extrapolated towards the retention of the capsid as such in its structure. The results 
presented in this study, however, strongly suggest this capsid structure retention. This has 
considerable implications towards the understanding of how these big macromolecule complexes 




4.2.6 How do These Structures Enter the Nucleus? 
While most of the regions of interest contained single apparent nuclear PIC structures, we also 
found several apparent structures in close proximity (a few 100 nm) underlying single ROIs (see 
Table 1). Considering the size of the apparent structure and the nucleus itself, and the number of 
nuclear pores, the likelihood of several structures being found within a few hundred nanomenters 
seems small. Subviral particles do not freely diffuse in the cytoplasm but are actively transported 
towards the nucleus (Balasubramaniam and Freed, 2011). At this stage, clustering of structures 
could already be primed. Following transport into the nucleus, these already close structures could 
be imported through nuclear pores in close temporal and spatial proximity and be coclustered with 
host factors, such as CPSF6. Furthermore, taking into account the vast number of Nups, there might 
be heterogeneity among nuclear pore complexes (Kane et al., 2018). Different subsets might be 
involved in export and import of different cargo (macro)molecules. Assuming there were 
specialized NPC for HIV-1 subviral particle import, this would be another promoter for structure 
clustering: If the number of available entrance points was limited, the likelihood of structures 
appearing in close proximity would dramatically increase. A combination of both hypotheses is also 
possible. To date, we have no experimental data supporting either idea. However, live imaging of 
rCPSF6wtAA.mCh enrichment at subviral particles upon nuclear entry, as well as minimally 
invasive click labeling might in the future allow to shed light onto this question: Are there 
specialized points of entry at the nuclear envelope? Do subviral particles cluster during early 
postentry? A publication from 2002 already showed clustering of subviral particles at the MTOC 
(microtubule organizing center), which might be one starting point for RTC/PIC clustering at one 
location (McDonald et al., 2002). 
Irrespective of potentially specialized NPC and clustering of structures, it is questionable how 
exactly these structures enter the nucleus, considering their comparably huge size. 
(Macro)molecules bigger than 5- 9 nm in diameter cannot diffuse over the nuclear envelope but 
require active transport (Kabachinski and Schwartz, 2015; Knockenhauer and Schwartz, 2016; 
Paine et al., 1975). Hepatitis B Virus Particle cores are reported to be transported into the nuclear 
basket of nuclear pore complexes, having a diameter of ~40 nm (Kann et al., 1999; Panté and Kann, 
2002). This is very close to measurements of the central pore in NPC, measuring ~ 41 nm. The 
overall NPC has a diameter of ~ 82 nm. The space in between is taken in by nuclear pore proteins 
(Nup). Further to the inside, mostly intrinsically unstructured protein chains leave an opening of 27 
nm which is then mostly unoccupied (Bui et al., 2013). Our lab’s current working model suggests 
the CA-Nup153 interaction to be competed for by nuclear CPSF6, allowing the Nup153 to bind 




structure into the nucleoplasm (David Bejarano, manuscript under review). Yet, fitting a structure of 
~60 nm in width through the nuclear pore with a central channel of 41 nm is hard to envision.  It is 
reported that during viral DNA synthesis, some stress force is incurred to the viral core, which 
might lead to leakage of the fluid core-content marker (Mamede and Hope, 2016; Rankovic et al., 
2017). One can imagine that the sturdy nascent DNA cracks the core from within, potentially 
leading to a partial loss of structural CA. Similar observation have been made for HBV, where 
reverse transcribed DNA from within provides energy to “explode” the viral core structure. 
Rupturing the capsid might lead to a partial loss of structural CA elements. This, in turn, most likely 
lead to an increase in HIV-1 capsid structure flexibility. Would this allow “squeezing” the capsid(-
remnant) through the comparably narrow NPC? As described above, only higher resolution imaging 
of the apparent structure in combination with computational modeling of forces and flexibility 
would possibly provide the answer to this question. We were lucky to image 2 structures that seem 
to be just entering the nucleoplasm through NPC. Conclusions to the mode of entry with this 
resolution and sample size cannot be drawn. Rendering the structure itself against the also electron-
dense nuclear envelope is too error-prone. 
 
4.2.7 Comparison to Cytoplasmic RTC 
Additional to the nuclear PIC, we also wanted to visualize cytoplasmic structures. Since not only 
the structure itself, but also the surrounding environment can provide further insght into the HIV-1 
structure and trafficking. The main interest thereby lies within the truly productive RTC, 
recognizable by the presence of viral DNA. 
 
Due to the great loss of fluorescence signals upon sample preparation, the retention of EdU signals, 
which were very weak to begin with, during sample preparation was highly unlikely. Instead, we 
tried to click label EdU on embedded sections or to visualize EdU signals retained during EM 
sample preparation. While this worked well for nuclear EdU signals, it was not successful for 
mtDNA (see Figure 12 & Figure 13), which we used as a model for viral DNA (to circumvent BSL3 
work during protocol establishment). The EdU accessibility upon embedding cells in solid resins 
was most likely considerably reduced. Nuclear EdU signals were already weak, compared to cells 
prepared directly for light microscopy. 
 
The Tokuyasu technique is known for high accessibility of antigens and was therefore thought to 




retainability of virus particle cores. While only a subset of cores was clearly recognizable, those 
retained ones might represent the productively infectious ones. 
Efficient EdU click labeling was only possible without GA (see Figure 17). Henceforth, PFA only 
was used to fix samples before EdU click labeling, reducing the likelihood to retain viral cores. 
Labeling extranuclear mtDNA with EdU on Tokuyasu sections was cumbersome and eventually not 
reproducible. Furthermore, Cu-catalyzed EdU click labeling was incurring considerable damage to 
the observed ultrastructure, rendering electron micrographs mostly useless (see Figure 21). To limit 
ultrastructural extraction of sections, we considered embedding into solid resins more promising. 
 
Epon-embedded samples usually yield superb contrast and ultrastructural core preservation. GA 
plays an important role to retain the capsid structure. Since we experienced before that click 
labeling does not work efficiently after GA fixation, we first identified the necessary duration for 
proper EdU click labeling of extranuclear mtDNA. Even though we could prove that cells were 
stressed by - but survived the toxic Cu-treatment, already short times of labeling strongly reduced 
the ultrastructure quality in electron micrographs. Since cells were surviving the live labeling, we 
considered the ultrastructural damage and extraction to be due to the combination of dehydration 
and resin-embedding. We therefore assessed cryo-CLEM as a possible alternative. Live labeled 
cells were pelleted and vitrified, followed by cryo-sectioning. Although we could eventually 
visualize cell sections, we did not retain any fluorescence signal (see Figure 22).  
After all, visualizing viral DNA by EdU incorporation and subsequent labeling was not compatible 
with any of the electron microscopy methods we tried. 
We could pinpoint the Cu to negatively influence the ultrastructure. However, Cu can so far not be 
omitted in this labeling technique. Cu-independent techniques for viral DNA labeling are at the 
moment developed but are to date not at the stage of application. While direct effects of copper on 
cells are known (e.g. reactive oxygen species-formation), how exactly the ultrastructure is harmed, 
remains elusive. Copper can cause DNA fragmentation, which might be more easily extracted 
during sample preparation. Yet, this study is the first one directly showing the negative influence of 
Cu-catalyzed click labeling on the ultrastructural preservation of samples. 
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5 Summary and Outlook 
In conclusion, we were able to create a stable U874/4 cell line by lentiviral expression of 
rCPSF6wtAA.mCh, where the expressed fusion protein shows very similar behavior to the wildtype 
cell line’s endogenous CPSF6. rCPSF6wtAA.mCh cluster signals can be detected upon HIV-1 
infection. We prove these clusters to colocalize with CA, IN.eGFP and viral DNA. Whether these 
exact nuclear PICs would have led to productive infection cannot be reliably stated. Yet, these 
structures seem highly relevant, as they have the potential to be productively infectious, judged by 
the presence of viral DNA, and successfully entered the nucleus. 
The observed clusters therefore represent truly infectious subviral particles, or nPIC. On this basis, 
we were further able to develop a protocol allowing us to retain the cluster signal fluorescence 
phenotype throughout EM sample preparation. Light - and electron micrographs were successfully 
correlated, defining the regions of interest within the ultrastructure. By electron tomography, we 
could gain high resolution electron tomograms, in which core-reminiscent structures were observed. 
As a reference structure, we imaged intact virus particles bound to the cell surface. Both, viral cores 
and nPIC structures were modeled by hand and compared. The nPIC structure and the reference are 
very similar in shape, but quite different in size. What the observed structure is composed of and 
how it enters the nucleus can only be hypothesized about. The used method in this study does not 
allow defining the composition or integrity of the apparent PIC structure. 
 
In the future, it will be interesting to shed light onto the pathway of entry and the composition and 
integrity of the observed structure. The U874/4 rCPSF6wtAA.mCh cell line might serve as a good 
starting point for time-lapse imaging of subviral particles while entering the nucleus. Will there be 
distinct access points for subviral particles, potentially due to subsets of specialized nuclear pore 
complexes? Would this explain the clustering of apparent structures in close proximity within the 
nuclei of infected cells? 
Cryo-EM would most likely allow gathering higher resolution images of the observed structures. 
Applying subtomogram-averaging on such cryo-EM data would then allow pinpointing the 
molecular nature of the apparent structure. Is it made up of CA protein, or do we observe a 
structural CPSF6 coat, or some other protein, yet to be defined? Thorsten Müller (Ph.D. student, AG 
Kräusslich) developed an HIV-1 NL4-3 derivative, capable of reverse transcription, but impaired in 
integrating proviruses into the host cell genome. This construct is considered BSL1 (also due to a 
partial tat deletion) and could therefore be used in experiments without chemical fixation, which is 
known to negatively affect the ultrastructural preservation. U874/4 rCPSF6wtAA.mCh cells were 
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infected with the described construct and directly vitrified. It is in progress to perform cryo-CLEM 
on these samples, i.e. cryo-LM to identify the regions of interest, followed by cryo-ET. With much 
higher effort, but the circumvention of artifact-introduction by cryo-thin sectioning, we are also 
assessing to grow, infect and freeze sample cells on grids and use focused ion beam milling to 
create lamella in cell nuclei. These nuclei lamella would then be fed into the cryo-LM workflow to 
identify regions of interest within the lamella. Technical advances in cryo-light microscopy may 
reduce the necessary effort for this tremendously: Sample cells could be imaged before lamella 
milling and the position of ROI predefined, making the lamella milling not random, but targeted. 
Cryo-electron tomograms acquired this way would yield much higher resolution of the observed 
structure. It would allow to define the integrity and organization, and therefore potentially also 
allow conclusions towards the mode of entry into the nucleus via NPC. 
The study at hand is limited to the glioblastoma cell line U874/4, which is widely used in HIV-1 
research but yet represents an artificial system. Following up on the acquired data in this study, the 
next logical step will be to expand these experiments to primary cells, i.e. macrophages, being much 
more relevant for the HIV-1 biology. We did try to transduce the rCPSF6wtAA.mCh fusion protein 
into macrophages by adeno-associated virus gene delivery or microinjection, but so far did not 
succeed in expressing it. To not introduce artificial phenotypes, we omitted the use of lentiviral 
transduction vectors. 
The study at hand employs precisely correlated light - and electron microscopy. We could visualize 
nuclear PIC structures repeatedly. This opens the question of how this big structure enters the 
nucleus. We can now be sure that (complete) uncoating does not take place soon after infection, but 
only after nuclear entry of PIC. The developed method allows to analyze single, infectious particles, 
and thereby overcomes the limitations of bulk analyses. It will be interesting to see in the future, 
whether this new insight can be reproduced in more relevant primary cells, and if it lays the 
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